NCT_ID,OVERALL_STATUS,COMPLETION_DATE_TYPE,PHASE,STUDY_TYPE,NUMBER_OF_ARMS,NUMBER_OF_GROUPS,ENROLLMENT_TYPE,ENROLLMENT,GENDER,MINIMUM_AGE,MAXIMUM_AGE,TARGET_DURATION,CONDITION,CONDITION_ID,INTERVENTION_TYPE,SERIOUS_TOTAL_SUB_AT_RISK,SERIOUS_TOTAL_SUB_AFFECTED,OTHER_TOTAL_SUB_AT_RISK,OTHER_TOTAL_SUB_AFFECTED,MIN_P_VALUE,MAX_P_VALUE,NUMBER_OF_COUNTRIES,NUMBER_OF_FACILITIES,NUMBER_OF_INVESTIGATORS,PARTFLOW_COUNT_STARTED,PARTFLOW_COUNT_NOT_COMPLETED,PARTFLOW_COUNT_COMPLETED,INTERVENTION_MODEL,OBSERVATION_MODEL,MASKING,TIME_PERSPECTIVE,PRIMARY_PURPOSE,ENDPOINT_CLASSIFICATION
NCT00000378,Completed,Actual,Phase 4,Interventional,2,,Actual,110,Both,60 Years,95 Years,,133,2194019288,Drug,,,110,6,0.05,0.05,1,1,,1636,477,1159,Parallel Assignment,,Double Blind,,Treatment,Efficacy Study
NCT00001656,Completed,Actual,Phase 4,Interventional,2,,Actual,25,Both,7 Years,18 Years,,90,2188822896,Drug,25,3,25,25,0.04,0.96,1,1,,1636,477,1159,Parallel Assignment,,Double Blind,,Treatment,Efficacy Study
NCT00004859,Terminated,Actual,Phase 3,Interventional,2,,Actual,589,Both,18 Years,0,,271,2288821332,Drug,577,471,577,567,0.99,0.99,2,236,,1636,477,1159,Parallel Assignment,,Open Label,,Treatment,Efficacy Study
NCT00001959,Completed,Actual,Phase 2,Interventional,1,,Actual,21,Both,18 Years,0,,181,1694915496,Drug,21,3,21,16,0.16,0.01,1,1,,1636,477,1159,Single Group Assignment,,Open Label,,Treatment,Safety/Efficacy Study
NCT00003222,Completed,,Phase 2,Interventional,2,,Actual,40,Both,18 Years,79 Years,,288,3256609041,Biological,37,5,37,36,0.004,0.13,1,1,,1636,477,1159,Parallel Assignment,,Open Label,,Treatment,Efficacy Study
NCT00003389,"Active, not recruiting",Anticipated,Phase 3,Interventional,2,,Actual,854,Both,16 Years,0,,276,1696214900,Drug,836,756,836,835,0.32,0.86,3,539,,1636,477,1159,Parallel Assignment,,Open Label,,Treatment,Safety/Efficacy Study
NCT00004054,Completed,Actual,Phase 3,Interventional,2,,Actual,397,Male,18 Years,0,,378,3123971163,Drug,397,76,397,387,0.81,0.81,2,54,,1636,477,1159,Parallel Assignment,,Open Label,,Treatment,
NCT00004228,"Active, not recruiting",,Phase 3,Interventional,7,,Actual,393,Both,1 Years,30 Years,,276,1696214900,Drug,374,51,374,370,0.63,0.97,5,176,,1636,477,1159,Parallel Assignment,,Open Label,,Treatment,Efficacy Study
NCT00004412,Completed,Actual,Phase 2,Interventional,3,,Actual,23,Both,16 Years,60 Years,,414,1996600544,Other,26,14,26,1,0.05,0.05,1,4,,1636,477,1159,Parallel Assignment,,Open Label,,Treatment,Efficacy Study
NCT00004732,"Active, not recruiting",Anticipated,Phase 3,Interventional,2,,Actual,2502,Both,18 Years,0,,49,2002447835,Procedure,2502,614,2502,425,,,2,116,,1636,477,1159,Parallel Assignment,,Open Label,,Prevention,
NCT00004888,Completed,Actual,Phase 2,Interventional,2,,Actual,84,Female,18 Years,0,,388,380129175,Drug,89,89,89,89,,,1,1,,1636,477,1159,Parallel Assignment,,Open Label,,Treatment,Safety/Efficacy Study
NCT00014911,Completed,Actual,Phase 2,Interventional,1,,Actual,36,Both,18 Years,65 Years,,141,3520364124,Procedure,36,17,36,36,,,5,,,1636,477,1159,Single Group Assignment,,Open Label,,Treatment,
NCT00004978,Completed,Actual,Phase 3,Interventional,2,,Actual,4150,Both,18 Years,0,,199,2889579184,Drug,4111,849,4111,225,0.003,0.97,25,248,,1636,477,1159,Parallel Assignment,,Open Label,,Treatment,Efficacy Study
NCT00004980,Completed,Actual,Phase 2,Interventional,2,,Actual,50,Both,18 Years,60 Years,,405,2119471695,Device,,,50,19,0.001,0.01,1,1,,1636,477,1159,Parallel Assignment,,Double Blind,,Treatment,Efficacy Study
NCT00005947,Completed,Actual,Phase 3,Interventional,2,,Actual,127,Male,18 Years,0,,378,3123971163,Biological,127,30,127,126,0.01,0.052,1,,,1636,477,1159,,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00006011,Completed,,Phase 3,Interventional,2,,Actual,659,Female,0,0,,163,727628577,Biological,539,31,539,537,,,1,,,1636,477,1159,Parallel Assignment,,Double Blind,,Treatment,Efficacy Study
NCT00006170,Completed,Actual,Phase 4,Interventional,2,,Actual,349,Female,18 Years,65 Years,,443,179058863,Drug,,,,,0.001,0.001,1,,,1636,477,1159,Factorial Assignment,,Double Blind,,Treatment,Efficacy Study
NCT00006721,"Active, not recruiting",,Phase 3,Interventional,3,,Actual,571,Both,18 Years,0,,276,1696214900,Drug,539,19,539,536,0.08,0.11,1,,,1636,477,1159,Parallel Assignment,,Open Label,,Treatment,Safety/Efficacy Study
NCT00010803,Completed,Actual,Phase 3,Interventional,2,,Actual,3069,Both,75 Years,0,,129,1878179548,Drug,3069,1961,3069,2973,0.65,0.98,1,,,1636,477,1159,Parallel Assignment,,Double Blind,,Prevention,Safety/Efficacy Study
NCT00013611,Completed,Actual,Phase 3,Interventional,2,,Actual,1695,Both,18 Years,0,,198,3223041150,Drug,1695,389,,,0.1,0.001,1,,,1636,477,1159,Parallel Assignment,,Open Label,,Treatment,Safety/Efficacy Study
NCT00023309,Completed,Actual,Phase 2,Interventional,2,,Actual,41,Both,18 Years,0,,196,2835725183,Drug,,,,,0.0049,0.0913,1,,,1636,477,1159,Parallel Assignment,,Open Label,,Treatment,Safety/Efficacy Study
NCT00035932,Completed,Actual,Phase 3,Interventional,3,,Actual,571,Both,16 Years,0,,199,2889579184,Drug,347,63,347,300,0.05,0.05,1,,,1636,477,1159,Parallel Assignment,,Open Label,,Treatment,Safety/Efficacy Study
NCT00023452,Completed,Actual,Phase 3,Interventional,2,,Actual,8595,Both,2 Years,0,,446,3377839684,Drug,7799,162,7799,474,0.02,0.001,4,,,1636,477,1159,Parallel Assignment,,Open Label,,Prevention,Safety/Efficacy Study
NCT00024102,Completed,Actual,Phase 3,Interventional,2,,Actual,633,Female,65 Years,0,,73,1499605101,Drug,611,58,611,568,0.02,0.001,3,,,1636,477,1159,Parallel Assignment,,Open Label,,Treatment,Safety/Efficacy Study
NCT00027378,Completed,Actual,Phase 2,Interventional,2,,Actual,50,Both,15 Years,20 Years,,17,1576823743,Drug,,,,,0.05,0.05,1,,,1636,477,1159,Parallel Assignment,,Double Blind,,Treatment,Efficacy Study
NCT00028093,Completed,Actual,Phase 4,Interventional,2,,Actual,50,Both,18 Years,0,,95,587377062,Drug,,,,,0.54,0.54,1,,,1636,477,1159,Parallel Assignment,,Open Label,,Treatment,Safety/Efficacy Study
NCT00029146,Terminated,Actual,Phase 3,Interventional,2,,Actual,700,Both,18 Years,85 Years,,433,678611600,Procedure,195,16,,,0.33,0.85,1,,,1636,477,1159,Parallel Assignment,,Single Blind,,Treatment,Efficacy Study
NCT00032591,Completed,Actual,Phase 4,Interventional,2,,Actual,2922,Both,18 Years,0,,51,734346743,Procedure,2922,497,2922,731,0.14,0.14,2,,,1636,477,1159,Parallel Assignment,,Open Label,,Treatment,Safety/Efficacy Study
NCT00033657,Completed,Actual,Phase 2,Interventional,2,,Actual,97,Both,18 Years,0,,170,458737369,Drug,151,97,151,148,0.48,0.48,1,,,1636,477,1159,Parallel Assignment,,Open Label,,Treatment,Efficacy Study
NCT00035815,Completed,Actual,Phase 3,Interventional,2,,Actual,330,Both,18 Years,80 Years,,27,40759743,Drug,330,30,330,195,0.321,0.529,2,,,1636,477,1159,Parallel Assignment,,Double Blind,,Treatment,Efficacy Study
NCT00047008,"Active, not recruiting",,Phase 3,Interventional,2,,Actual,743,Both,18 Years,0,,204,599964,Procedure,721,572,721,716,0.18,0.18,1,,,1636,477,1159,Parallel Assignment,,Open Label,,Treatment,
NCT00036270,Completed,Actual,Phase 3,Interventional,2,,Actual,9779,Female,50 Years,0,,74,3128271172,Drug,9666,1615,9666,7118,0.118,0.951,1,,,1636,477,1159,Parallel Assignment,,Open Label,,Treatment,Safety/Efficacy Study
NCT00037830,Completed,Actual,Phase 2,Interventional,3,,Actual,94,Both,39 Years,85 Years,,345,3641618925,Drug,94,3,94,77,0.0003,0.05,1,,,1636,477,1159,Crossover Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00039741,Completed,Actual,Phase 2/Phase 3,Interventional,4,,Actual,266,Both,0,18 Years,,199,2889579184,Drug,263,48,,,0.26,0.56,2,,,1636,477,1159,Factorial Assignment,,Open Label,,Treatment,Efficacy Study
NCT00040742,Completed,Actual,Phase 2/Phase 3,Interventional,4,,Actual,745,Both,18 Years,0,,311,1233291739,Other,745,1,745,23,0.017,0.738,1,,,1636,477,1159,Parallel Assignment,,Double Blind,,Prevention,Efficacy Study
NCT00040937,"Active, not recruiting",Anticipated,Phase 2,Interventional,1,,Actual,147,Both,18 Years,65 Years,,303,1739707547,Biological,321,8,321,319,,,1,,,1636,477,1159,Single Group Assignment,,Open Label,,Treatment,Efficacy Study
NCT00042991,Completed,Actual,Phase 1/Phase 2,Interventional,1,,Actual,69,Both,3 Years,21 Years,,452,3777646411,Other,69,30,69,69,0.0546,0.0001,1,,,1636,477,1159,Single Group Assignment,,Open Label,,Treatment,Safety/Efficacy Study
NCT00044044,Completed,Actual,Phase 2,Interventional,5,,Actual,356,Both,18 Years,64 Years,,405,2119471695,Drug,353,28,353,259,0.05,0.05,1,,,1636,477,1159,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00046475,Completed,Actual,Phase 4,Interventional,,,Actual,140,Both,18 Years,0,,235,1347978219,Drug,625,11,625,122,0.001,0.001,1,,,1636,477,1159,Crossover Assignment,,Double-Blind,,Treatment,Safety/Efficacy Study
NCT00046891,Completed,Actual,Phase 3,Interventional,2,,Actual,226,Female,18 Years,0,,73,1499605101,Drug,205,7,205,183,0.84,0.84,1,,,1636,477,1159,,,Double-Blind,,Supportive Care,
NCT00054847,Completed,Actual,N/A,Interventional,2,,Actual,733,Both,0,0,,83,2867382159,Procedure,733,330,733,313,0.61,0.99,1,,,1636,477,1159,Parallel Assignment,,Single Blind,,Treatment,Bio-equivalence Study
NCT00047385,Completed,Actual,Phase 3,Interventional,2,,Actual,53454,Both,55 Years,74 Years,,271,2288821332,Device,53454,2,,,0.004,0.02,1,,,1636,477,1159,Parallel Assignment,,Open Label,,Screening,
NCT00047463,Completed,Actual,Phase 2,Interventional,2,,Actual,35,Both,18 Years,0,,167,2963929165,Device,,,35,7,0.26,0.26,1,,,1636,477,1159,Parallel Assignment,,Double Blind,,Treatment,Safety Study
NCT00048542,Completed,Actual,Phase 3,Interventional,8,,Actual,171,Both,4 Years,17 Years,,42,2261255864,Biological,367,45,367,285,0.002,0.156,8,,,1636,477,1159,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00048997,Completed,,Phase 3,Interventional,2,,Actual,356,Both,18 Years,0,,271,2288821332,Radiation,163,5,163,83,0.2853,0.2853,1,,,1636,477,1159,Parallel Assignment,,Open Label,,Treatment,
NCT00049530,"Active, not recruiting",Anticipated,Phase 2,Interventional,1,,Actual,32,Both,18 Years,0,,288,3256609041,Biological,32,13,32,31,0.001,0.001,1,,,1636,477,1159,Single Group Assignment,,Open Label,,Treatment,
NCT00050089,Completed,Actual,N/A,Interventional,4,,Actual,368,Both,18 Years,0,,0,3058073368,Other,339,214,,,0.49,0.92,2,,,1636,477,1159,Factorial Assignment,,Open Label,,Treatment,Efficacy Study
NCT00050778,Completed,Actual,Phase 2,Interventional,3,,Actual,334,Both,18 Years,50 Years,,305,3529108695,Biological,539,155,539,538,0.0001,0.0001,5,,,1636,477,1159,Parallel Assignment,,Single Blind,,Treatment,Safety/Efficacy Study
NCT00051558,Completed,Actual,Phase 3,Interventional,2,,Actual,428,Both,21 Years,0,,337,2339607719,Drug,,134,,367,0.002,0.001,6,,,1636,477,1159,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00053703,Completed,Actual,Phase 4,Interventional,3,,Actual,116,Both,8 Years,19 Years,,405,2119471695,Drug,116,8,116,97,0.05,0.05,1,,,1636,477,1159,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00060944,Completed,Actual,Phase 2,Interventional,2,,Actual,271,Both,18 Years,0,,259,1049890625,Drug,260,89,260,257,0.0302,0.192,8,,,1636,477,1159,Parallel Assignment,,Open Label,,Treatment,Safety/Efficacy Study
NCT00055237,Completed,Actual,Phase 2,Interventional,2,,Actual,19,Both,18 Years,0,,251,622266319,Biological,19,4,19,19,,,1,,,1636,477,1159,Single Group Assignment,,Open Label,,Treatment,Safety/Efficacy Study
NCT00056472,Completed,Actual,Phase 3,Interventional,2,,Actual,259,Both,18 Years,0,,281,2438250757,Drug,259,12,259,74,0.02,0.001,2,,,1636,477,1159,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00056498,Completed,Actual,Phase 4,Interventional,2,,Actual,65,Both,18 Years,65 Years,,405,2119471695,Drug,65,3,,,0.05,0.05,1,,,1636,477,1159,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00056862,Completed,Actual,Phase 4,Interventional,2,,Actual,58,Both,18 Years,0,,222,1420832983,Drug,57,3,57,3,0.002,0.2,1,,,1636,477,1159,Parallel Assignment,,Open Label,,Treatment,Safety/Efficacy Study
NCT00057577,Completed,Actual,Phase 4,Interventional,2,,Actual,452,Both,18 Years,0,,133,2194019288,Behavioral,452,141,,,0.01,0.038,1,,,1636,477,1159,Parallel Assignment,,Single Blind,,Prevention,Efficacy Study
NCT00058019,Completed,Actual,Phase 2,Interventional,1,,Actual,51,Both,18 Years,0,,28,3991674064,Drug,51,11,51,48,0.022,1,1,,,1636,477,1159,Single Group Assignment,,Open Label,,Treatment,Safety/Efficacy Study
NCT00059215,Completed,Actual,Phase 2,Interventional,4,,Actual,905,Both,18 Years,75 Years,,84,3416315868,Drug,904,66,904,691,0.26,1,2,,,1636,477,1159,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00059332,Completed,Actual,Phase 3,Interventional,2,,Actual,1700,Both,40 Years,95 Years,,87,550104849,Drug,1700,861,1700,660,0.12,0.95,1,,,1636,477,1159,Parallel Assignment,,Double Blind,,Treatment,Efficacy Study
NCT00060008,Terminated,Actual,N/A,Interventional,1,,Actual,18,Both,0,25 Years,,316,635999104,Radiation,,,,,0.016,0.016,1,,,1636,477,1159,Single Group Assignment,,Open Label,,Diagnostic,
NCT00065468,Completed,Actual,Phase 3,Interventional,3,,Actual,626,Both,18 Years,0,,81,1588592340,Drug,616,303,616,610,0.0011,0.0001,25,,,1636,477,1159,Parallel Assignment,,Open Label,,Treatment,Efficacy Study
NCT00061633,Completed,Actual,Phase 2,Interventional,2,,Actual,169,Both,18 Years,0,,1,321984546,Drug,167,12,167,96,0.5289,0.5289,1,,,1636,477,1159,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00062010,Completed,Actual,Phase 2,Interventional,1,,Actual,37,Both,18 Years,0,,271,2288821332,Drug,34,21,34,33,,,1,,,1636,477,1159,Single Group Assignment,,Open Label,,Treatment,Safety/Efficacy Study
NCT00062764,Completed,Actual,Phase 2,Interventional,1,,Actual,18,Both,18 Years,0,,220,1949604403,Drug,18,0,18,14,0.004,0.004,1,,,1636,477,1159,Single Group Assignment,,Open Label,,Treatment,Safety/Efficacy Study
NCT00063622,Completed,Actual,Phase 3,Interventional,3,,Actual,247,Both,18 Years,0,,266,2597930394,Drug,247,19,247,127,0.001,0.001,1,,,1636,477,1159,Parallel Assignment,,Double Blind,,Treatment,Efficacy Study
NCT00064350,Completed,Actual,Phase 2,Interventional,3,,Actual,342,Both,18 Years,0,,271,2288821332,Drug,463,173,463,429,0.005,0.12,1,,,1636,477,1159,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00064662,Completed,Actual,Phase 2/Phase 3,Interventional,2,,Actual,655,Female,21 Years,0,,454,3722636346,Procedure,655,74,655,362,0.01,0.001,1,,,1636,477,1159,Parallel Assignment,,Open Label,,Treatment,Efficacy Study
NCT00064701,Completed,Actual,Phase 3,Interventional,3,,Actual,668,Both,12 Years,0,,256,3993050794,Drug,638,428,638,628,,,3,,,1636,477,1159,Parallel Assignment,,Open Label,,Treatment,Safety/Efficacy Study
NCT00064844,Completed,Actual,Phase 4,Interventional,2,,Actual,96,Both,18 Years,0,,418,2521044459,Behavioral,,,96,8,0.01,0.01,1,,,1636,477,1159,Parallel Assignment,,Double Blind,,Treatment,Efficacy Study
NCT00065442,Completed,Actual,Phase 3,Interventional,2,,Actual,512,Male,18 Years,0,,378,3123971163,Biological,506,122,506,496,0.023,0.628,2,,,1636,477,1159,Parallel Assignment,,Double Blind,,Treatment,Efficacy Study
NCT00065507,Completed,Actual,Phase 3,Interventional,2,,Actual,195,Both,16 Years,0,,221,3320253692,Drug,191,129,191,153,0.0193,0.0001,17,,,1636,477,1159,Parallel Assignment,,Open Label,,Treatment,Safety/Efficacy Study
NCT00069784,Completed,Actual,Phase 3,Interventional,4,,Actual,12537,Both,50 Years,0,,142,765036385,Drug,12504,535,,,0.2692,0.6273,40,,,1636,477,1159,Factorial Assignment,,Open Label,,Treatment,Efficacy Study
NCT00066066,Completed,Actual,Phase 2,Interventional,3,,Actual,146,Both,20 Years,0,,353,3595900821,Drug,146,9,146,36,0.05,0.05,1,,,1636,477,1159,Parallel Assignment,,Double Blind,,Treatment,Efficacy Study
NCT00066963,Completed,Actual,Phase 3,Interventional,3,,Actual,376,Both,6 Months,36 Months,,132,387858106,Device,,,280,1,0.001,0.001,1,,,1636,477,1159,Parallel Assignment,,Double Blind,,Prevention,Efficacy Study
NCT00067236,Completed,Actual,Phase 2,Interventional,2,,Actual,253,Both,18 Years,80 Years,,212,2224452751,Drug,253,142,253,248,0.4239,0.4239,3,,,1636,477,1159,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00068107,Completed,Actual,Phase 2,Interventional,1,,Actual,13,Male,0,0,,174,3582084673,Drug,13,10,13,13,0.01,0.01,1,,,1636,477,1159,Single Group Assignment,,Open Label,,Treatment,Safety/Efficacy Study
NCT00068770,Terminated,Actual,Phase 2,Interventional,2,,Actual,35,Both,18 Years,0,,72,660508271,Radiation,,,35,35,0.11,0.82,1,,,1636,477,1159,Parallel Assignment,,Open Label,,Treatment,Safety/Efficacy Study
NCT00068822,Completed,Actual,Phase 3,Interventional,2,,Actual,131,Both,50 Years,0,,423,2635962032,Device,129,2,,,0.13,0.83,1,,,1636,477,1159,Crossover Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00069160,Completed,Actual,Phase 2,Interventional,2,,Actual,48,Both,18 Years,0,,272,3968936251,Drug,48,14,48,48,0.05,0.05,1,,,1636,477,1159,Single Group Assignment,,Open Label,,Treatment,Pharmacokinetics Study
NCT00069641,Completed,Actual,Phase 2/Phase 3,Interventional,3,,Actual,96,Male,5 Years,25 Years,,301,2453006443,Biological,96,26,96,96,0.0049,0.0049,4,,,1636,477,1159,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00073021,Completed,Actual,Phase 3,Interventional,2,,Actual,386,Both,18 Years,75 Years,,450,675069312,Drug,268,5,386,153,0.0357,0.0001,3,,,1636,477,1159,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00069823,Completed,Actual,Phase 3,Interventional,2,,Actual,403,Both,18 Years,0,,48,2527395224,Drug,402,26,,,0.04,0.87,1,,,1636,477,1159,Parallel Assignment,,Double Blind,,Treatment,Efficacy Study
NCT00071032,Completed,Actual,Phase 3,Interventional,2,,Actual,2016,Both,50 Years,0,,29,1185043251,Biological,2016,142,,,,,1,,,1636,477,1159,Parallel Assignment,,Single Blind,,Treatment,Safety/Efficacy Study
NCT00071110,Completed,Actual,Phase 2,Interventional,2,,Actual,57,Both,18 Years,80 Years,,133,2194019288,Procedure,,,57,48,0.09,0.32,1,,,1636,477,1159,Parallel Assignment,,Single Blind,,Treatment,Safety/Efficacy Study
NCT00071487,Completed,Actual,Phase 2,Interventional,4,,Actual,449,Both,18 Years,65 Years,,273,2811241671,Drug,794,109,794,727,0.0882,0.9705,2,,,1636,477,1159,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00071799,Completed,Actual,Phase 3,Interventional,2,,Actual,358,Both,18 Years,0,,307,1004845582,Drug,340,226,340,324,0.0001,0.0001,15,,,1636,477,1159,Parallel Assignment,,Open Label,,,Safety/Efficacy Study
NCT00071812,Completed,Actual,Phase 2,Interventional,4,,Actual,283,Both,18 Years,65 Years,,44,1506984474,Drug,520,47,520,364,0.0051,0.9769,1,,,1636,477,1159,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00071890,Completed,Actual,Phase 2,Interventional,2,,Actual,148,Both,18 Years,0,,199,2889579184,Drug,,,,,0.025,0.069,2,,,1636,477,1159,Parallel Assignment,,Open Label,,Treatment,Efficacy Study
NCT00071981,"Active, not recruiting",Anticipated,Phase 2,Interventional,4,,Actual,175,Both,18 Years,0,,288,3256609041,Biological,167,25,167,125,0.532,0.001,1,,,1636,477,1159,Parallel Assignment,,Open Label,,Treatment,Efficacy Study
NCT00073008,Terminated,Actual,Phase 2,Interventional,1,,Actual,131,Both,18 Years,0,,324,3756632883,Drug,131,32,131,127,,,2,,,1636,477,1159,Single Group Assignment,,Open Label,,Treatment,Safety/Efficacy Study
NCT00073307,Completed,Actual,Phase 3,Interventional,2,,Actual,903,Both,18 Years,0,,81,1588592340,Drug,1570,633,1570,1378,0.0287,0.000001,19,,,1636,477,1159,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00077974,Completed,Actual,Phase 2,Interventional,1,,Actual,106,Both,18 Years,0,,81,1588592340,Drug,106,46,106,106,,,1,,,1636,477,1159,Single Group Assignment,,Open Label,,Treatment,Safety/Efficacy Study
NCT00074412,Completed,Actual,Phase 3,Interventional,2,,Actual,2026,Both,0,0,,199,2889579184,Drug,1519,293,1519,1232,0.049,0.805,4,,,1636,477,1159,Parallel Assignment,,Double Blind,,Prevention,Safety/Efficacy Study
NCT00074984,Completed,Actual,Phase 4,Interventional,2,,Actual,82,Both,16 Years,0,,174,3582084673,Biological,164,60,164,160,0.0577,0.5261,6,,,1636,477,1159,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00075218,Completed,Actual,Phase 3,Interventional,2,,Actual,361,Both,18 Years,0,,185,2448023912,Drug,,232,,587,0.004,0.001,11,,,1636,477,1159,Crossover Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00075270,Completed,Actual,Phase 3,Interventional,2,,Actual,580,Female,18 Years,0,,313,1776861857,Drug,579,166,579,565,0.094,0.142,25,,,1636,477,1159,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00075946,"Active, not recruiting",Anticipated,Phase 3,Interventional,2,,Actual,545,Both,18 Years,0,,276,1696214900,Biological,846,38,846,55,0.0002,0.33,1,,,1636,477,1159,Parallel Assignment,,Open Label,,Treatment,Efficacy Study
NCT00076024,Completed,Actual,Phase 1/Phase 2,Interventional,2,,Actual,174,Female,18 Years,0,,74,3128271172,Drug,189,74,189,185,0.038,0.156,8,,,1636,477,1159,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00076804,Terminated,Actual,Phase 2,Interventional,2,,Actual,274,Both,18 Years,0,,199,2889579184,Behavioral,274,48,274,160,0.14,0.89,1,,,1636,477,1159,Parallel Assignment,,Open Label,,Treatment,Efficacy Study
NCT00077675,Completed,Actual,Phase 2,Interventional,2,,Actual,201,Both,18 Years,0,,241,1933240641,Drug,195,10,195,110,0.5318,0.5318,1,,,1636,477,1159,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00080912,Completed,Actual,Phase 3,Interventional,2,,Actual,850,Both,18 Years,0,,296,1868624750,Radiation,850,1,,,0.03,0.03,1,,,1636,477,1159,Parallel Assignment,,Open Label,,Treatment,
NCT00078286,Completed,Actual,Phase 2/Phase 3,Interventional,2,,Actual,469,Both,45 Years,0,,214,1697312720,Drug,469,120,469,45,0.78,0.89,1,,,1636,477,1159,Parallel Assignment,,Double Blind,,Treatment,Efficacy Study
NCT00078403,Completed,Actual,Phase 2,Interventional,3,,Actual,338,Both,18 Years,0,,199,2889579184,Drug,255,45,255,250,0.58,0.58,2,,,1636,477,1159,Parallel Assignment,,Open Label,,Treatment,Efficacy Study
NCT00078559,Completed,Actual,Phase 1/Phase 2,Interventional,1,,Actual,10,Both,18 Years,65 Years,,256,3993050794,Drug,10,5,10,10,,,1,,,1636,477,1159,Single Group Assignment,,Open Label,,Treatment,Safety/Efficacy Study
NCT00078715,Completed,Actual,Phase 2,Interventional,2,,Actual,11,Both,18 Years,65 Years,,134,2416318511,Drug,,,12,2,0.527,0.527,1,,,1636,477,1159,Crossover Assignment,,Double Blind,,,Efficacy Study
NCT00078949,"Active, not recruiting",Anticipated,Phase 3,Interventional,4,,Actual,619,Both,16 Years,65 Years,,276,1696214900,Biological,834,86,834,768,0.005,0.55,3,,,1636,477,1159,Parallel Assignment,,Open Label,,Treatment,
NCT00079001,Completed,Actual,Phase 3,Interventional,2,,Actual,645,Male,18 Years,0,,296,1868624750,Drug,618,121,618,535,0.22,0.385,2,,,1636,477,1159,Parallel Assignment,,Double Blind,,Treatment,Efficacy Study
NCT00079040,Completed,Actual,Phase 2,Interventional,1,,Actual,65,Both,18 Years,0,,173,1454481731,Drug,64,49,64,63,,,1,,,1636,477,1159,Single Group Assignment,,Open Label,,Treatment,Safety/Efficacy Study
NCT00080119,Terminated,Actual,Phase 2/Phase 3,Interventional,4,,Actual,1354,Both,91 Days,120 Days,,198,3223041150,Drug,1351,140,1351,1253,0.43,0.93,2,,,1636,477,1159,Parallel Assignment,,Double Blind,,Prevention,Efficacy Study
NCT00080301,Completed,Actual,Phase 3,Interventional,2,,Actual,752,Female,18 Years,0,,73,1499605101,Drug,737,278,737,710,0.0002,0.0001,22,,,1636,477,1159,Parallel Assignment,,Open Label,,Treatment,Safety/Efficacy Study
NCT00081458,Completed,Actual,Phase 3,Interventional,3,,Actual,84,Both,18 Years,0,,410,984094672,Drug,83,29,83,79,0.005,0.007,9,,,1636,477,1159,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00086281,Completed,Actual,Phase 4,Interventional,4,,Actual,60,Both,18 Years,0,,332,942388683,Drug,218,1,218,65,0.009,0.5055,2,,,1636,477,1159,Crossover Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00082381,Completed,Actual,Phase 3,Interventional,2,,Actual,551,Both,30 Years,75 Years,,144,3633170488,Drug,,18,,386,0.3002,0.0001,13,,,1636,477,1159,Parallel Assignment,,Open Label,,Treatment,Safety/Efficacy Study
NCT00082407,Completed,Actual,Phase 3,Interventional,2,,Actual,505,Both,30 Years,75 Years,,144,3633170488,Drug,,30,,307,0.0001,0.7888,12,,,1636,477,1159,Parallel Assignment,,Open Label,,Treatment,Safety/Efficacy Study
NCT00083759,Terminated,,Phase 2,Interventional,2,,Actual,299,Both,18 Years,75 Years,,401,2326608903,Drug,,,,,0.089,0.526,2,,,1636,477,1159,Parallel Assignment,,Double-Blind,,Treatment,Safety/Efficacy Study
NCT00084266,Completed,Actual,Phase 4,Interventional,2,,Actual,1225,Both,18 Years,0,,297,2638998868,Drug,1184,286,1184,729,0.042,0.9344,23,,,1636,477,1159,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00085202,"Active, not recruiting",Anticipated,Phase 3,Interventional,2,,Actual,416,Both,3 Years,21 Years,,72,660508271,Procedure,413,34,413,354,0.0206,0.8001,3,,,1636,477,1159,Parallel Assignment,,Open Label,,Treatment,Safety/Efficacy Study
NCT00085644,Completed,Actual,Phase 3,Interventional,2,,Actual,315,Both,18 Years,0,,33,3267503137,Biological,311,96,311,279,0.985,0.001,1,,,1636,477,1159,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00085709,Completed,Actual,Phase 3,Interventional,4,,Actual,637,Both,18 Years,60 Years,,260,180008924,Other,1039,88,1039,989,0.001,0.0025,3,,,1636,477,1159,Parallel Assignment,,Open Label,,Treatment,Safety/Efficacy Study
NCT00086047,Completed,Actual,Phase 3,Interventional,2,,Actual,114,Both,11 Years,18 Years,,180,3671355921,Behavioral,,,,,0.007,0.007,1,,,1636,477,1159,Parallel Assignment,,Single Blind,,Treatment,Efficacy Study
NCT00086346,Terminated,Actual,Phase 3,Interventional,2,,Actual,607,Both,13 Years,0,,269,295097427,Drug,,272,599,587,0.017,0.05,12,,,1636,477,1159,Parallel Assignment,,Open Label,,Treatment,Safety/Efficacy Study
NCT00089999,Completed,Actual,Phase 2,Interventional,,,Actual,138,Female,18 Years,0,,313,1776861857,Drug,138,33,138,111,0.443,0.691,11,,,1636,477,1159,Parallel Assignment,,Open Label,,Treatment,Safety/Efficacy Study
NCT00086580,Completed,Actual,Phase 3,Interventional,2,,Actual,335,Both,18 Years,0,,57,2255890431,Biological,329,95,329,307,0.014,0.001,15,,,1636,477,1159,Parallel Assignment,,Open Label,,Treatment,Safety/Efficacy Study
NCT00087438,Completed,,Phase 2,Interventional,1,,Actual,59,Both,18 Years,0,,271,2288821332,Radiation,55,16,55,50,0.013,0.013,1,,,1636,477,1159,Single Group Assignment,,Open Label,,Treatment,
NCT00088153,Completed,Actual,Phase 2/Phase 3,Interventional,2,,Actual,110,Female,12 Years,18 Years,,34,1531614257,Drug,110,28,110,38,0.05,0.05,1,,,1636,477,1159,Parallel Assignment,,Double Blind,,Treatment,Efficacy Study
NCT00088634,Completed,Actual,Phase 2,Interventional,2,,Actual,180,Both,18 Years,64 Years,,405,2119471695,Drug,180,5,180,90,0.05,0.05,1,,,1636,477,1159,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00088907,Terminated,Actual,Phase 3,Interventional,2,,Actual,270,Both,18 Years,0,,389,308097561,Drug,272,127,272,43,0.19,0.6,1,,,1636,477,1159,Parallel Assignment,,Double Blind,,Treatment,Efficacy Study
NCT00089141,Terminated,Actual,Phase 3,Interventional,2,,Actual,151,Both,4 Years,0,,76,3991381194,Drug,,,,,0.03,0.55,2,,,1636,477,1159,Parallel Assignment,,Double Blind,,Treatment,Efficacy Study
NCT00089648,Completed,Actual,Phase 2,Interventional,1,,Actual,61,Both,18 Years,0,,81,1588592340,Drug,61,30,61,60,,,1,,,1636,477,1159,Single Group Assignment,,Open Label,,Treatment,Safety/Efficacy Study
NCT00089843,Completed,Actual,Phase 2/Phase 3,Interventional,4,,Actual,77,Female,18 Years,45 Years,,34,1531614257,Drug,77,14,77,56,0.002,0.0001,1,,,1636,477,1159,Factorial Assignment,,Double Blind,,Treatment,Efficacy Study
NCT00090051,Completed,Actual,Phase 3,Interventional,2,,Actual,552,Both,18 Years,0,,101,1706704250,Drug,546,270,546,483,0.0002,0.0001,17,,,1636,477,1159,Parallel Assignment,,Open Label,,Treatment,Safety/Efficacy Study
NCT00095121,Completed,Actual,Phase 3,Interventional,2,,Actual,173,Both,2 Years,17 Years,,94,2307672194,Drug,335,25,335,261,0.051,0.001,1,,,1636,477,1159,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00090402,Completed,,Phase 1/Phase 2,Interventional,3,,Actual,39,Both,55 Years,0,,23,4032982200,Other,39,2,39,21,0.93,0.93,1,,,1636,477,1159,Parallel Assignment,,Double-Blind,,Treatment,Safety/Efficacy Study
NCT00091026,Completed,Actual,Phase 2,Interventional,2,,Actual,143,Both,18 Years,0,,10,2799339370,Drug,139,38,139,101,0.22,0.95,1,,,1636,477,1159,Parallel Assignment,,Open Label,,Treatment,Safety/Efficacy Study
NCT00091390,"Active, not recruiting",,Phase 2,Interventional,1,,Actual,129,Male,18 Years,0,,378,3123971163,Radiation,112,46,112,110,0.0001,0.0001,1,,,1636,477,1159,Single Group Assignment,,Open Label,,Treatment,
NCT00091442,Completed,Actual,Phase 3,Interventional,2,,Actual,751,Female,18 Years,0,,73,1499605101,Drug,750,128,750,699,0.0085,0.0001,18,,,1636,477,1159,Parallel Assignment,,Open Label,,Treatment,Safety/Efficacy Study
NCT00091507,Completed,Actual,Phase 3,Interventional,2,,Actual,911,Both,30 Years,0,,31,1678923890,Drug,871,69,871,494,0.01,0.28,1,,,1636,477,1159,Parallel Assignment,,Double Blind,,Treatment,Efficacy Study
NCT00091819,Completed,Actual,Phase 3,Interventional,2,,Actual,862,Both,18 Years,0,,429,136073174,Drug,855,58,855,693,,,1,,,1636,477,1159,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00094172,Completed,Actual,Phase 2,Interventional,2,,Actual,82,Both,18 Years,55 Years,,304,3878017841,Drug,83,4,83,80,0.208,0.929,2,,,1636,477,1159,Parallel Assignment,,Double Blind,,Prevention,Efficacy Study
NCT00094458,Completed,Actual,Phase 3,Interventional,3,,Actual,508,Both,21 Years,0,,122,240489291,Biological,,90,,422,0.006,0.001,15,,,1636,477,1159,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00095199,Completed,Actual,Phase 3,Interventional,4,,Actual,939,Both,18 Years,0,,319,3940632058,Biological,889,349,889,876,0.091,0.887,2,,,1636,477,1159,Parallel Assignment,,Open Label,,Treatment,Safety/Efficacy Study
NCT00098293,Completed,Actual,Phase 3,Interventional,3,,Actual,916,Both,16 Years,0,,202,3937948214,Drug,1022,210,1022,797,0.002,0.0001,14,,,1636,477,1159,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00095212,Completed,Actual,N/A,Interventional,2,,Actual,25,Female,18 Years,55 Years,,198,3223041150,Drug,25,2,25,15,0.01,0.94,1,,,1636,477,1159,Parallel Assignment,,Double Blind,,Treatment,Efficacy Study
NCT00095238,Completed,Actual,Phase 3,Interventional,2,,Actual,4128,Both,60 Years,0,,114,2971302321,Drug,4126,2301,4126,2446,,,25,,,1636,477,1159,Parallel Assignment,,Double Blind,,Treatment,Efficacy Study
NCT00096265,Terminated,Actual,Phase 3,Interventional,3,,Actual,126,Both,18 Years,0,,390,3735875245,Radiation,124,44,124,94,0.93,0.95,2,,,1636,477,1159,Parallel Assignment,,Open Label,,Treatment,Efficacy Study
NCT00097253,Completed,Actual,Phase 1,Interventional,3,,Actual,56,Both,18 Years,44 Years,,431,1254644797,Behavioral,,,,,0.014,0.83,1,,,1636,477,1159,Crossover Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00097500,Completed,Actual,Phase 3,Interventional,2,,Actual,69,Both,30 Years,75 Years,,449,2402940714,Drug,69,4,69,63,0.0001,0.0001,3,,,1636,477,1159,Parallel Assignment,,Open Label,,Treatment,Safety/Efficacy Study
NCT00097591,Completed,Actual,Phase 3,Interventional,2,,Actual,13619,Both,18 Years,0,,118,1856855603,Drug,13457,3406,13457,10404,0.002,0.001,1,,,1636,477,1159,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00097773,Completed,Actual,Phase 2,Interventional,4,,Actual,304,Both,1 Years,12 Years,,124,191177468,Drug,304,83,304,270,0.12,0.86,1,,,1636,477,1159,Parallel Assignment,,Double Blind,,Prevention,Safety/Efficacy Study
NCT00097981,Completed,Actual,Phase 3,Interventional,2,,Actual,225,Both,18 Years,0,,303,1739707547,Drug,216,101,216,214,0.42,0.93,1,,,1636,477,1159,Parallel Assignment,,Open Label,,Treatment,Safety/Efficacy Study
NCT00098306,Completed,Actual,Phase 2/Phase 3,Interventional,3,,Actual,601,Both,16 Years,0,,199,2889579184,Drug,1305,148,1305,470,0.0006,0.0001,2,,,1636,477,1159,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00103194,Completed,Actual,Phase 2,Interventional,1,,Actual,49,Male,18 Years,0,,391,2376027775,Drug,49,4,49,46,0.006,0.006,1,,,1636,477,1159,Single Group Assignment,,Open Label,,Treatment,Efficacy Study
NCT00098475,"Active, not recruiting",,Phase 3,Interventional,4,,Actual,452,Both,18 Years,0,,125,1513883386,Drug,468,265,468,463,,,1,,,1636,477,1159,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00098748,Completed,Actual,Phase 2/Phase 3,Interventional,3,,Actual,190,Both,16 Years,0,,199,2889579184,Drug,186,40,186,139,0.254,0.8243,9,,,1636,477,1159,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00099359,Completed,Actual,Phase 3,Interventional,3,,Actual,1735,Both,0,2 Days,,152,247033278,Drug,1735,682,1735,1454,0.0001,0.0001,5,,,1636,477,1159,Parallel Assignment,,Open Label,,Prevention,Safety/Efficacy Study
NCT00099632,Completed,Actual,Phase 2,Interventional,6,,Actual,484,Female,13 Years,0,,199,2889579184,Drug,422,4,,,0.091,0.37,6,,,1636,477,1159,Parallel Assignment,,Open Label,,Treatment,Efficacy Study
NCT00100698,Completed,Actual,N/A,Interventional,2,,Actual,56,Both,18 Years,60 Years,,0,3058073368,Drug,55,5,55,8,0.049,0.049,1,,,1636,477,1159,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00101283,Completed,Actual,Phase 2,Interventional,2,,Actual,32,Both,18 Years,0,,293,1136820113,Drug,29,23,29,29,,,1,,,1636,477,1159,Parallel Assignment,,Open Label,,Treatment,Safety/Efficacy Study
NCT00101361,Terminated,Actual,Phase 3,Interventional,2,,Actual,212,Both,18 Years,0,,374,2416978262,Drug,212,25,212,180,0.05,0.05,2,,,1636,477,1159,Parallel Assignment,,Double Blind,,Treatment,Efficacy Study
NCT00101686,Completed,Actual,Phase 3,Interventional,5,,Actual,547,Both,18 Years,0,,109,254331034,Drug,530,220,530,526,0.0042,0.9364,4,,,1636,477,1159,Parallel Assignment,,Open Label,,Treatment,Safety/Efficacy Study
NCT00106080,Completed,Actual,N/A,Interventional,2,,Actual,376,Both,18 Years,0,,160,523876482,Behavioral,,,,,0.03,0.03,1,,,1636,477,1159,Parallel Assignment,,Double Blind,,,Efficacy Study
NCT00104247,Completed,Actual,Phase 3,Interventional,,,Actual,89,Both,8 Years,0,,356,1288876632,Drug,,,,55,0.001,0.001,1,,,1636,477,1159,Parallel Assignment,,Double-Blind,,Treatment,Safety/Efficacy Study
NCT00104299,Completed,Actual,Phase 2/Phase 3,Interventional,2,,Actual,197,Both,15 Years,0,,458,264192817,Drug,197,107,197,194,0.133,0.001,2,,,1636,477,1159,Parallel Assignment,,Double Blind,,Treatment,Efficacy Study
NCT00104416,Completed,Actual,Phase 3,Interventional,2,,Actual,153,Both,13 Years,0,,167,2963929165,Drug,314,8,314,116,0.0001,0.0001,9,,,1636,477,1159,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00105001,"Active, not recruiting",,Phase 2,Interventional,3,,Actual,210,Both,0,0,,426,1987242768,Drug,210,27,210,109,0.004,0.96,3,,,1636,477,1159,Parallel Assignment,,Open Label,,Treatment,Efficacy Study
NCT00105196,Completed,Actual,Phase 3,Interventional,2,,Actual,349,Both,18 Years,65 Years,,279,960571772,Drug,348,2,348,169,0.037,0.001,1,,,1636,477,1159,Parallel Assignment,,Double Blind,,Diagnostic,Safety/Efficacy Study
NCT00105235,Completed,Actual,Phase 2,Interventional,1,,Actual,27,Both,18 Years,0,,265,1428429816,Procedure,27,27,27,26,,,2,,,1636,477,1159,Single Group Assignment,,Open Label,,Treatment,Safety/Efficacy Study
NCT00105443,Completed,Actual,Phase 3,Interventional,2,,Actual,602,Both,18 Years,0,,78,343272651,Drug,1245,719,1245,1129,0.000007,0.7676,23,,,1636,477,1159,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00105989,Completed,Actual,Phase 3,Interventional,2,,Actual,514,Both,18 Years,0,,136,1049032054,Drug,,17,,218,0.003,0.001,6,,,1636,477,1159,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00106028,Completed,Actual,Phase 3,Interventional,2,,Actual,143,Both,4 Years,15 Years,,336,1524497998,Drug,279,48,279,258,0.003,0.0001,13,,,1636,477,1159,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00108732,Completed,Actual,Phase 2,Interventional,1,,Actual,50,Male,18 Years,0,,392,3524331487,Biological,50,2,50,44,0.003,0.02,1,,,1636,477,1159,Single Group Assignment,,Open Label,,Treatment,Efficacy Study
NCT00106392,Completed,Actual,Phase 4,Interventional,2,,Actual,131,Male,0,65 Years,,169,2214996678,Drug,124,1,124,12,0.099,0.879,1,,,1636,477,1159,Parallel Assignment,,Double Blind,,Prevention,Safety/Efficacy Study
NCT00106535,Completed,Actual,Phase 3,Interventional,3,,Actual,1196,Both,18 Years,0,,401,2326608903,Drug,2045,351,2045,1307,0.0001,0.0001,16,,,1636,477,1159,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00106964,Completed,Actual,Phase 4,Interventional,3,,Actual,371,Both,12 Years,24 Years,,198,3223041150,Biological,,,371,78,0.0157,0.8698,3,,,1636,477,1159,Parallel Assignment,,Open Label,,Prevention,Safety/Efficacy Study
NCT00107575,Completed,Actual,Phase 2,Interventional,2,,Actual,236,Both,18 Years,95 Years,,443,179058863,Other,236,2,,,0.027,0.05,1,,,1636,477,1159,Factorial Assignment,,Double Blind,,Treatment,Efficacy Study
NCT00107900,Completed,Actual,Phase 2,Interventional,6,,Actual,606,Both,18 Years,0,,46,2804796376,Drug,606,40,606,264,0.238,0.238,1,,,1636,477,1159,Parallel Assignment,,Open Label,,Prevention,Safety/Efficacy Study
NCT00107978,Completed,Actual,Phase 3,Interventional,2,,Actual,1035,Both,18 Years,0,,429,136073174,Drug,1012,53,1012,718,,,1,,,1636,477,1159,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00108082,Completed,Actual,Phase 3,Interventional,1,,Actual,287,Both,18 Years,80 Years,,233,2554888772,Drug,,22,,167,0.1711,0.7651,1,,,1636,477,1159,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00108160,Completed,Actual,Phase 4,Interventional,2,,Actual,146,Both,18 Years,0,,428,3411817248,Drug,146,3,,,0.356,0.356,1,,,1636,477,1159,Parallel Assignment,,Double Blind,,Prevention,Efficacy Study
NCT00108550,Completed,Actual,Phase 2,Interventional,2,,Actual,108,Both,21 Years,70 Years,,99,3964941165,Drug,,,108,63,0.4237,0.458,1,,,1636,477,1159,Parallel Assignment,,Double Blind,,Treatment,Efficacy Study
NCT00110214,Completed,Actual,Phase 3,Interventional,2,,Actual,1050,Male,18 Years,0,,227,3208547707,Biological,1009,415,1009,783,0.181,0.001,1,,,1636,477,1159,Parallel Assignment,,Double Blind,,Treatment,Efficacy Study
NCT00108862,Completed,Actual,Phase 4,Interventional,2,,Actual,809,Both,13 Years,0,,198,3223041150,Other,806,99,806,780,0.02,0.67,13,,,1636,477,1159,Parallel Assignment,,Open Label,,Treatment,Safety/Efficacy Study
NCT00108953,Completed,Actual,Phase 2,Interventional,2,,Actual,96,Both,18 Years,0,,78,343272651,Drug,95,39,95,95,0.007,0.038,6,,,1636,477,1159,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00109590,Completed,Actual,Phase 2,Interventional,3,,Actual,175,Female,18 Years,0,,199,2889579184,Drug,339,102,339,269,0.009,0.048,1,,,1636,477,1159,Parallel Assignment,,Open Label,,Treatment,Pharmacokinetics/Dynamics Study
NCT00109733,Completed,Actual,Phase 3,Interventional,2,,Actual,31,Both,13 Years,25 Years,,91,2613333871,Biological,31,1,31,27,0.002,0.001,1,,,1636,477,1159,Parallel Assignment,,Open Label,,Treatment,Efficacy Study
NCT00109772,Terminated,Actual,Phase 2,Interventional,2,,Actual,184,Both,18 Years,0,,111,2671661174,Drug,180,28,180,149,0.894,0.894,1,,,1636,477,1159,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00109837,Completed,Actual,Phase 2,Interventional,1,,Actual,79,Both,18 Years,64 Years,,260,180008924,Drug,176,5,176,169,,,1,,,1636,477,1159,Single Group Assignment,,Open Label,,Treatment,
NCT00110019,"Active, not recruiting",,Phase 3,Interventional,2,,Actual,823,Both,18 Years,0,,302,4061726511,Other,790,643,790,769,0.092,0.863,2,,,1636,477,1159,Parallel Assignment,,Double Blind,,Treatment,Efficacy Study
NCT00110084,Completed,Actual,Phase 2,Interventional,1,,Actual,50,Female,18 Years,0,,73,1499605101,Drug,50,11,50,50,,,1,,,1636,477,1159,Single Group Assignment,,Open Label,,Treatment,
NCT00110136,Terminated,Actual,Phase 2,Interventional,1,,Actual,9,Female,18 Years,0,,73,1499605101,Drug,,,9,6,0.1042,0.9995,1,,,1636,477,1159,Single Group Assignment,,Open Label,,Supportive Care,
NCT00110461,Completed,Actual,Phase 3,Interventional,3,,Actual,296,Both,10 Years,17 Years,,64,2594871937,Drug,294,18,294,226,0.0001,0.0001,1,,,1636,477,1159,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00113087,Completed,Actual,Phase 3,Interventional,2,,Actual,230,Both,0,45 Days,,209,2903305172,Drug,230,175,230,147,0.81,1,2,,,1636,477,1159,Parallel Assignment,,Double Blind,,Treatment,Efficacy Study
NCT00110812,Completed,Actual,Phase 2,Interventional,3,,Actual,267,Both,18 Years,0,,199,2889579184,Drug,267,15,267,13,0.003,0.001,11,,,1636,477,1159,Parallel Assignment,,Open Label,,Treatment,Safety/Efficacy Study
NCT00110994,Completed,Actual,Phase 2,Interventional,2,,Actual,101,Both,18 Years,0,,76,3991381194,Drug,101,36,101,94,0.039,0.973,1,,,1636,477,1159,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00111007,Completed,Actual,Phase 3,Interventional,2,,Actual,270,Both,18 Years,0,,287,326450020,Drug,268,131,268,266,0.146,0.979,7,,,1636,477,1159,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00112047,Completed,Actual,Phase 3,Interventional,2,,Actual,517,Both,18 Years,0,,199,2889579184,Drug,957,102,957,797,0.001,0.001,1,,,1636,477,1159,Parallel Assignment,,Open Label,,Treatment,Safety/Efficacy Study
NCT00112294,Completed,Actual,Phase 3,Interventional,2,,Actual,755,Both,18 Years,0,,325,3552216531,Drug,645,304,645,639,0.0066,0.26,1,,,1636,477,1159,Parallel Assignment,,Open Label,,Treatment,Efficacy Study
NCT00112359,Completed,Actual,Phase 3,Interventional,2,,Actual,166,Both,6 Years,0,,124,191177468,Drug,164,17,164,130,0.0005,0.0001,4,,,1636,477,1159,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00112918,Completed,Actual,Phase 3,Interventional,3,,Actual,3451,Both,18 Years,0,,108,1696863024,Drug,3406,807,3406,3356,0.2024,0.2024,1,,,1636,477,1159,Parallel Assignment,,Open Label,,Treatment,
NCT00113022,Terminated,Actual,Phase 2,Interventional,2,,Actual,9,Both,21 Years,70 Years,,133,2194019288,Drug,9,1,9,5,0.919,0.919,1,,,1636,477,1159,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00113269,Completed,Actual,Phase 4,Interventional,4,,Actual,501,Both,18 Years,0,,256,3993050794,Drug,474,245,474,435,0.001,0.0001,1,,,1636,477,1159,Parallel Assignment,,Open Label,,Treatment,Safety/Efficacy Study
NCT00113516,Completed,Actual,Phase 2,Interventional,1,,Actual,84,Both,18 Years,0,,326,1982470504,Drug,150,58,150,142,0.0074,0.929,3,,,1636,477,1159,Single Group Assignment,,Open Label,,Treatment,Safety/Efficacy Study
NCT00115349,Terminated,Actual,Phase 2,Interventional,2,,Actual,20,Both,18 Years,0,,84,3416315868,Drug,20,9,20,14,0.89,0.89,1,,,1636,477,1159,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00113607,Completed,Actual,Phase 3,Interventional,2,,Actual,672,Female,18 Years,0,,339,2909107598,Drug,663,235,663,651,0.008,0.8203,20,,,1636,477,1159,Parallel Assignment,,Open Label,,Treatment,Safety/Efficacy Study
NCT00113841,Completed,Actual,N/A,Interventional,2,,Actual,42,Both,0,0,,303,1739707547,Drug,,,33,18,0.16,0.16,1,,,1636,477,1159,Parallel Assignment,,Open Label,,Treatment,Safety/Efficacy Study
NCT00113880,Completed,Actual,N/A,Observational,,3,Actual,63061,Both,5 Years,49 Years,,205,2158746441,Biological,63061,202,,,0.01,0.05,1,,,1636,477,1159,,Cohort,,Prospective,,
NCT00114101,"Active, not recruiting",,Phase 3,Interventional,2,,Actual,460,Both,18 Years,70 Years,,125,1513883386,Other,460,85,460,361,0.7,0.001,1,,,1636,477,1159,Parallel Assignment,,Double Blind,,Treatment,Efficacy Study
NCT00114127,Completed,Actual,Phase 3,Interventional,3,,Actual,28,Both,18 Years,0,,35,2074914426,Drug,28,2,28,2,0.292,0.132,1,,,1636,477,1159,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00114634,Completed,Actual,Phase 2,Interventional,2,,Actual,13,Both,4 Years,17 Years,,417,4274467713,Drug,,,,,1,1,1,,,1636,477,1159,Crossover Assignment,,Double Blind,,Treatment,Efficacy Study
NCT00115063,Terminated,Actual,Phase 4,Interventional,2,,Actual,390,Both,20 Years,60 Years,,329,1330809903,Behavioral,390,28,,,0.001,0.001,1,,,1636,477,1159,Parallel Assignment,,Open Label,,Treatment,Safety/Efficacy Study
NCT00115934,Completed,Actual,Phase 3,Interventional,2,,Actual,555,Both,0,0,,209,2903305172,Procedure,549,258,549,500,0.001,0.001,2,,,1636,477,1159,Parallel Assignment,,Open Label,,Treatment,Safety/Efficacy Study
NCT00117637,Completed,Actual,Phase 2,Interventional,2,,Actual,189,Both,18 Years,0,,81,1588592340,Drug,297,127,297,272,0.0004,0.5,7,,,1636,477,1159,Parallel Assignment,,Open Label,,Treatment,Safety/Efficacy Study
NCT00116272,Completed,Actual,N/A,Observational,,3,Actual,830,Both,0,0,,372,629356050,Drug,1032,126,,,,,1,,,1636,477,1159,,Cohort,,,,
NCT00116428,Completed,Actual,Phase 3,Interventional,2,,Actual,167,Both,18 Years,0,,211,2189995785,Drug,164,25,164,23,0.001,0.001,5,,,1636,477,1159,Parallel Assignment,,Open Label,,Treatment,Safety/Efficacy Study
NCT00116753,Completed,Actual,Phase 2,Interventional,3,,Actual,460,Male,18 Years,0,,378,3123971163,Drug,447,72,447,334,0.1557,0.9587,11,,,1636,477,1159,Parallel Assignment,,Open Label,,Treatment,Safety/Efficacy Study
NCT00116779,Completed,Actual,Phase 2,Interventional,2,,Actual,127,Male,18 Years,0,,378,3123971163,Drug,,15,,107,0.778,0.8413,2,,,1636,477,1159,Parallel Assignment,,Open Label,,Treatment,Safety/Efficacy Study
NCT00116805,"Active, not recruiting",Anticipated,Phase 3,Interventional,2,,Actual,266,Both,18 Years,69 Years,,94,2307672194,Drug,504,56,504,408,0.018,0.001,15,,,1636,477,1159,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00116831,Completed,Actual,Phase 3,Interventional,2,,Actual,672,Both,30 Years,80 Years,,322,3904661288,Drug,668,142,668,215,0.1221,0.1221,20,,,1636,477,1159,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00117559,Completed,Actual,N/A,Interventional,2,,Actual,19,Both,18 Years,0,,133,2194019288,Behavioral,,,,,0.05,0.05,1,,,1636,477,1159,Parallel Assignment,,Open Label,,Treatment,Efficacy Study
NCT00117598,Completed,Actual,Phase 3,Interventional,3,,Actual,169,Both,18 Years,0,,276,1696214900,Drug,174,84,174,172,0.0004,0.0001,18,,,1636,477,1159,Parallel Assignment,,Open Label,,Treatment,Safety/Efficacy Study
NCT00119158,Completed,Actual,Phase 4,Interventional,2,,Actual,90,Both,2 Years,65 Years,,50,3422213208,Drug,,,,,0.05,0.05,1,,,1636,477,1159,Parallel Assignment,,Double Blind,,Treatment,Efficacy Study
NCT00117793,Completed,Actual,N/A,Interventional,2,,Actual,20,Both,18 Years,70 Years,,26,3762057219,Device,,,17,1,0.0021,0.05,1,,,1636,477,1159,Crossover Assignment,,Single Blind,,Treatment,Efficacy Study
NCT00117806,"Active, not recruiting",Anticipated,N/A,Interventional,2,,Actual,249,Both,18 Years,65 Years,,421,2393866971,Behavioral,,,,,0.008,0.008,1,,,1636,477,1159,Parallel Assignment,,Open Label,,Treatment,Efficacy Study
NCT00117949,Completed,Actual,Phase 2,Interventional,4,,Actual,82,Male,18 Years,0,,378,3123971163,Drug,,2,,57,0.003,0.001,1,,,1636,477,1159,Parallel Assignment,,Open Label,,Treatment,Safety/Efficacy Study
NCT00118378,Completed,Actual,Phase 4,Interventional,2,,Actual,115,Both,18 Years,75 Years,,199,2889579184,Drug,,,,,0.052,0.24,1,,,1636,477,1159,Parallel Assignment,,Double Blind,,Treatment,Efficacy Study
NCT00118404,Completed,Actual,Phase 3,Interventional,3,,Actual,523,Both,18 Years,70 Years,,133,2194019288,Behavioral,,,,,0.01,0.61,1,,,1636,477,1159,Parallel Assignment,,Double Blind,,Treatment,Efficacy Study
NCT00118534,Completed,Actual,N/A,Interventional,2,,Actual,943,Both,18 Years,80 Years,,291,2540811761,Behavioral,943,438,943,82,0.007,0.001,1,,,1636,477,1159,Parallel Assignment,,Open Label,,Treatment,Efficacy Study
NCT00118742,Completed,Actual,Phase 4,Interventional,2,,Actual,293,Both,18 Years,74 Years,,269,295097427,Drug,294,132,294,275,0.0006,0.0001,2,,,1636,477,1159,Parallel Assignment,,Open Label,,Treatment,Safety/Efficacy Study
NCT00118911,Completed,Actual,N/A,Interventional,2,,Actual,86,Both,18 Years,65 Years,,54,1600057117,Behavioral,,,,,0.03,0.05,1,,,1636,477,1159,Parallel Assignment,,Open Label,,Treatment,Efficacy Study
NCT00119041,Completed,Actual,N/A,Interventional,3,,Actual,304,Both,18 Years,0,,140,2231272133,Behavioral,,,,,0.153,0.25,1,,,1636,477,1159,Parallel Assignment,,Open Label,,Health Services Research,Efficacy Study
NCT00122460,Completed,Actual,Phase 3,Interventional,2,,Actual,442,Both,18 Years,0,,204,599964,Drug,434,212,434,412,0.0001,0.0001,17,,,1636,477,1159,Parallel Assignment,,Open Label,,Treatment,Efficacy Study
NCT00119262,Completed,Actual,Phase 2,Interventional,2,,Actual,226,Both,18 Years,0,,284,3838063299,Biological,223,136,223,223,0.12,0.32,1,,,1636,477,1159,Parallel Assignment,,Open Label,,Treatment,Efficacy Study
NCT00120042,Completed,Actual,N/A,Interventional,3,,Actual,251,Female,16 Years,50 Years,,357,3765223373,Drug,,,,,0.05,0.05,1,,,1636,477,1159,Parallel Assignment,,Open Label,,Prevention,Safety/Efficacy Study
NCT00120289,Terminated,Actual,Phase 3,Interventional,2,,Actual,3414,Both,45 Years,0,,87,550104849,Drug,3414,1138,3414,2758,0.3,0.8,2,,,1636,477,1159,Parallel Assignment,,Double Blind,,Prevention,Efficacy Study
NCT00120406,Completed,Actual,N/A,Interventional,2,,Actual,474,Both,18 Years,0,,354,911035767,Device,471,58,471,153,0.01,0.01,3,,,1636,477,1159,Parallel Assignment,,Open Label,,Treatment,Safety/Efficacy Study
NCT00120627,Completed,Actual,N/A,Interventional,2,,Actual,146,Both,18 Years,0,,432,1538451997,Behavioral,,,,,0.01,0.66,1,,,1636,477,1159,Parallel Assignment,,Single Blind,,Treatment,Efficacy Study
NCT00121641,Completed,Actual,Phase 3,Interventional,5,,Actual,1035,Both,18 Years,77 Years,,144,3633170488,Drug,467,55,467,320,0.0002,0.0001,6,,,1636,477,1159,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00121667,Completed,Actual,Phase 3,Interventional,4,,Actual,1462,Both,18 Years,77 Years,,144,3633170488,Drug,743,87,743,534,0.0001,0.0001,9,,,1636,477,1159,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00121810,Completed,Actual,Phase 4,Interventional,2,,Actual,305,Both,18 Years,75 Years,,256,3993050794,Drug,301,124,301,295,0.003,0.001,1,,,1636,477,1159,Parallel Assignment,,Open Label,,Treatment,Safety/Efficacy Study
NCT00122382,Completed,Actual,Phase 3,Interventional,2,,Actual,1052,Both,18 Years,0,,401,2326608903,Drug,509,40,509,305,0.005,0.04,18,,,1636,477,1159,Parallel Assignment,,Double Blind,,Treatment,Efficacy Study
NCT00125593,Completed,Actual,Phase 4,Interventional,3,,Actual,9438,Both,40 Years,0,,253,518539727,Drug,9270,2257,9270,1952,0.001,0.41,1,,,1636,477,1159,Parallel Assignment,,Double Blind,,Prevention,Safety/Efficacy Study
NCT00122980,Terminated,Actual,Phase 3,Interventional,2,,Actual,134,Both,5 Years,18 Years,,217,143551650,Procedure,133,43,133,130,0.033,0.05,1,,,1636,477,1159,Parallel Assignment,,Open Label,,Prevention,Efficacy Study
NCT00123123,Completed,Actual,Phase 2,Interventional,3,,Actual,175,Both,18 Years,0,,358,564386991,Drug,,,,,0.675,0.675,1,,,1636,477,1159,Parallel Assignment,,Double Blind,,,Efficacy Study
NCT00123422,Completed,Actual,N/A,Interventional,3,,Actual,103,Both,40 Years,0,,384,1255276805,Behavioral,103,6,103,4,0.015,0.05,1,,,1636,477,1159,Parallel Assignment,,Single Blind,,Treatment,Efficacy Study
NCT00123474,Completed,Actual,Phase 3,Interventional,4,,Actual,724,Both,18 Years,90 Years,,309,1375871599,Drug,662,334,662,640,,,31,,,1636,477,1159,Parallel Assignment,,Open Label,,Treatment,Safety/Efficacy Study
NCT00123487,Completed,Actual,Phase 3,Interventional,2,,Actual,638,Both,18 Years,0,,308,1799455519,Drug,609,464,609,579,,,32,,,1636,477,1159,Parallel Assignment,,Open Label,,Treatment,Safety/Efficacy Study
NCT00124657,Completed,Actual,Phase 1/Phase 2,Interventional,1,,Actual,62,Both,3 Years,21 Years,,72,660508271,Drug,67,37,67,66,,,1,,,1636,477,1159,Single Group Assignment,,Open Label,,Treatment,Safety/Efficacy Study
NCT00124709,Terminated,Actual,Phase 4,Interventional,2,,Actual,1091,Both,3 Months,18 Months,,50,3422213208,Drug,1087,79,1087,949,0.7901,0.7901,1,,,1636,477,1159,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00125138,Completed,Actual,Phase 2,Interventional,4,,Actual,90,Both,0,0,,346,4003884833,Drug,89,6,89,30,0.1519,0.9212,3,,,1636,477,1159,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00125242,Completed,Actual,N/A,Interventional,2,,Actual,110,Both,21 Years,80 Years,,37,2281125483,Behavioral,,,,,,,1,,,1636,477,1159,Parallel Assignment,,Open Label,,Treatment,Efficacy Study
NCT00125957,Completed,Actual,Phase 3,Interventional,2,,Actual,32,Both,18 Years,70 Years,,451,3681315025,Drug,,,,,0.04,0.09,1,,,1636,477,1159,Crossover Assignment,,Double Blind,,Treatment,Efficacy Study
NCT00129441,Completed,Actual,Phase 2,Interventional,2,,Actual,16,Male,18 Years,50 Years,,405,2119471695,Drug,,,16,4,0.01,0.05,1,,,1636,477,1159,Parallel Assignment,,Double Blind,,Treatment,Efficacy Study
NCT00126737,Completed,Actual,N/A,Interventional,4,,Actual,110,Both,50 Years,0,,93,3095176967,Other,,,110,22,0.0002,0.0535,1,,,1636,477,1159,Factorial Assignment,,Single Blind,,Treatment,Efficacy Study
NCT00126776,Completed,Actual,N/A,Interventional,2,,Actual,743,Both,0,0,,102,2661081659,Behavioral,,,,,0.001,0.001,1,,,1636,477,1159,Parallel Assignment,,Single Blind,,Prevention,Efficacy Study
NCT00127712,Completed,Actual,Phase 4,Interventional,2,,Actual,130,Both,40 Years,0,,51,734346743,Drug,130,3,130,43,0.001,0.79,1,,,1636,477,1159,Parallel Assignment,,Open Label,,Prevention,Safety/Efficacy Study
NCT00127790,Completed,Actual,N/A,Interventional,4,,Actual,28,Both,35 Years,75 Years,,245,4173685762,Behavioral,,,,,0.01,0.786,1,,,1636,477,1159,Parallel Assignment,,Open Label,,Treatment,Efficacy Study
NCT00128180,Completed,Actual,Phase 2,Interventional,2,,Actual,66,Both,2 Years,0,,203,4075247975,Drug,66,39,66,34,0.18,0.18,1,,,1636,477,1159,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00128219,Completed,Actual,Phase 2,Interventional,2,,Actual,667,Female,18 Years,40 Years,,62,3463638132,Biological,663,36,663,624,0.044,0.256,1,,,1636,477,1159,Parallel Assignment,,Double Blind,,Prevention,Efficacy Study
NCT00128713,Completed,Actual,Phase 3,Interventional,3,,Actual,1351,Both,0,0,,439,631942930,Procedure,1351,101,1351,582,0.02,0.001,1,,,1636,477,1159,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00129220,Completed,Actual,Phase 3,Interventional,3,,Actual,224,Both,20 Years,65 Years,,64,2594871937,Drug,221,4,221,156,0.003,0.001,1,,,1636,477,1159,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00129766,Completed,Actual,Phase 3,Interventional,2,,Actual,6635,Both,0,24 Months,,397,493705133,Biological,6613,991,6613,5561,0.005,0.652,24,,,1636,477,1159,Parallel Assignment,,Double Blind,,Prevention,Safety/Efficacy Study
NCT00134563,Completed,Actual,Phase 3,Interventional,3,,Actual,1088,Both,18 Years,55 Years,,304,3878017841,Drug,1086,155,1086,795,0.0002,0.8271,21,,,1636,477,1159,Parallel Assignment,,Double Blind,,Treatment,Efficacy Study
NCT00129961,Completed,Actual,Phase 4,Interventional,2,,Actual,86,Both,18 Years,0,,413,389013820,Drug,86,36,86,78,0.004,0.999,4,,,1636,477,1159,Parallel Assignment,,Open Label,,Prevention,Efficacy Study
NCT00130247,Completed,Actual,Phase 3,Interventional,2,,Actual,394,Both,18 Years,60 Years,,446,3377839684,Drug,394,41,394,334,,,3,,,1636,477,1159,Parallel Assignment,,Open Label,,Treatment,Efficacy Study
NCT00131352,Completed,Actual,Phase 3,Interventional,2,,Actual,253,Both,40 Years,0,,335,399641608,Device,413,10,413,167,0.005,0.679,6,,,1636,477,1159,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00131456,Completed,Actual,Phase 2,Interventional,2,,Actual,123,Both,18 Years,60 Years,,133,2194019288,Drug,,,103,57,0.01,0.01,1,,,1636,477,1159,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00131508,Terminated,Actual,Phase 2,Interventional,2,,Actual,27,Both,5 Years,18 Years,,30,1181951473,Drug,,,,,0.14,1,1,,,1636,477,1159,Parallel Assignment,,Double Blind,,Prevention,Efficacy Study
NCT00132132,Completed,Actual,N/A,Interventional,2,,Actual,30,Both,10 Years,20 Years,,329,1330809903,Behavioral,,,,,0.006,0.14,1,,,1636,477,1159,Parallel Assignment,,Open Label,,Prevention,Efficacy Study
NCT00132314,Completed,Actual,Phase 3,Interventional,2,,Actual,382,Both,18 Years,0,,404,2348241859,Drug,369,187,369,255,0.39,0.39,1,,,1636,477,1159,Parallel Assignment,,Open Label,,Treatment,Efficacy Study
NCT00132691,Completed,Actual,Phase 4,Interventional,2,,Actual,255,Both,13 Years,0,,456,2253127107,Drug,255,122,255,226,0.0008,0.0001,3,,,1636,477,1159,Parallel Assignment,,Open Label,,Treatment,Efficacy Study
NCT00135330,Completed,Actual,Phase 3,Interventional,3,,Actual,137,Both,18 Years,75 Years,,144,3633170488,Drug,,11,,109,0.004,0.001,1,,,1636,477,1159,Parallel Assignment,,Open Label,,Treatment,Safety/Efficacy Study
NCT00137436,Completed,Actual,Phase 1/Phase 2,Interventional,1,,Actual,93,Male,18 Years,0,,380,2035633480,Drug,55,28,55,55,0.164,1,1,,,1636,477,1159,Single Group Assignment,,Open Label,,Treatment,Safety/Efficacy Study
NCT00135798,Completed,Actual,Phase 2,Interventional,3,,Actual,79,Both,18 Years,0,,222,1420832983,Drug,79,51,,,0.0153,0.9513,1,,,1636,477,1159,Parallel Assignment,,Open Label,,Treatment,Safety/Efficacy Study
NCT00136084,Completed,Actual,Phase 3,Interventional,2,,Actual,238,Both,0,21 Years,,262,3413094094,Drug,223,42,223,219,0.1559,0.6,1,,,1636,477,1159,Parallel Assignment,,Open Label,,Treatment,Efficacy Study
NCT00136916,Terminated,Actual,Phase 3,Interventional,2,,Actual,635,Both,35 Years,75 Years,,139,1050540193,Drug,627,152,627,609,,,4,,,1636,477,1159,Parallel Assignment,,Open Label,,Treatment,Safety/Efficacy Study
NCT00137046,Terminated,Actual,Phase 3,Interventional,2,,Actual,582,Both,18 Years,65 Years,,143,2617365673,Drug,580,115,580,579,,,5,,,1636,477,1159,Parallel Assignment,,Open Label,,Treatment,Safety/Efficacy Study
NCT00137111,"Active, not recruiting",Anticipated,Phase 3,Interventional,2,,Actual,501,Both,12 Months,18 Years,,275,3825896021,Drug,498,74,498,468,0.0062,0.15,1,,,1636,477,1159,Parallel Assignment,,Open Label,,Treatment,Safety/Efficacy Study
NCT00137267,Completed,Actual,N/A,Interventional,2,,Actual,102,Both,18 Years,0,,405,2119471695,Behavioral,,,,,0.152,0.001,1,,,1636,477,1159,Parallel Assignment,,Open Label,,Prevention,Efficacy Study
NCT00137280,Completed,Actual,N/A,Interventional,2,,Actual,1067,Both,18 Years,0,,97,667092360,Behavioral,,,,,0.03,0.01,1,,,1636,477,1159,Factorial Assignment,,Open Label,,Health Services Research,Safety/Efficacy Study
NCT00137423,Completed,Actual,Phase 2,Interventional,1,,Actual,107,Both,18 Years,0,,82,2078448118,Drug,,41,,107,,,7,,,1636,477,1159,Single Group Assignment,,Open Label,,Treatment,Safety/Efficacy Study
NCT00141778,Completed,Actual,Phase 2/Phase 3,Interventional,3,,Actual,455,Both,18 Years,80 Years,,51,734346743,Drug,445,19,445,53,0.006,0.95,1,,,1636,477,1159,Parallel Assignment,,Double Blind,,Prevention,Efficacy Study
NCT00137449,Completed,Actual,Phase 2,Interventional,1,,Actual,60,Both,18 Years,0,,186,1634903594,Drug,,25,,60,,,3,,,1636,477,1159,Single Group Assignment,,Open Label,,Treatment,Safety/Efficacy Study
NCT00138424,Terminated,Actual,Phase 1/Phase 2,Interventional,2,,Actual,22,Both,18 Years,0,,58,2972785372,Drug,22,2,22,15,0.05,0.87,1,,,1636,477,1159,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00138671,Terminated,Actual,Phase 3,Interventional,2,,Actual,105,Both,30 Years,77 Years,,139,1050540193,Drug,,31,,97,,,5,,,1636,477,1159,Parallel Assignment,,Open Label,,Treatment,Safety/Efficacy Study
NCT00139776,Completed,Actual,Phase 4,Interventional,2,,Actual,875,Both,18 Years,80 Years,,335,399641608,Drug,,16,,488,0.001,0.001,8,,,1636,477,1159,Parallel Assignment,,Double Blind,,Treatment,Efficacy Study
NCT00141037,Completed,Actual,Phase 1/Phase 2,Interventional,2,,Actual,130,Both,0,21 Years,,254,3371916612,Drug,130,112,130,120,0.79,0.85,1,,,1636,477,1159,Parallel Assignment,,Open Label,,Treatment,Safety/Efficacy Study
NCT00141102,Completed,Actual,Phase 4,Interventional,2,,Actual,4484,Both,18 Years,0,,334,3213715074,Drug,4460,122,4460,1199,0.0006,0.0001,32,,,1636,477,1159,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00141219,Completed,Actual,Phase 3,Interventional,2,,Actual,241,Both,18 Years,0,,150,1972684966,Drug,240,3,240,91,0.504,0.979,1,,,1636,477,1159,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00141271,Completed,Actual,Phase 3,Interventional,3,,Actual,536,Both,18 Years,0,,64,2594871937,Drug,,16,,216,0.0082,0.9855,1,,,1636,477,1159,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00141453,Completed,Actual,Phase 3,Interventional,2,,Actual,577,Both,30 Years,70 Years,,149,4168899067,Drug,575,318,575,529,0.039,0.79,2,,,1636,477,1159,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00145600,"Active, not recruiting",Anticipated,Phase 2,Interventional,4,,Actual,296,Both,0,21 Years,,226,3732200463,Drug,296,1,293,221,0.0001,0.0001,1,,,1636,477,1159,Single Group Assignment,,Open Label,,Treatment,Efficacy Study
NCT00142935,Completed,Actual,N/A,Interventional,3,,Actual,87,Both,18 Years,0,,200,3492718500,Behavioral,87,3,69,26,0.02,0.001,1,,,1636,477,1159,Parallel Assignment,,Open Label,,Prevention,Efficacy Study
NCT00143312,Completed,Actual,Phase 4,Interventional,1,,Actual,45,Both,18 Years,0,,377,151271015,Drug,45,23,45,42,,,8,,,1636,477,1159,Single Group Assignment,,Open Label,,Prevention,Safety/Efficacy Study
NCT00143390,Completed,Actual,Phase 3,Interventional,2,,Actual,298,Female,20 Years,0,,74,3128271172,Drug,298,38,298,239,,,1,,,1636,477,1159,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00143403,Completed,Actual,Phase 3,Interventional,2,,Actual,321,Both,18 Years,75 Years,,109,254331034,Drug,306,47,306,296,0.468,0.468,16,,,1636,477,1159,Parallel Assignment,,Open Label,,Treatment,Efficacy Study
NCT00143455,Completed,Actual,Phase 3,Interventional,2,,Actual,485,Both,18 Years,75 Years,,416,1143266442,Drug,482,87,482,482,0.011,0.7544,13,,,1636,477,1159,Parallel Assignment,,Open Label,,Treatment,Efficacy Study
NCT00144027,Completed,Actual,N/A,Interventional,2,,Actual,75,Both,18 Years,70 Years,,405,2119471695,Behavioral,,,,,0.03,0.03,1,,,1636,477,1159,Parallel Assignment,,Single Blind,,,Efficacy Study
NCT00144300,Completed,,Phase 4,Interventional,2,,Actual,246,Both,30 Years,0,,345,3641618925,Drug,246,43,246,198,,,1,,,1636,477,1159,Parallel Assignment,,Open Label,,Diagnostic,Safety Study
NCT00144339,Completed,,Phase 3,Interventional,,,Actual,5993,Both,40 Years,0,,385,1533570944,Drug,,3049,,5265,0.0001,0.0001,37,,,1636,477,1159,Parallel Assignment,,,,Treatment,Safety/Efficacy Study
NCT00145574,Completed,Actual,Phase 4,Interventional,3,,Actual,194,Both,10 Years,17 Years,,231,1565522294,Drug,378,6,378,130,0.0002,0.0001,8,,,1636,477,1159,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00149643,Completed,Actual,Phase 2,Interventional,2,,Actual,70,Both,14 Years,25 Years,,136,1049032054,Drug,,,,,0.05,0.05,1,,,1636,477,1159,Parallel Assignment,,Double Blind,,Treatment,Efficacy Study
NCT00145795,Completed,Actual,Phase 4,Interventional,2,,Actual,20,Both,18 Years,75 Years,,199,2889579184,Drug,,,20,1,0.03,0.81,1,,,1636,477,1159,Parallel Assignment,,Single Blind,,Treatment,Efficacy Study
NCT00146848,Completed,Actual,Phase 4,Interventional,3,,Actual,1742,Both,18 Years,0,,213,3865579137,Device,,,1433,360,0.04,0.86,1,,,1636,477,1159,Parallel Assignment,,Single Blind,,Treatment,Efficacy Study
NCT00147199,Completed,Actual,Phase 3,Interventional,2,,Actual,235,Both,18 Years,75 Years,,386,1248981652,Drug,235,22,235,201,0.0003,0.807,10,,,1636,477,1159,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00147446,Completed,Actual,Phase 2,Interventional,2,,Actual,121,Both,18 Years,0,,304,3878017841,Behavioral,,,,,0.005,0.04,1,,,1636,477,1159,Parallel Assignment,,Single Blind,,Prevention,Efficacy Study
NCT00147537,Completed,Actual,Phase 1/Phase 2,Interventional,2,,Actual,282,Both,18 Years,0,,80,4164722591,Drug,300,124,300,298,0.027,0.121,4,,,1636,477,1159,Parallel Assignment,,Open Label,,Treatment,Efficacy Study
NCT00148109,Completed,Actual,Phase 2,Interventional,2,,Actual,36,Both,16 Years,0,,402,2142848470,Drug,36,19,36,21,0.05,0.05,1,,,1636,477,1159,Parallel Assignment,,Open Label,,Treatment,
NCT00148798,Completed,Actual,Phase 3,Interventional,2,,Actual,1861,Both,18 Years,0,,320,3433929639,Drug,1110,569,1110,1069,0.0101,0.6801,28,,,1636,477,1159,Parallel Assignment,,Open Label,,Treatment,Efficacy Study
NCT00148954,Completed,Actual,Phase 4,Interventional,2,,Actual,1962,Both,18 Years,0,,437,3478470100,Device,,,1962,1043,0.003,0.003,1,,,1636,477,1159,Parallel Assignment,,Open Label,,Prevention,Efficacy Study
NCT00149227,Completed,Actual,Phase 4,Interventional,2,,Actual,3031,Both,20 Years,79 Years,,233,2554888772,Drug,,,,,0.05,0.05,1,,,1636,477,1159,Parallel Assignment,,Open Label,,Diagnostic,Safety/Efficacy Study
NCT00149799,Completed,Actual,Phase 3,Interventional,2,,Actual,100,Both,18 Years,0,,36,3102921191,Drug,,,158,132,0.048,0.048,1,,,1636,477,1159,Parallel Assignment,,Double Blind,,Treatment,Efficacy Study
NCT00154102,Completed,Actual,Phase 3,Interventional,2,,Actual,1221,Both,18 Years,0,,166,324608979,Drug,1202,467,1202,1184,0.0012,0.0001,30,,,1636,477,1159,Parallel Assignment,,Open Label,,Treatment,Safety/Efficacy Study
NCT00149825,Completed,Actual,Phase 2,Interventional,2,,Actual,30,Both,18 Years,75 Years,,279,960571772,Drug,,,,,0.05,0.13,1,,,1636,477,1159,Parallel Assignment,,Double Blind,,Treatment,Efficacy Study
NCT00150345,Completed,Actual,Phase 3,Interventional,2,,Actual,147,Both,18 Years,0,,363,968260693,Drug,147,16,147,96,0.049,0.955,1,,,1636,477,1159,Parallel Assignment,,Double Blind,,Treatment,Efficacy Study
NCT00150969,Completed,Actual,Phase 3,Interventional,2,,Actual,440,Female,0,0,,365,526887464,Dietary Supplement,440,40,440,21,0.05,0.05,1,,,1636,477,1159,Parallel Assignment,,Double Blind,,Prevention,Efficacy Study
NCT00151775,Completed,Actual,Phase 2/Phase 3,Interventional,3,,Actual,362,Both,1 Years,16 Years,,233,2554888772,Drug,1048,37,1045,522,0.0008,0.0001,11,,,1636,477,1159,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00151892,Completed,Actual,Phase 3,Interventional,2,,Actual,829,Both,18 Years,0,,107,310117854,Drug,826,9,,,,,28,,,1636,477,1159,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00152971,Completed,,Phase 3,Interventional,3,,Actual,2615,Both,18 Years,0,,47,2338741005,Drug,2596,161,2596,2153,0.0004,1,4,,,1636,477,1159,Parallel Assignment,,Double-Blind,,Prevention,Safety/Efficacy Study
NCT00153062,Completed,,Phase 4,Interventional,4,,Actual,20332,Both,50 Years,0,,433,678611600,Drug,,4657,,5342,0.1007,0.8292,36,,,1636,477,1159,Parallel Assignment,,Double-Blind,,Prevention,Safety/Efficacy Study
NCT00153101,Completed,,Phase 4,Interventional,,,Actual,31546,Both,55 Years,0,,84,3416315868,Drug,31546,19760,,,0.0004,0.9563,41,,,1636,477,1159,Parallel Assignment,,,,Prevention,
NCT00165841,Completed,Actual,Phase 2,Interventional,2,,Actual,200,Both,18 Years,65 Years,,184,2110570532,Drug,,4,,74,0.0001,0.0001,1,,,1636,477,1159,Parallel Assignment,,Double-Blind,,Treatment,Efficacy Study
NCT00157014,Completed,Actual,Phase 3,Interventional,4,,Actual,111,Both,0,0,,215,3640311864,Drug,109,53,109,109,0.4725,0.8373,2,,,1636,477,1159,Parallel Assignment,,Open Label,,Treatment,Safety/Efficacy Study
NCT00158197,Completed,Actual,N/A,Interventional,4,,Actual,119,Both,18 Years,65 Years,,25,2236239595,Behavioral,476,10,476,10,0.02,0.01,1,,,1636,477,1159,Parallel Assignment,,Open Label,,Treatment,Efficacy Study
NCT00158600,Completed,Actual,Phase 3,Interventional,2,,Actual,90,Both,8 Years,0,,361,1454328214,Drug,180,38,180,180,0.0055,0.8333,3,,,1636,477,1159,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00159861,Completed,Actual,Phase 3,Interventional,,,Actual,267,Both,16 Years,0,,386,1248981652,Drug,265,204,265,264,,,11,,,1636,477,1159,Parallel Assignment,,Double Blind,,Treatment,Efficacy Study
NCT00159965,Completed,Actual,Phase 4,Interventional,2,,Actual,38,Both,18 Years,95 Years,,116,2268400135,Drug,,,38,5,0.03,0.05,1,,,1636,477,1159,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00161616,Completed,Actual,Phase 4,Interventional,2,,Actual,277,Both,18 Years,0,,441,745428858,Drug,,56,,250,0.0541,0.8961,12,,,1636,477,1159,Single Group Assignment,,Single Blind,,Treatment,Efficacy Study
NCT00162942,Completed,Actual,Phase 3,Interventional,2,,Actual,235,Both,18 Years,75 Years,,123,2517084291,Device,,,,,0.858,1,2,,,1636,477,1159,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00162981,Completed,Actual,Phase 2,Interventional,2,,Actual,68,Both,2 Years,30 Years,,167,2963929165,Drug,68,4,68,58,0.0001,0.0182,1,,,1636,477,1159,Parallel Assignment,,Double Blind,,Treatment,Efficacy Study
NCT00163293,Completed,Actual,Phase 3,Interventional,3,,Actual,240,Both,4 Years,11 Years,,48,2527395224,Drug,239,6,239,167,0.0145,0.7303,3,,,1636,477,1159,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00166205,Completed,Actual,Phase 3,Interventional,1,,Actual,276,Both,18 Years,60 Years,,330,3336604758,Device,276,78,276,266,0.001,0.001,1,,,1636,477,1159,Single Group Assignment,,Open Label,,Treatment,Safety/Efficacy Study
NCT00174252,Completed,Actual,Phase 3,Interventional,1,,Actual,57,Both,4 Years,9 Years,,178,2905656074,Drug,57,6,57,30,0.002,0.708,1,,,1636,477,1159,Single Group Assignment,,Open Label,,Treatment,Safety/Efficacy Study
NCT00166296,Completed,Actual,Phase 2,Interventional,2,,Actual,133,Both,18 Years,65 Years,,282,3300006449,Drug,,,132,118,0.441,0.05,1,,,1636,477,1159,Parallel Assignment,,Double Blind,,Prevention,Safety/Efficacy Study
NCT00167245,Completed,Actual,Phase 2,Interventional,2,,Actual,170,Both,18 Years,0,,17,1576823743,Drug,,,170,70,0.01,0.45,1,,,1636,477,1159,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00168064,Completed,Actual,Phase 2,Interventional,2,,Actual,260,Both,0,0,,306,3486115913,Drug,,,255,207,,,1,,,1636,477,1159,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00168103,Completed,Actual,Phase 2/Phase 3,Interventional,3,,Actual,126,Both,6 Years,0,,224,2322988993,Biological,,,126,38,0.0014,0.0329,15,,,1636,477,1159,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00168805,Completed,,Phase 3,Interventional,3,,Actual,2101,Both,18 Years,0,,47,2338741005,Drug,2076,118,2076,1269,0.0385,1,15,,,1636,477,1159,Parallel Assignment,,Double-Blind,,Prevention,Safety/Efficacy Study
NCT00168818,Completed,,Phase 3,Interventional,3,,Actual,3494,Both,18 Years,0,,440,1048045504,Drug,3463,262,3463,1910,0.0212,0.7052,16,,,1636,477,1159,Parallel Assignment,,Double-Blind,,Prevention,Efficacy Study
NCT00168831,Completed,,Phase 3,Interventional,3,,Actual,1007,Both,40 Years,0,,385,1533570944,Drug,,191,,533,0.0002,0.0001,15,,,1636,477,1159,Parallel Assignment,,Double-Blind,,Treatment,
NCT00170846,Completed,Actual,Phase 4,Interventional,3,,Actual,394,Both,18 Years,0,,394,1913707372,Drug,394,202,394,339,0.6332,0.7943,1,,,1636,477,1159,Parallel Assignment,,Open Label,,Treatment,Safety/Efficacy Study
NCT00183456,Completed,Actual,Phase 2,Interventional,4,,Actual,746,Both,18 Years,74 Years,,199,2889579184,Behavioral,,,,,0.01,0.01,1,,,1636,477,1159,Parallel Assignment,,Double Blind,,Prevention,Efficacy Study
NCT00174382,Terminated,Actual,Phase 3,Interventional,1,,Actual,149,Both,50 Years,0,,131,106232196,Drug,,24,,53,0.004,0.906,1,,,1636,477,1159,Single Group Assignment,,Open Label,,Treatment,Safety/Efficacy Study
NCT00174460,Completed,Actual,Phase 2,Interventional,2,,Actual,33,Both,4 Years,10 Years,,195,3045026739,Drug,33,6,33,24,0.007,0.001,1,,,1636,477,1159,Parallel Assignment,,Open Label,,Treatment,Safety/Efficacy Study
NCT00177294,Completed,Actual,Phase 4,Interventional,2,,Actual,319,Both,60 Years,0,,133,2194019288,Drug,,,,,0.14,0.14,1,,,1636,477,1159,Parallel Assignment,,Single Blind,,Treatment,Efficacy Study
NCT00178503,Completed,Actual,Phase 2/Phase 3,Interventional,4,,Actual,24,Both,7 Years,12 Years,,56,4055640828,Drug,,,96,60,0.005,0.001,1,,,1636,477,1159,Single Group Assignment,,Double Blind,,Treatment,Efficacy Study
NCT00178633,Completed,Actual,N/A,Observational,,1,Actual,43,Both,18 Years,70 Years,,145,3054233798,Procedure,,,,,0.0001,0.0001,1,,,1636,477,1159,,Cohort,,Prospective,,
NCT00180271,Completed,Actual,Phase 2/Phase 3,Interventional,2,,Actual,1820,Both,21 Years,0,,437,3478470100,Device,1791,219,1791,126,0.05,0.05,1,,,1636,477,1159,Parallel Assignment,,Open Label,,Treatment,Safety/Efficacy Study
NCT00180479,Completed,Actual,Phase 3,Interventional,2,,Actual,1002,Both,18 Years,0,,430,527538929,Device,,345,,126,0.0001,0.0001,1,,,1636,477,1159,Parallel Assignment,,Single Blind,,Treatment,Safety/Efficacy Study
NCT00182078,Completed,Actual,Phase 4,Interventional,2,,Actual,26,Both,6 Years,20 Years,,369,1929858239,Drug,,,26,1,0.001,0.65,1,,,1636,477,1159,Parallel Assignment,,Double Blind,,Prevention,Safety/Efficacy Study
NCT00183092,Completed,Actual,Phase 2,Interventional,2,,Actual,69,Both,18 Years,0,,121,1154335332,Drug,75,41,75,34,0.01,0.92,1,,,1636,477,1159,Parallel Assignment,,Double Blind,,Treatment,Efficacy Study
NCT00190775,Completed,Actual,Phase 4,Interventional,2,,Actual,502,Both,18 Years,0,,55,933064736,Drug,500,7,500,439,0.792,0.001,2,,,1636,477,1159,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00183625,Completed,Actual,Phase 4,Interventional,4,,Actual,107,Both,18 Years,60 Years,,405,2119471695,Drug,107,28,,,0.0176,0.66,1,,,1636,477,1159,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00184548,Terminated,Actual,Phase 3,Interventional,4,,Actual,554,Both,18 Years,70 Years,,2,2465663586,Drug,560,362,560,283,0.03,0.934,14,,,1636,477,1159,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00185211,Completed,Actual,Phase 3,Interventional,2,,Actual,468,Both,18 Years,48 Years,,304,3878017841,Drug,468,103,468,452,0.000006,0.000001,20,,,1636,477,1159,Parallel Assignment,,Open Label,,Treatment,Safety/Efficacy Study
NCT00185458,Completed,Actual,Phase 3,Interventional,1,,Actual,394,Female,46 Years,51 Years,,290,121024348,Drug,394,25,394,357,0.027,0.001,4,,,1636,477,1159,Single Group Assignment,,Open Label,,Treatment,Safety/Efficacy Study
NCT00186888,"Active, not recruiting",Anticipated,Phase 3,Interventional,3,,Actual,107,Both,0,0,,400,2039344290,Procedure,105,11,105,68,0.106,0.844,1,,,1636,477,1159,Parallel Assignment,,Open Label,,Treatment,Efficacy Study
NCT00187889,Completed,Actual,Phase 4,Interventional,2,,Actual,70,Female,21 Years,75 Years,,249,2806977916,Drug,50,1,50,6,0.15,0.92,1,,,1636,477,1159,Parallel Assignment,,Double Blind,,Treatment,Efficacy Study
NCT00189098,Completed,Actual,N/A,Interventional,2,,Actual,101,Both,1 Years,12 Years,,104,3825874814,Drug,101,2,101,5,,,1,,,1636,477,1159,Parallel Assignment,,Double Blind,,Treatment,Efficacy Study
NCT00189423,Terminated,Actual,N/A,Interventional,2,,Actual,1653,Both,18 Years,0,,208,2481567300,Device,1653,1553,,,0.0001,0.681,1,,,1636,477,1159,Parallel Assignment,,Single Blind,,Treatment,Safety/Efficacy Study
NCT00189540,Completed,Actual,Phase 2,Interventional,2,,Actual,27,Both,40 Years,0,,41,3133420132,Genetic,27,20,27,25,0.04,1,1,,,1636,477,1159,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00191945,Completed,Actual,Phase 3,Interventional,2,,Actual,151,Both,6 Years,15 Years,,55,933064736,Drug,151,1,151,118,0.0009,0.001,1,,,1636,477,1159,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00191139,Completed,Actual,Phase 2,Interventional,2,,Actual,64,Both,18 Years,0,,326,1982470504,Drug,64,31,64,64,0.08,0.38,4,,,1636,477,1159,Parallel Assignment,,Open Label,,Treatment,Efficacy Study
NCT00191152,Completed,Actual,Phase 3,Interventional,2,,Actual,475,Both,18 Years,0,,73,1499605101,Drug,463,127,463,454,0.117,0.99,8,,,1636,477,1159,Crossover Assignment,,Open Label,,Treatment,Efficacy Study
NCT00191165,Completed,Actual,Phase 3,Interventional,2,,Actual,27,Both,0,14 Years,,194,1177800271,Drug,,1,,18,0.061,0.388,1,,,1636,477,1159,Parallel Assignment,,Open Label,,Treatment,Safety/Efficacy Study
NCT00191282,Completed,Actual,Phase 4,Interventional,2,,Actual,1116,Both,30 Years,0,,144,3633170488,Drug,,287,,702,0.086,0.982,17,,,1636,477,1159,Parallel Assignment,,Open Label,,Treatment,Safety/Efficacy Study
NCT00191386,Completed,Actual,Phase 3,Interventional,1,,Actual,228,Both,6 Years,17 Years,,55,933064736,Drug,228,6,228,222,0.001,0.001,1,,,1636,477,1159,Single Group Assignment,,Open Label,,Treatment,Safety Study
NCT00191477,Terminated,Actual,Phase 3,Interventional,2,,Actual,355,Both,18 Years,0,,67,2486064534,Drug,328,27,328,74,0.777,0.777,1,,,1636,477,1159,Parallel Assignment,,Double Blind,,Treatment,Efficacy Study
NCT00191646,Completed,Actual,Phase 3,Interventional,2,,Actual,919,Female,18 Years,0,,190,2982276392,Drug,1327,210,1327,1274,0.013,0.784,2,,,1636,477,1159,Crossover Assignment,,Open Label,,Treatment,Safety/Efficacy Study
NCT00191724,Completed,Actual,Phase 2,Interventional,5,,Actual,47,Both,18 Years,80 Years,,435,576207025,Drug,,7,,36,0.018,0.985,1,,,1636,477,1159,Parallel Assignment,,Double Blind,,Treatment,Safety Study
NCT00191906,Completed,Actual,Phase 4,Interventional,4,,Actual,121,Both,8 Years,12 Years,,55,933064736,Drug,,,175,87,0.003,0.001,2,,,1636,477,1159,Crossover Assignment,,Double Blind,,Treatment,Efficacy Study
NCT00195819,Completed,Actual,Phase 3,Interventional,2,,Actual,82,Both,18 Years,0,,33,3267503137,Biological,82,20,82,78,0.06,0.387,1,,,1636,477,1159,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00192023,Completed,Actual,Phase 3,Interventional,2,,Actual,139,Both,6 Years,15 Years,,55,933064736,Drug,,,139,91,0.001,0.001,1,,,1636,477,1159,Parallel Assignment,,Double Blind,,Treatment,Efficacy Study
NCT00194025,Completed,Actual,Phase 4,Interventional,1,,Actual,20,Both,50 Years,0,,405,2119471695,Drug,,,,,0.017,0.001,1,,,1636,477,1159,Single Group Assignment,,Open Label,,Treatment,Safety/Efficacy Study
NCT00195273,Completed,Actual,Phase 3,Interventional,2,,Actual,61,Both,18 Years,0,,193,4053992763,Drug,,50,,61,0.4662,0.6081,2,,,1636,477,1159,Parallel Assignment,,Open Label,,Treatment,Safety/Efficacy Study
NCT00195351,Completed,Actual,Phase 4,Interventional,2,,Actual,467,Both,18 Years,0,,39,3118204704,Drug,,100,,384,0.009,0.02,6,,,1636,477,1159,Single Group Assignment,,Open Label,,Treatment,Safety/Efficacy Study
NCT00195403,Completed,Actual,N/A,Observational,,1,Actual,1014,Both,4 Years,0,,401,2326608903,Drug,998,3,998,142,0.0001,0.0001,1,,,1636,477,1159,,Case-Only,,Prospective,,
NCT00195429,Completed,Actual,Phase 4,Interventional,2,,Actual,47,Both,13 Years,0,,255,2427876087,Drug,,,47,45,0.361,1,1,,,1636,477,1159,Parallel Assignment,,Open Label,,Treatment,Safety/Efficacy Study
NCT00195494,Completed,Actual,Phase 4,Interventional,4,,Actual,542,Both,18 Years,0,,401,2326608903,Drug,,108,,817,0.001,0.001,1,,,1636,477,1159,Parallel Assignment,,Double Blind,,Treatment,Efficacy Study
NCT00195663,Completed,Actual,Phase 3,Interventional,3,,Actual,799,Both,18 Years,0,,157,120873158,Biological,1496,488,1496,1329,0.5402,0.001,19,,,1636,477,1159,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00195702,Completed,Actual,Phase 3,Interventional,6,,Actual,619,Both,18 Years,0,,401,2326608903,Biological,1172,352,1172,975,0.001,0.01,2,,,1636,477,1159,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00203892,Completed,Actual,Phase 1/Phase 2,Interventional,3,,Actual,23,Both,18 Years,0,,342,1476279783,Biological,,,19,7,0.028,0.99,1,,,1636,477,1159,Parallel Assignment,,Open Label,,Treatment,Safety/Efficacy Study
NCT00196105,Completed,Actual,N/A,Interventional,3,,Actual,241,Both,21 Years,0,,63,2512545532,Device,,,,,0.007,0.69,1,,,1636,477,1159,Parallel Assignment,,Open Label,,Treatment,Efficacy Study
NCT00197106,Completed,Actual,Phase 4,Interventional,1,,Actual,176,Both,6 Years,12 Years,,48,2527395224,Drug,158,5,158,84,0.63,0.63,1,,,1636,477,1159,Parallel Assignment,,Double Blind,,Treatment,Efficacy Study
NCT00198822,Completed,Actual,Phase 3,Interventional,3,,Actual,59666,Female,15 Years,49 Years,,461,2825133744,Dietary Supplement,,,,,0.05,0.05,2,,,1636,477,1159,Parallel Assignment,,Double Blind,,Prevention,Efficacy Study
NCT00200057,Completed,Actual,N/A,Interventional,1,,Actual,285,Both,18 Years,0,,177,3043226755,Device,120,41,120,88,0.0001,0.0001,2,,,1636,477,1159,Single Group Assignment,,Open Label,,Treatment,Safety/Efficacy Study
NCT00200967,Completed,Actual,Phase 3,Interventional,2,,Actual,87,Both,18 Years,90 Years,,48,2527395224,Drug,87,5,87,40,0.004,0.99,1,,,1636,477,1159,Crossover Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00201201,Completed,Actual,N/A,Interventional,2,,Actual,160,Both,60 Years,0,,84,3416315868,Other,,,,,0.0001,0.1,1,,,1636,477,1159,Parallel Assignment,,Open Label,,,
NCT00201643,Completed,Actual,Phase 4,Interventional,2,,Actual,437,Female,18 Years,60 Years,,375,3505650681,Drug,1014,81,,,0.002,0.002,1,,,1636,477,1159,Parallel Assignment,,Double Blind,,Prevention,Safety/Efficacy Study
NCT00203268,Completed,Actual,N/A,Interventional,1,,Actual,13,Both,18 Years,65 Years,,299,3712179563,Drug,,,18,6,0.3025,0.3025,1,,,1636,477,1159,Single Group Assignment,,Open Label,,Treatment,Efficacy Study
NCT00203294,Completed,Actual,N/A,Interventional,2,,Actual,45,Both,18 Years,65 Years,,299,3712179563,Drug,,,,,0.01,0.01,1,,,1636,477,1159,Parallel Assignment,,Single Blind,,Treatment,Safety/Efficacy Study
NCT00203931,Terminated,Actual,Phase 2,Interventional,2,,Actual,55,Both,18 Years,0,,326,1982470504,Drug,43,18,43,32,0.029,0.91,1,,,1636,477,1159,Parallel Assignment,,Open Label,,Treatment,Safety/Efficacy Study
NCT00208507,Completed,Actual,N/A,Interventional,2,,Actual,264,Both,20 Years,75 Years,,250,1724926904,Device,264,41,264,124,0.001,0.001,1,,,1636,477,1159,Parallel Assignment,,Single Blind,,Treatment,Safety/Efficacy Study
NCT00204932,Completed,Actual,Phase 2,Interventional,2,,Actual,53,Both,18 Years,44 Years,,329,1330809903,Drug,,,48,3,0.05,0.05,1,,,1636,477,1159,Parallel Assignment,,Double Blind,,Treatment,Efficacy Study
NCT00205777,Completed,Actual,Phase 3,Interventional,2,,Actual,7609,Female,55 Years,80 Years,,337,2339607719,Drug,7492,1847,7492,7216,0.001,0.001,30,,,1636,477,1159,Single Group Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00205803,Completed,Actual,Phase 1/Phase 2,Interventional,2,,Actual,249,Both,42 Days,98 Days,,206,4045688794,Biological,624,24,624,351,,,1,,,1636,477,1159,Parallel Assignment,,Double-Blind,,Prevention,Safety Study
NCT00206726,Completed,Actual,Phase 2,Interventional,1,,Actual,60,Both,18 Years,0,,261,651820616,Drug,57,41,57,55,0.014,0.014,1,,,1636,477,1159,Single Group Assignment,,Open Label,,Treatment,Safety/Efficacy Study
NCT00207090,Completed,Actual,Phase 1,Interventional,1,,Actual,19,Both,18 Years,0,,14,2822688266,Drug,15,4,15,14,,,1,,,1636,477,1159,Single Group Assignment,,Open Label,,Treatment,Pharmacokinetics Study
NCT00207142,Completed,Actual,Phase 4,Interventional,3,,Actual,252,Both,18 Years,0,,199,2889579184,Drug,252,23,252,199,,,10,,,1636,477,1159,Parallel Assignment,,Open Label,,Treatment,Efficacy Study
NCT00207740,Completed,Actual,Phase 2,Interventional,2,,Actual,309,Both,18 Years,0,,48,2527395224,Drug,309,86,309,293,0.021,0.986,11,,,1636,477,1159,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00208091,Completed,Actual,Phase 4,Interventional,1,,Actual,16,Both,25 Years,69 Years,,182,719727155,Drug,,,,,0.06,0.23,1,,,1636,477,1159,Single Group Assignment,,Open Label,,Treatment,Efficacy Study
NCT00216320,Completed,Actual,N/A,Interventional,3,,Actual,121,Both,18 Years,0,,433,678611600,Device,112,3,112,13,0.001,0.001,1,,,1636,477,1159,Crossover Assignment,,Open Label,,Treatment,Efficacy Study
NCT00209131,Terminated,Actual,N/A,Interventional,2,,Actual,24,Both,18 Years,0,,455,2640149670,Drug,,,,,0.05,0.05,1,,,1636,477,1159,Parallel Assignment,,Open Label,,Treatment,Efficacy Study
NCT00210626,Terminated,Actual,Phase 2,Interventional,2,,Actual,192,Both,18 Years,55 Years,,29,1185043251,Drug,188,37,188,164,0.3807,0.7038,1,,,1636,477,1159,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00211536,Completed,Actual,Phase 3,Interventional,2,,Actual,107,Both,18 Years,65 Years,,447,3017351476,Drug,107,16,107,78,0.05,0.05,1,,,1636,477,1159,Parallel Assignment,,Open Label,,Treatment,Efficacy Study
NCT00212134,Completed,Actual,Phase 3,Interventional,2,,Actual,114,Both,0,210 Days,,113,2209951279,Device,,,114,78,0.008,0.05,1,,,1636,477,1159,Parallel Assignment,,Open Label,,Treatment,Efficacy Study
NCT00215137,Completed,Actual,Phase 2,Interventional,3,,Actual,14,Both,18 Years,0,,328,429793797,Drug,,,,,0.0417,0.0002,1,,,1636,477,1159,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00215150,Completed,Actual,Phase 2,Interventional,3,,Actual,51,Both,18 Years,65 Years,,420,719201761,Drug,,,,,0.001,0.05,1,,,1636,477,1159,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00215540,Terminated,Actual,Phase 2,Interventional,3,,Actual,136,Both,0,10 Days,,396,154706622,Drug,136,104,136,136,0.006,0.944,1,,,1636,477,1159,Parallel Assignment,,Double Blind,,Prevention,Safety/Efficacy Study
NCT00215553,Terminated,Actual,Phase 2,Interventional,7,,Actual,124,Both,16 Years,75 Years,,7,3391465483,Drug,124,49,124,114,0.028,0.964,1,,,1636,477,1159,Parallel Assignment,,Open Label,,Treatment,Safety/Efficacy Study
NCT00216476,Completed,Actual,Phase 3,Interventional,3,,Actual,753,Both,18 Years,0,,405,2119471695,Drug,711,147,711,442,0.0446,0.0001,24,,,1636,477,1159,Parallel Assignment,,Open Label,,Treatment,Safety/Efficacy Study
NCT00220779,Completed,Actual,Phase 2,Interventional,3,,Actual,128,Both,18 Years,55 Years,,305,3529108695,Drug,128,5,128,87,0.221,0.471,12,,,1636,477,1159,Parallel Assignment,,Double Blind,,Treatment,Efficacy Study
NCT00216671,Completed,Actual,Phase 4,Interventional,2,,Actual,220,Both,18 Years,65 Years,,405,2119471695,Drug,220,40,220,124,0.519,0.001,10,,,1636,477,1159,Parallel Assignment,,Open Label,,Treatment,Safety/Efficacy Study
NCT00217087,Completed,Actual,Phase 2,Interventional,2,,Actual,73,Both,18 Years,0,,158,1639129743,Procedure,73,5,73,24,0.0098,0.34,1,,,1636,477,1159,Parallel Assignment,,Open Label,,Treatment,Efficacy Study
NCT00218296,Completed,Actual,Phase 2,Interventional,2,,Actual,332,Both,18 Years,70 Years,,443,179058863,Drug,,,199,71,0.002,0.056,1,,,1636,477,1159,Parallel Assignment,,Open Label,,Treatment,Efficacy Study
NCT00218439,Completed,Actual,N/A,Interventional,2,,Actual,105,Both,18 Years,65 Years,,443,179058863,Drug,,,124,69,0.006,0.001,1,,,1636,477,1159,Crossover Assignment,,Double Blind,,Treatment,Pharmacodynamics Study
NCT00218634,Completed,Actual,N/A,Interventional,2,,Actual,89,Both,18 Years,65 Years,,11,3704993648,Behavioral,,,,,0.05,0.05,1,,,1636,477,1159,Parallel Assignment,,Single Blind,,Treatment,Efficacy Study
NCT00219544,Completed,Actual,Phase 3,Interventional,4,,Actual,158,Both,18 Years,0,,317,2211147477,Drug,,1,,258,0.0003,0.0001,1,,,1636,477,1159,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00219557,Completed,Actual,Phase 2,Interventional,2,,Actual,111,Both,18 Years,0,,344,1385352340,Drug,107,48,107,100,0.1026,0.661,8,,,1636,477,1159,Parallel Assignment,,Open Label,,Treatment,Safety/Efficacy Study
NCT00220636,Completed,Actual,Phase 4,Interventional,1,,Actual,15,Both,18 Years,70 Years,,136,1049032054,Drug,,,15,8,0.008,0.001,1,,,1636,477,1159,Single Group Assignment,,Open Label,,Treatment,Efficacy Study
NCT00220740,Completed,Actual,Phase 3,Interventional,2,,Actual,117,Both,18 Years,0,,360,3280533209,Drug,208,14,208,106,0.001,0.001,10,,,1636,477,1159,Parallel Assignment,,Double Blind,,Treatment,Efficacy Study
NCT00230971,Completed,Actual,Phase 4,Interventional,2,,Actual,473,Both,18 Years,0,,39,3118204704,Drug,467,75,467,328,0.001,0.75,19,,,1636,477,1159,Parallel Assignment,,Open Label,,Treatment,Safety/Efficacy Study
NCT00223236,Completed,Actual,Phase 3,Interventional,2,,Actual,44,Both,18 Years,70 Years,,286,3805192690,Drug,44,3,,,0.4637,0.4637,1,,,1636,477,1159,Parallel Assignment,,Double Blind,,Treatment,Efficacy Study
NCT00223652,Completed,Actual,Phase 2,Interventional,2,,Actual,85,Both,18 Years,0,,135,1716088513,Behavioral,,,,,0.07,0.37,1,,,1636,477,1159,Parallel Assignment,,Single Blind,,Treatment,Efficacy Study
NCT00224770,Completed,Actual,Phase 2,Interventional,3,,Actual,141,Both,18 Years,80 Years,,246,4065823762,Drug,110,57,110,73,0.156,0.0001,4,,,1636,477,1159,Parallel Assignment,,Open Label,,Treatment,Safety/Efficacy Study
NCT00225017,Completed,Actual,Phase 3,Interventional,2,,Actual,50,Both,18 Years,0,,198,3223041150,Drug,,,,,0.141,0.009,3,,,1636,477,1159,Parallel Assignment,,Open Label,,Treatment,Safety/Efficacy Study
NCT00225147,Completed,Actual,Phase 2/Phase 3,Interventional,3,,Actual,77,Both,12 Years,0,,32,1706155871,Drug,100,4,100,25,0.001,0.001,1,,,1636,477,1159,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00225251,Completed,Actual,Phase 4,Interventional,2,,Actual,18,Both,18 Years,65 Years,,156,3252367856,Drug,,,18,9,0.05,0.05,1,,,1636,477,1159,Parallel Assignment,,Double Blind,,Treatment,Efficacy Study
NCT00227266,Completed,Actual,Phase 2,Interventional,3,,Actual,94,Both,2 Years,17 Years,,424,1686373220,Drug,94,9,94,69,0.001,0.001,2,,,1636,477,1159,Crossover Assignment,,Double Blind,,Treatment,Efficacy Study
NCT00227903,Completed,Actual,Phase 2,Interventional,2,,Actual,168,Female,16 Years,45 Years,,16,2154971641,Behavioral,,,,,0.01,0.05,1,,,1636,477,1159,Parallel Assignment,,Open Label,,Treatment,Efficacy Study
NCT00228566,Completed,Actual,Phase 3,Interventional,,,Actual,247,Both,18 Years,65 Years,,172,2180414515,Drug,246,6,246,134,,,1,,,1636,477,1159,Single Group Assignment,,Open Label,,Treatment,
NCT00234078,Completed,Actual,Phase 2,Interventional,4,,Actual,290,Both,20 Years,0,,154,136942581,Drug,290,5,290,127,0.004,0.601,1,,,1636,477,1159,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00231153,Completed,Actual,Phase 3,Interventional,2,,Actual,1859,Both,13 Years,0,,239,385418706,Drug,,,,,0.002,0.001,4,,,1636,477,1159,Parallel Assignment,,Open Label,,Prevention,Safety/Efficacy Study
NCT00231179,Completed,Actual,Phase 3,Interventional,2,,Actual,302,Both,4 Years,5 Years,,89,3175281679,Behavioral,,,,,0.59,0.05,1,,,1636,477,1159,Parallel Assignment,,Single Blind,,Prevention,Efficacy Study
NCT00231283,Completed,Actual,Phase 3,Interventional,1,,Actual,100,Both,18 Years,0,,119,2281658183,Device,95,1,96,12,,,1,,,1636,477,1159,Single Group Assignment,,Open Label,,Treatment,Safety/Efficacy Study
NCT00232141,Completed,Actual,Phase 3,Interventional,2,,Actual,302,Both,18 Years,0,,199,2889579184,Drug,,,,,0.004,0.9964,2,,,1636,477,1159,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00232180,Completed,Actual,Phase 3,Interventional,1,,Actual,2743,Both,55 Years,0,,213,3865579137,Drug,6710,2646,6710,2673,0.0081,0.0001,29,,,1636,477,1159,Single Group Assignment,,Open Label,,Treatment,Safety Study
NCT00232596,Completed,Actual,Phase 3,Interventional,2,,Actual,306,Both,18 Years,75 Years,,348,2794048920,Drug,520,38,520,311,0.001,0.001,5,,,1636,477,1159,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00232739,Completed,Actual,Phase 3,Interventional,1,,Actual,100,Both,18 Years,0,,119,2281658183,Device,91,5,96,39,N/A,N/A,1,,,1636,477,1159,Single Group Assignment,,Open Label,,Treatment,Safety/Efficacy Study
NCT00233064,Completed,Actual,Phase 4,Interventional,2,,Actual,417,Both,0,24 Months,,100,609893392,Biological,413,30,,,,,1,,,1636,477,1159,Parallel Assignment,,Double Blind,,Treatment,Safety Study
NCT00234065,Completed,Actual,Phase 4,Interventional,2,,Actual,2800,Both,20 Years,80 Years,,85,3646913257,Drug,2672,805,2672,2527,0.0004,0.86,1,,,1636,477,1159,Parallel Assignment,,Double Blind,,Prevention,Safety/Efficacy Study
NCT00234104,Completed,Actual,Phase 2,Interventional,,,Actual,122,Both,20 Years,80 Years,,214,1697312720,Drug,118,7,118,81,0.001,0.0459,1,,,1636,477,1159,Parallel Assignment,,Double-Blind,,Treatment,Safety/Efficacy Study
NCT00237666,Completed,Actual,Phase 4,Interventional,1,,Actual,30,Both,18 Years,0,,65,758287255,Drug,30,1,30,20,0.0001,0.0001,1,,,1636,477,1159,Single Group Assignment,,Open Label,,Treatment,Safety/Efficacy Study
NCT00234286,Completed,Actual,N/A,Interventional,1,,Actual,78,Both,0,0,,126,2245485319,Behavioral,,,,,0.003,0.86,1,,,1636,477,1159,Single Group Assignment,,Open Label,,Health Services Research,Efficacy Study
NCT00234832,Completed,Actual,Phase 3,Interventional,3,,Actual,10777,Both,55 Years,0,,329,1330809903,Drug,20529,4465,,,0.015,0.948,1,,,1636,477,1159,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00235716,Completed,Actual,Phase 3,Interventional,4,,Actual,613,Both,40 Years,0,,23,4032982200,Drug,613,344,613,367,0.03,0.94,2,,,1636,477,1159,Factorial Assignment,,Double Blind,,Treatment,Efficacy Study
NCT00235755,Completed,Actual,Phase 3,Interventional,3,,Actual,539,Both,18 Years,75 Years,,348,2794048920,Drug,931,44,931,350,0.007,0.001,13,,,1636,477,1159,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00236080,Completed,,Phase 3,Interventional,5,,Actual,136,Both,18 Years,65 Years,,105,912304318,Drug,,,134,29,0.0945,0.1236,1,,,1636,477,1159,Parallel Assignment,,Double-Blind,,Treatment,Efficacy Study
NCT00236184,Completed,Actual,Phase 3,Interventional,2,,Actual,629,Both,19 Years,0,,216,1501901890,Drug,629,3,629,11,0.001,0.001,1,,,1636,477,1159,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00236899,Completed,Actual,Phase 3,Interventional,4,,Actual,241,Female,18 Years,0,,295,377576721,Drug,238,37,238,224,0.0028,0.976,1,,,1636,477,1159,Factorial Assignment,,Open Label,,Treatment,Safety/Efficacy Study
NCT00237042,Completed,Actual,N/A,Interventional,3,,Actual,252,Female,18 Years,45 Years,,438,836342297,Behavioral,,,140,23,0.003,0.27,1,,,1636,477,1159,Parallel Assignment,,Single Blind,,Treatment,Efficacy Study
NCT00243269,Completed,Actual,Phase 1/Phase 2,Interventional,4,,Actual,83,Female,18 Years,0,,311,1233291739,Behavioral,,,,,0.84,0.932,1,,,1636,477,1159,Parallel Assignment,,Double Blind,,Supportive Care,Efficacy Study
NCT00237718,Completed,Actual,Phase 2,Interventional,2,,Actual,385,Both,18 Years,0,,161,1124500464,Drug,325,96,325,176,0.05,0.05,1,,,1636,477,1159,Parallel Assignment,,Double Blind,,Treatment,Efficacy Study
NCT00238615,Terminated,Actual,Phase 2,Interventional,1,,Actual,13,Both,18 Years,0,,271,2288821332,Drug,13,8,13,10,,,1,,,1636,477,1159,Single Group Assignment,,Open Label,,Treatment,Efficacy Study
NCT00239226,Completed,Actual,Phase 4,Interventional,4,,Actual,102,Both,18 Years,0,,411,791024063,Procedure,97,3,,,0.047,0.047,1,,,1636,477,1159,Parallel Assignment,,Single Blind,,Prevention,Efficacy Study
NCT00239681,Terminated,Actual,Phase 3,Interventional,2,,Actual,17802,Both,50 Years,0,,159,1744629141,Drug,17733,2421,17733,6398,0.018,0.172,27,,,1636,477,1159,Parallel Assignment,,Double Blind,,Prevention,Safety/Efficacy Study
NCT00240487,Completed,Actual,Phase 3,Interventional,2,,Actual,52,Both,1 Months,18 Years,,7,3391465483,Drug,,,,,0.05,0.05,1,,,1636,477,1159,Parallel Assignment,,Open Label,,Treatment,Safety/Efficacy Study
NCT00241176,Completed,Actual,Phase 4,Interventional,1,,Actual,11,Both,7 Years,18 Years,,444,3453728878,Drug,,,11,11,0.05,0.05,1,,,1636,477,1159,Single Group Assignment,,Open Label,,Treatment,Safety/Efficacy Study
NCT00242385,Completed,Actual,Phase 1,Interventional,2,,Actual,25,Both,18 Years,0,,20,1595060059,Biological,,,50,42,,,2,,,1636,477,1159,Crossover Assignment,,Double-Blind,,Treatment,Pharmacokinetics Study
NCT00242710,Completed,Actual,Phase 3,Interventional,4,,Actual,1083,Female,40 Years,65 Years,,164,1069563061,Drug,1061,55,1061,948,0.003,0.001,1,,,1636,477,1159,Parallel Assignment,,Double Blind,,Prevention,Safety/Efficacy Study
NCT00243022,Terminated,Actual,Phase 2,Interventional,2,,Actual,12,Both,18 Years,0,,72,660508271,Drug,12,2,12,6,0.12,0.9,1,,,1636,477,1159,Parallel Assignment,,Open Label,,Treatment,Efficacy Study
NCT00247676,Completed,Actual,Phase 2,Interventional,1,,Actual,37,Both,18 Years,0,,267,683971202,Drug,37,24,37,37,,,3,,,1636,477,1159,Single Group Assignment,,Open Label,,Treatment,Efficacy Study
NCT00243386,Completed,Actual,Phase 4,Interventional,2,,Actual,82,Both,7 Years,65 Years,,218,483804573,Drug,140,13,140,29,0.0002,0.0001,10,,,1636,477,1159,Parallel Assignment,,Open Label,,Treatment,Efficacy Study
NCT00244140,Completed,Actual,Phase 3,Interventional,2,,Actual,435,Both,18 Years,0,,112,2653119705,Drug,434,2,434,33,,,4,,,1636,477,1159,Parallel Assignment,,Open Label,,Diagnostic,Safety/Efficacy Study
NCT00244712,Completed,Actual,Phase 4,Interventional,2,,Actual,688,Both,18 Years,0,,198,3223041150,Drug,,87,,364,0.913,0.913,2,,,1636,477,1159,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00244764,Completed,Actual,Phase 2,Interventional,2,,Actual,225,Both,21 Years,0,,81,1588592340,Drug,225,80,225,215,,,9,,,1636,477,1159,Single Group Assignment,,Open Label,,Treatment,Safety/Efficacy Study
NCT00245050,Completed,Actual,Phase 3,Interventional,2,,Actual,34,Female,0,0,,73,1499605101,Drug,29,14,29,23,0.916,0.05,1,,,1636,477,1159,Parallel Assignment,,Double Blind,,Supportive Care,Efficacy Study
NCT00246025,Completed,,Phase 2,Interventional,4,,Actual,512,Both,20 Years,0,,47,2338741005,Drug,512,10,512,224,0.0006,0.0001,1,,,1636,477,1159,Parallel Assignment,,Double-Blind,,Prevention,Efficacy Study
NCT00246571,Completed,Actual,Phase 2,Interventional,2,,Actual,217,Both,18 Years,0,,74,3128271172,Drug,213,61,213,207,0.814,0.9624,12,,,1636,477,1159,Parallel Assignment,,Open Label,,Treatment,Safety/Efficacy Study
NCT00247273,Completed,Actual,Phase 3,Interventional,2,,Actual,1294,Female,50 Years,0,,367,1461450240,Drug,1292,128,1292,1132,1,1,14,,,1636,477,1159,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00247611,Completed,Actual,Phase 2,Interventional,2,,Actual,594,Both,18 Years,0,,197,2709160825,Behavioral,,,,,0.024,0.5,1,,,1636,477,1159,Parallel Assignment,,Open Label,,Treatment,Efficacy Study
NCT00251758,Completed,Actual,Phase 3,Interventional,3,,Actual,908,Both,18 Years,0,,184,2110570532,Drug,,3,,146,0.00001,0.00001,1,,,1636,477,1159,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00247962,Completed,Actual,Phase 4,Interventional,2,,Actual,566,Both,18 Years,0,,33,3267503137,Drug,,11,,313,0.01,0.001,18,,,1636,477,1159,Parallel Assignment,,Double Blind,,Treatment,Efficacy Study
NCT00248547,Completed,Actual,N/A,Interventional,2,,Actual,40,Both,18 Years,0,,76,3991381194,Drug,40,2,,,0.041,0.041,1,,,1636,477,1159,Parallel Assignment,,Double Blind,,Supportive Care,Safety/Efficacy Study
NCT00249288,Completed,Actual,Phase 4,Interventional,2,,Actual,46,Both,18 Years,68 Years,,405,2119471695,Drug,,,,,0.37,0.37,1,,,1636,477,1159,Parallel Assignment,,Double Blind,,Treatment,Efficacy Study
NCT00249613,Completed,Actual,N/A,Interventional,2,,Actual,291,Female,18 Years,75 Years,,436,1195930968,Behavioral,,,,,0.01,0.33,1,,,1636,477,1159,Parallel Assignment,,Open Label,,Treatment,Efficacy Study
NCT00249873,Completed,Actual,Phase 3,Interventional,2,,Actual,7554,Both,18 Years,0,,51,734346743,Drug,7554,2223,7554,5044,0.0133,0.001,30,,,1636,477,1159,Parallel Assignment,,Double Blind,,Prevention,Efficacy Study
NCT00251303,Completed,Actual,Phase 2,Interventional,2,,Actual,78,Both,7 Years,17 Years,,331,1244656958,Drug,60,1,60,56,0.959,0.959,1,,,1636,477,1159,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00251693,Completed,Actual,Phase 3,Interventional,3,,Actual,2038,Both,18 Years,0,,171,3175721293,Drug,2038,13,2038,166,0.001,0.927,15,,,1636,477,1159,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00251719,Completed,Actual,Phase 3,Interventional,3,,Actual,2054,Both,18 Years,0,,171,3175721293,Drug,2054,10,2054,84,0.019,0.993,16,,,1636,477,1159,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00251745,Completed,Actual,Phase 3,Interventional,3,,Actual,908,Both,18 Years,0,,184,2110570532,Drug,,3,,146,0.00001,0.00001,1,,,1636,477,1159,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00255190,Completed,Actual,Phase 3,Interventional,2,,Actual,591,Both,18 Years,0,,184,2110570532,Drug,,30,,228,0.005,0.001,1,,,1636,477,1159,Parallel Assignment,,Open Label,,Treatment,Safety Study
NCT00251862,Completed,Actual,N/A,Interventional,3,,Actual,825,Both,50 Years,75 Years,,108,1696863024,Behavioral,,,,,0.046,0.001,1,,,1636,477,1159,Parallel Assignment,,Single Blind,,Prevention,Efficacy Study
NCT00252187,Completed,Actual,Phase 1/Phase 2,Interventional,2,,Actual,45,Both,18 Years,0,,114,2971302321,Drug,45,4,45,37,0.001,0.14,1,,,1636,477,1159,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00252629,Completed,Actual,N/A,Interventional,2,,Actual,29,Male,32 Years,52 Years,,38,633347903,Other,,,,,0.0001,0.004,1,,,1636,477,1159,Parallel Assignment,,Single Blind,,Treatment,Efficacy Study
NCT00253370,Completed,Actual,Phase 2,Interventional,1,,Actual,44,Both,18 Years,0,,9,3114325493,Drug,44,40,44,44,0.0012,0.0012,1,,,1636,477,1159,Single Group Assignment,,Open Label,,Treatment,Efficacy Study
NCT00253890,Completed,Actual,Phase 3,Interventional,2,,Actual,137,Both,18 Years,75 Years,,362,1867826490,Drug,,,,,0.05,0.05,1,,,1636,477,1159,Parallel Assignment,,Double Blind,,Treatment,Efficacy Study
NCT00254540,Completed,Actual,Phase 2,Interventional,1,,Actual,51,Both,20 Years,0,,81,1588592340,Drug,51,28,51,51,,,1,,,1636,477,1159,Single Group Assignment,,Open Label,,Treatment,Safety/Efficacy Study
NCT00254566,Completed,Actual,Phase 3,Interventional,2,,Actual,398,Both,50 Years,0,,92,2668162075,Other,,13,,51,0.159,0.87,6,,,1636,477,1159,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00255151,Completed,Actual,Phase 3,Interventional,3,,Actual,451,Both,18 Years,0,,171,3175721293,Drug,,7,,65,0.37161,0.00001,1,,,1636,477,1159,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00255164,Completed,Actual,Phase 3,Interventional,3,,Actual,451,Both,18 Years,0,,171,3175721293,Drug,,7,,65,0.37161,0.00001,1,,,1636,477,1159,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00260832,Completed,Actual,Phase 3,Interventional,2,,Actual,485,Both,65 Years,0,,5,1001156887,Drug,475,352,475,468,0.1079,0.1079,15,,,1636,477,1159,Parallel Assignment,,Open Label,,Treatment,Safety/Efficacy Study
NCT00255970,Completed,Actual,Phase 2/Phase 3,Interventional,2,,Actual,40,Both,18 Years,0,,352,3703859271,Other,,,,,0.05,0.05,1,,,1636,477,1159,Parallel Assignment,,Double Blind,,Prevention,Safety/Efficacy Study
NCT00256997,Terminated,Actual,Phase 4,Interventional,2,,Actual,167,Both,18 Years,65 Years,,405,2119471695,Drug,167,20,167,139,0.5498,0.5498,4,,,1636,477,1159,Parallel Assignment,,Open Label,,Treatment,Safety/Efficacy Study
NCT00257192,Terminated,Actual,Phase 3,Interventional,2,,Actual,284,Both,13 Years,17 Years,,405,2119471695,Drug,283,10,283,137,0.0412,0.4661,9,,,1636,477,1159,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00257556,Completed,Actual,Phase 4,Interventional,2,,Actual,80,Female,20 Years,35 Years,,242,1134102512,Drug,76,13,76,39,,,2,,,1636,477,1159,Parallel Assignment,,Open Label,,Treatment,Safety/Efficacy Study
NCT00257920,Completed,,Phase 4,Interventional,2,,Actual,41,Both,20 Years,0,,98,1111248481,Drug,,6,,33,0.573,0.67,1,,,1636,477,1159,Crossover Assignment,,Open Label,,Treatment,Safety/Efficacy Study
NCT00258310,Completed,Actual,Phase 2,Interventional,1,,Actual,35,Both,18 Years,0,,204,599964,Drug,35,2,35,3,,,1,,,1636,477,1159,Single Group Assignment,,Open Label,,Treatment,Safety/Efficacy Study
NCT00258674,Completed,Actual,N/A,Interventional,3,,Actual,1891,Both,65 Years,0,,139,1050540193,Other,,,,,0.307,0.996,1,,,1636,477,1159,Parallel Assignment,,Open Label,,Health Services Research,Efficacy Study
NCT00259012,Completed,Actual,Phase 3,Interventional,2,,Actual,67,Both,1 Months,11 Months,,183,1227007759,Drug,,5,,30,0.003,0.982,8,,,1636,477,1159,Parallel Assignment,,Open Label,,Treatment,Pharmacokinetics/Dynamics Study
NCT00259298,Completed,Actual,Phase 4,Interventional,1,,Actual,12,Female,50 Years,85 Years,,337,2339607719,Drug,12,1,12,12,0.002,1,1,,,1636,477,1159,Single Group Assignment,,Open Label,,Treatment,Safety/Efficacy Study
NCT00261443,Completed,Actual,Phase 4,Interventional,2,,Actual,1270,Both,18 Years,0,,64,2594871937,Drug,1057,34,1057,542,0.003,0.001,9,,,1636,477,1159,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00263887,Completed,Actual,Phase 2,Interventional,2,,Actual,77,Both,18 Years,0,,20,1595060059,Drug,77,24,77,75,0.049,0.049,3,,,1636,477,1159,Parallel Assignment,,Double Blind,,Treatment,Efficacy Study
NCT00261495,Completed,Actual,Phase 3,Interventional,2,,Actual,504,Both,18 Years,0,,341,3299448680,Drug,504,46,504,418,0.01,0.001,10,,,1636,477,1159,Parallel Assignment,,Open Label,,Treatment,Safety/Efficacy Study
NCT00261833,Completed,Actual,Phase 4,Interventional,2,,Actual,180,Both,18 Years,65 Years,,21,2117749679,Biological,180,56,180,174,0.017,0.115,13,,,1636,477,1159,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00262041,Completed,,Phase 2,Interventional,3,,Actual,524,Both,11 Years,17 Years,,376,3128510237,Biological,524,13,524,408,0.003,0.001,1,,,1636,477,1159,Parallel Assignment,,Single Blind,,Prevention,Safety/Efficacy Study
NCT00262301,Completed,Actual,Phase 3,Interventional,2,,Actual,75,Both,16 Years,0,,224,2322988993,Drug,89,2,89,13,0.003,0.005,2,,,1636,477,1159,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00262522,Completed,Actual,Phase 3,Interventional,4,,Actual,664,Both,18 Years,0,,229,4253814299,Drug,664,87,664,579,0.249,0.1,19,,,1636,477,1159,Parallel Assignment,,Open Label,,Treatment,Safety/Efficacy Study
NCT00262730,Completed,Actual,Phase 2,Interventional,1,,Actual,97,Both,18 Years,0,,191,2999136560,Drug,,,97,5,0.1,0.1,1,,,1636,477,1159,Single Group Assignment,,Open Label,,Treatment,Safety/Efficacy Study
NCT00262834,Completed,Actual,N/A,Interventional,1,,Actual,54,Female,18 Years,0,,73,1499605101,Drug,,,25,17,0.42,0.5,1,,,1636,477,1159,Single Group Assignment,,Open Label,,Treatment,Safety Study
NCT00262847,Completed,Actual,Phase 3,Interventional,3,,Actual,1873,Female,18 Years,0,,427,1924775213,Other,1864,783,1864,1770,0.131,0.001,4,,,1636,477,1159,Parallel Assignment,,Double Blind,,Treatment,Efficacy Study
NCT00267046,Completed,Actual,Phase 2,Interventional,2,,Actual,49,Both,15 Years,65 Years,,402,2142848470,Drug,,,48,39,0.001,0.001,1,,,1636,477,1159,Parallel Assignment,,Double Blind,,Prevention,Safety/Efficacy Study
NCT00264303,Completed,Actual,Phase 4,Interventional,2,,Actual,886,Both,18 Years,0,,96,1153606,Drug,886,2,886,157,0.002,0.001,9,,,1636,477,1159,Parallel Assignment,,Double-Blind,,Treatment,Safety/Efficacy Study
NCT00264576,Completed,Actual,Phase 2,Interventional,2,,Actual,613,Both,18 Years,49 Years,,244,1679987934,Biological,613,8,613,473,,,1,,,1636,477,1159,Parallel Assignment,,Single Blind,,Prevention,Safety/Efficacy Study
NCT00264550,Completed,Actual,Phase 3,Interventional,4,,Actual,444,Both,18 Years,0,,401,2326608903,Drug,434,172,434,374,0.001,0.001,12,,,1636,477,1159,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00265096,Completed,Actual,Phase 3,Interventional,3,,Actual,407,Both,18 Years,0,,43,760806292,Biological,394,83,394,311,0.011,0.001,6,,,1636,477,1159,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00265122,Completed,Actual,Phase 2,Interventional,6,,Actual,131,Both,18 Years,0,,122,240489291,Drug,120,10,120,98,0.292,0.337,3,,,1636,477,1159,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00265317,Completed,Actual,Phase 2,Interventional,2,,Actual,162,Both,18 Years,0,,80,4164722591,Drug,158,69,158,149,0.0091,0.0001,8,,,1636,477,1159,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00266032,Completed,Actual,Phase 3,Interventional,3,,Actual,1166,Female,18 Years,35 Years,,115,1291749007,Drug,1067,29,1067,547,0.0001,0.0001,3,,,1636,477,1159,Parallel Assignment,,Open Label,,Prevention,Safety/Efficacy Study
NCT00266409,Completed,Actual,Phase 4,Interventional,4,,Actual,418,Both,18 Years,0,,188,1272109837,Drug,414,7,414,47,0.0001,0.9988,1,,,1636,477,1159,Parallel Assignment,,Open Label,,Treatment,Efficacy Study
NCT00266864,Completed,Actual,Phase 2/Phase 3,Interventional,2,,Actual,31,Male,18 Years,49 Years,,422,2839930689,Drug,18,1,18,11,0.051,0.01,1,,,1636,477,1159,Parallel Assignment,,Open Label,,Treatment,Safety/Efficacy Study
NCT00267098,Completed,Actual,N/A,Interventional,2,,Actual,918,Both,18 Years,0,,53,371147933,Device,918,491,918,398,0.189,0.9999,2,,,1636,477,1159,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00269152,Completed,Actual,Phase 2,Interventional,2,,Actual,122,Both,18 Years,0,,323,3115687674,Drug,118,23,118,113,,,3,,,1636,477,1159,Parallel Assignment,,Open Label,,Treatment,Safety Study
NCT00267111,Completed,Actual,Phase 2,Interventional,2,,Actual,110,Both,0,0,,341,3299448680,Drug,,,107,12,0.05,0.05,1,,,1636,477,1159,Parallel Assignment,,Double Blind,,Treatment,Efficacy Study
NCT00267293,Completed,Actual,Phase 4,Interventional,3,,Actual,60,Both,6 Months,7 Years,,179,1502818448,Drug,,,,,0.0001,0.001,1,,,1636,477,1159,Parallel Assignment,,Open Label,,Treatment,Efficacy Study
NCT00267670,Completed,Actual,Phase 2/Phase 3,Interventional,2,,Actual,26,Both,18 Years,65 Years,,327,431973634,Drug,,,,,0.16,0.94,1,,,1636,477,1159,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00267748,Completed,Actual,Phase 2,Interventional,2,,Actual,317,Both,18 Years,0,,81,1588592340,Drug,314,111,314,311,0.075,0.866,1,,,1636,477,1159,Parallel Assignment,,Open Label,,Treatment,Safety/Efficacy Study
NCT00267956,Completed,Actual,Phase 2,Interventional,2,,Actual,146,Both,18 Years,0,,382,3318947731,Drug,277,9,277,91,0.004,0.001,5,,,1636,477,1159,Crossover Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00267969,Completed,Actual,Phase 3,Interventional,3,,Actual,766,Both,18 Years,0,,381,1711367644,Drug,1514,117,1514,893,0.001,0.001,3,,,1636,477,1159,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00269113,Completed,Actual,Phase 3,Interventional,2,,Actual,360,Both,18 Years,75 Years,,321,2973869801,Drug,360,38,360,309,0.0002,0.0001,1,,,1636,477,1159,Parallel Assignment,,Open Label,,Treatment,Safety/Efficacy Study
NCT00271154,Completed,Actual,N/A,Interventional,2,,Actual,684,Both,18 Years,0,,213,3865579137,Device,648,403,648,203,0.1,0.0001,15,,,1636,477,1159,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00277212,Completed,Actual,Phase 4,Interventional,2,,Actual,1169,Both,18 Years,0,,64,2594871937,Drug,1128,46,1128,680,0.001,0.971,2,,,1636,477,1159,Parallel Assignment,,Open Label,,Treatment,Safety/Efficacy Study
NCT00271544,Completed,Actual,N/A,Interventional,1,,Actual,190,Both,18 Years,0,,213,3865579137,Device,,,,,,,2,,,1636,477,1159,Single Group Assignment,,Open Label,,Treatment,Safety/Efficacy Study
NCT00272779,Completed,Actual,Phase 3,Interventional,2,,Actual,1057,Both,18 Years,0,,199,2889579184,Drug,878,109,878,725,0.0058,0.1847,29,,,1636,477,1159,Parallel Assignment,,Open Label,,Treatment,Safety/Efficacy Study
NCT00272792,Completed,Actual,Phase 3,Interventional,2,,Actual,45,Both,4 Years,12 Years,,356,1288876632,Drug,,,,34,0.009,0.001,1,,,1636,477,1159,Parallel Assignment,,Double-Blind,,Treatment,Safety/Efficacy Study
NCT00273182,Completed,Actual,N/A,Observational,,1,Actual,1999,Both,18 Years,0,,213,3865579137,Device,1999,450,1999,175,,,1,,,1636,477,1159,,Cohort,,Prospective,,
NCT00274456,Completed,Actual,Phase 2,Interventional,4,,Actual,302,Female,18 Years,0,,294,2238648170,Drug,300,93,300,296,0.001,0.05,1,,,1636,477,1159,Parallel Assignment,,Open Label,,Treatment,Safety/Efficacy Study
NCT00274625,Completed,Actual,N/A,Interventional,2,,Actual,402,Both,18 Years,0,,225,3427550757,Device,,,380,149,0.6,0.6,1,,,1636,477,1159,Parallel Assignment,,Open Label,,Treatment,Efficacy Study
NCT00275340,Completed,Actual,Phase 1,Interventional,,,Actual,101,Both,0,0,,119,2281658183,Other,,,,,0.2,0.2,1,,,1636,477,1159,Single Group Assignment,,Single Blind,,Treatment,Safety/Efficacy Study
NCT00275392,Completed,Actual,N/A,Interventional,2,,Actual,39,Both,60 Years,0,,153,151272800,Behavioral,,,,,0.016,0.05,1,,,1636,477,1159,Parallel Assignment,,Single Blind,,Treatment,Efficacy Study
NCT00275561,Completed,Actual,Phase 2,Interventional,2,,Actual,42,Both,18 Years,60 Years,,165,2383553813,Drug,,,34,13,0.49,0.001,1,,,1636,477,1159,Single Group Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00282113,Completed,Actual,N/A,Interventional,3,,Actual,90,Both,0,7 Days,,373,234682948,Dietary Supplement,,,,,0.06,0.5,1,,,1636,477,1159,Parallel Assignment,,Double Blind,,Prevention,Safety/Efficacy Study
NCT00277446,Completed,Actual,N/A,Interventional,1,,Actual,13,Both,18 Years,50 Years,,48,2527395224,Drug,,,,,0.02,0.03,1,,,1636,477,1159,Single Group Assignment,,Open Label,,Treatment,Safety/Efficacy Study
NCT00279201,Completed,Actual,Phase 4,Interventional,6,,Actual,2091,Both,30 Years,79 Years,,144,3633170488,Drug,3727,241,3667,2855,0.001,0.001,12,,,1636,477,1159,Parallel Assignment,,Open Label,,Treatment,Safety/Efficacy Study
NCT00279591,Terminated,Actual,N/A,Interventional,2,,Actual,94,Both,1 Years,17 Years,,350,2715128815,Device,,,,,0.03,0.03,1,,,1636,477,1159,Parallel Assignment,,Double Blind,,Treatment,Efficacy Study
NCT00280059,Completed,Actual,Phase 3,Interventional,2,,Actual,660,Both,16 Years,0,,168,1819384088,Drug,660,76,660,357,0.0003,0.8047,29,,,1636,477,1159,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00280566,Completed,Actual,Phase 3,Interventional,2,,Actual,584,Both,18 Years,0,,66,1752722647,Drug,,20,,408,0.0003,0.9972,13,,,1636,477,1159,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00281099,Terminated,Actual,N/A,Interventional,2,,Actual,1031,Both,18 Years,0,,210,2419787588,Device,1031,249,1031,229,0.0053,0.1,12,,,1636,477,1159,Parallel Assignment,,Single Blind,,Prevention,Safety/Efficacy Study
NCT00281632,Completed,Actual,Phase 2,Interventional,1,,Actual,35,Female,21 Years,0,,285,2762284701,Drug,36,6,36,35,,,3,,,1636,477,1159,Single Group Assignment,,Open Label,,Treatment,Safety/Efficacy Study
NCT00281918,Completed,Actual,Phase 3,Interventional,2,,Actual,817,Both,18 Years,0,,260,180008924,Drug,800,350,800,307,0.001,0.0001,11,,,1636,477,1159,Parallel Assignment,,Open Label,,Treatment,
NCT00282087,Completed,Actual,Phase 2,Interventional,1,,Actual,47,Female,18 Years,0,,259,1049890625,Drug,47,9,47,14,0.15,0.15,1,,,1636,477,1159,Single Group Assignment,,Open Label,,Treatment,Safety/Efficacy Study
NCT00285012,Completed,Actual,Phase 3,Interventional,2,,Actual,504,Both,35 Years,0,,419,3898843642,Drug,499,17,499,278,0.0002,0.0001,4,,,1636,477,1159,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00282243,Completed,Actual,Phase 2,Interventional,1,,Actual,70,Both,18 Years,65 Years,,269,295097427,Drug,69,37,69,51,,,1,,,1636,477,1159,Single Group Assignment,,Open Label,,Prevention,Safety/Efficacy Study
NCT00282256,Completed,Actual,Phase 2,Interventional,1,,Actual,19,Both,0,12 Years,,269,295097427,Drug,18,6,18,11,,,1,,,1636,477,1159,Single Group Assignment,,Open Label,,Prevention,Safety/Efficacy Study
NCT00282464,Completed,Actual,Phase 3,Interventional,2,,Actual,392,Both,18 Years,0,,64,2594871937,Drug,,7,,166,0.0005,0.9863,1,,,1636,477,1159,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00282568,Completed,Actual,Phase 2,Interventional,1,,Actual,70,Both,18 Years,65 Years,,256,3993050794,Drug,67,39,67,48,,,2,,,1636,477,1159,Single Group Assignment,,Open Label,,Prevention,Safety/Efficacy Study
NCT00282984,Completed,Actual,Phase 3,Interventional,2,,Actual,714,Both,35 Years,75 Years,,419,3898843642,Drug,,44,,432,0.0001,0.0001,15,,,1636,477,1159,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00283387,Completed,Actual,Phase 2,Interventional,2,,Actual,15,Both,6 Years,70 Years,,232,3322263591,Drug,,,26,19,0.007,0.007,1,,,1636,477,1159,Crossover Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00283400,Terminated,Actual,N/A,Interventional,4,,Actual,47,Both,18 Years,79 Years,,434,1822793203,Drug,47,11,,,0.05,0.05,2,,,1636,477,1159,Parallel Assignment,,Open Label,,Treatment,
NCT00283712,Completed,Actual,Phase 2,Interventional,2,,Actual,20,Both,18 Years,0,,351,3857742708,Drug,20,3,20,19,0.65,1,1,,,1636,477,1159,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00283842,Terminated,Actual,Phase 3,Interventional,5,,Actual,408,Both,18 Years,0,,150,1972684966,Drug,,12,,325,0.001,0.375,1,,,1636,477,1159,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00288704,Completed,Actual,Phase 3,Interventional,3,,Actual,104,Both,7 Years,0,,175,2987399814,Drug,128,7,47,30,0.0001,0.01,1,,,1636,477,1159,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00285779,Terminated,Actual,Phase 2,Interventional,2,,Actual,27,Both,18 Years,0,,263,2503015782,Drug,38,1,38,18,0.0978,0.0978,1,,,1636,477,1159,Crossover Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00286156,Completed,Actual,Phase 1/Phase 2,Interventional,3,,Actual,30,Both,18 Years,75 Years,,359,2752214730,Drug,30,4,30,24,0.01,0.01,1,,,1636,477,1159,Factorial Assignment,,Open Label,,Treatment,Efficacy Study
NCT00286325,Completed,Actual,Phase 1/Phase 2,Interventional,1,,Actual,8,Both,18 Years,0,,75,1559062851,Drug,,,,,0.0078,0.0156,1,,,1636,477,1159,Single Group Assignment,,Open Label,,Treatment,Safety/Efficacy Study
NCT00286429,Completed,Actual,Phase 3,Interventional,3,,Actual,390,Both,18 Years,80 Years,,139,1050540193,Drug,389,21,389,162,0.001,0.001,16,,,1636,477,1159,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00286442,Completed,Actual,Phase 3,Interventional,3,,Actual,527,Both,18 Years,80 Years,,139,1050540193,Drug,524,18,524,140,0.002,0.001,17,,,1636,477,1159,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00286455,Completed,Actual,Phase 3,Interventional,3,,Actual,329,Both,18 Years,80 Years,,139,1050540193,Drug,329,8,329,119,0.001,0.001,18,,,1636,477,1159,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00286741,Completed,Actual,Phase 3,Interventional,2,,Actual,239,Both,0,0,,138,2883582343,Other,239,96,239,207,0.03,0.15,1,,,1636,477,1159,Parallel Assignment,,Single Blind,,Treatment,Efficacy Study
NCT00286754,Completed,Actual,N/A,Interventional,3,,Actual,533,Both,21 Years,0,,233,2554888772,Behavioral,533,7,533,30,0.001,0.009,1,,,1636,477,1159,Parallel Assignment,,Single Blind,,Treatment,Efficacy Study
NCT00287222,Completed,Actual,Phase 2,Interventional,1,,Actual,21,Both,18 Years,0,,223,4057390872,Drug,21,11,,,0.0006,0.0006,1,,,1636,477,1159,Single Group Assignment,,Open Label,,Treatment,Efficacy Study
NCT00292370,Completed,Actual,Phase 4,Interventional,3,,Actual,124,Both,18 Years,65 Years,,110,3054614311,Drug,174,7,174,33,0.05,0.05,1,,,1636,477,1159,Parallel Assignment,,Double Blind,,Treatment,Efficacy Study
NCT00288912,Completed,Actual,N/A,Interventional,3,,Actual,523,Both,0,0,,334,3213715074,Behavioral,523,31,523,94,0.007,0.79,1,,,1636,477,1159,Single Group Assignment,,Single Blind,,Health Services Research,Efficacy Study
NCT00289289,Completed,Actual,N/A,Interventional,3,,Actual,400,Both,0,0,,51,734346743,Device,400,19,,,0.165,0.629,2,,,1636,477,1159,Crossover Assignment,,Single Blind,,Prevention,Efficacy Study
NCT00289341,Completed,Actual,Phase 1/Phase 2,Interventional,2,,Actual,24,Male,18 Years,0,,378,3123971163,Biological,60,2,60,58,0.001,0.2,1,,,1636,477,1159,Crossover Assignment,,Single Blind,,Treatment,Safety/Efficacy Study
NCT00290186,Terminated,Actual,N/A,Interventional,2,,Actual,49,Both,3 Years,8 Years,,86,3979658093,Device,49,2,49,15,0.051,0.945,1,,,1636,477,1159,Parallel Assignment,,Double Blind,,Treatment,Efficacy Study
NCT00290290,Completed,Actual,Phase 3,Interventional,2,,Actual,849,Both,18 Years,0,,368,3328686844,Drug,849,7,849,6,0.004,0.004,1,,,1636,477,1159,Single Group Assignment,,Double Blind,,Prevention,Safety/Efficacy Study
NCT00291187,Completed,Actual,Phase 3,Interventional,4,,Actual,411,Both,21 Years,50 Years,,245,4173685762,Drug,,,411,23,0.001,0.001,1,,,1636,477,1159,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00291330,Completed,,Phase 3,Interventional,2,,Actual,2564,Both,18 Years,0,,440,1048045504,Drug,2539,315,2539,372,0.0002,0.0001,29,,,1636,477,1159,Parallel Assignment,,Double-Blind,,Treatment,Safety/Efficacy Study
NCT00291577,Completed,Actual,Phase 1,Interventional,1,,Actual,22,Female,18 Years,0,,74,3128271172,Drug,22,11,22,21,,,3,,,1636,477,1159,Single Group Assignment,,Open Label,,Treatment,Safety/Efficacy Study
NCT00292188,Completed,Actual,Phase 4,Interventional,2,,Actual,255,Both,18 Years,80 Years,,315,2797596796,Drug,,8,,259,0,0.846,11,,,1636,477,1159,Parallel Assignment,,Double Blind,,Treatment,Efficacy Study
NCT00293241,Completed,Actual,Phase 4,Interventional,2,,Actual,630,Both,18 Years,0,,84,3416315868,Device,605,157,605,63,0.03,0.0001,1,,,1636,477,1159,Parallel Assignment,,Single Blind,,Treatment,Efficacy Study
NCT00297102,Completed,Actual,Phase 3,Interventional,2,,Actual,1523,Both,40 Years,0,,103,3445665167,Drug,1524,297,1524,368,0.0003,0.0001,11,,,1636,477,1159,Parallel Assignment,,Double Blind,,Treatment,
NCT00293384,Completed,Actual,N/A,Interventional,1,,Actual,40,Both,18 Years,0,,73,1499605101,Drug,35,10,35,33,0.1,0.1,1,,,1636,477,1159,Single Group Assignment,,Open Label,,Supportive Care,
NCT00293462,Completed,Actual,N/A,Interventional,3,,Actual,91,Both,18 Years,0,,204,599964,Biological,85,6,85,71,0.09,0.92,1,,,1636,477,1159,Crossover Assignment,,Double Blind,,Supportive Care,Efficacy Study
NCT00294645,Completed,Actual,N/A,Interventional,2,,Actual,980,Both,0,0,,68,3362919,Other,,,,,0.0001,0.0001,1,,,1636,477,1159,Parallel Assignment,,Open Label,,Treatment,Efficacy Study
NCT00294723,Terminated,Actual,Phase 3,Interventional,4,,Actual,746,Both,18 Years,80 Years,,138,2883582343,Drug,888,73,888,602,0.0003,0.0001,3,,,1636,477,1159,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00295061,Completed,Actual,Phase 3,Interventional,2,,Actual,24,Both,18 Years,0,,20,1595060059,Drug,48,1,48,8,,,1,,,1636,477,1159,Crossover Assignment,,Double Blind,,Treatment,Pharmacokinetics Study
NCT00295750,Completed,Actual,Phase 3,Interventional,3,,Actual,620,Male,18 Years,0,,378,3123971163,Drug,,73,,480,0.0001,0.0001,12,,,1636,477,1159,Parallel Assignment,,Open Label,,Treatment,Safety/Efficacy Study
NCT00296231,Completed,Actual,Phase 1,Interventional,1,,Actual,14,Both,0,3 Months,,238,2108073750,Other,,,,,0.011,0.011,1,,,1636,477,1159,Crossover Assignment,,Open Label,,Treatment,Efficacy Study
NCT00296517,Completed,Actual,Phase 3,Interventional,2,,Actual,325,Both,18 Years,65 Years,,280,3624825644,Drug,,5,,249,0.036,0.805,1,,,1636,477,1159,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00297115,Completed,Actual,Phase 3,Interventional,2,,Actual,1568,Both,40 Years,0,,103,3445665167,Drug,1568,340,1568,226,0.0035,0.0001,8,,,1636,477,1159,Parallel Assignment,,Double Blind,,Treatment,
NCT00297167,Completed,Actual,Phase 3,Interventional,2,,Actual,34,Both,7 Years,0,,124,191177468,Drug,66,2,66,35,0.001,0.001,1,,,1636,477,1159,Crossover Assignment,,Double-Blind,,Treatment,Safety/Efficacy Study
NCT00297258,Completed,Actual,Phase 2,Interventional,,,Actual,148,Both,21 Years,0,,403,1077334832,Drug,142,39,142,137,0.003,0.001,5,,,1636,477,1159,Single Group Assignment,,Open Label,,Treatment,Safety/Efficacy Study
NCT00297492,Completed,Actual,Phase 2,Interventional,3,,Actual,750,Both,18 Years,0,,419,3898843642,Behavioral,,,,,0.3,0.3,1,,,1636,477,1159,Parallel Assignment,,Open Label,,Treatment,Efficacy Study
NCT00297778,Completed,,Phase 4,Interventional,2,,Actual,296,Both,30 Years,80 Years,,345,3641618925,Drug,,12,,129,0.0007,0.8471,13,,,1636,477,1159,Parallel Assignment,,Double Blind,,Treatment,
NCT00298090,Completed,Actual,N/A,Observational,,1,Actual,47,Both,18 Years,0,,340,2861880380,Device,,,,,0.55,0.55,1,,,1636,477,1159,,Cohort,,Prospective,,
NCT00298233,Completed,Actual,Phase 2,Interventional,4,,Actual,326,Both,1 Years,0,,243,2524740919,Drug,326,1,326,75,0.42,0.66,3,,,1636,477,1159,Parallel Assignment,,Double Blind,,Treatment,Efficacy Study
NCT00299221,Completed,Actual,Phase 4,Interventional,2,,Actual,150,Both,18 Years,80 Years,,236,346851351,Drug,150,3,,,0.44,0.44,1,,,1636,477,1159,Parallel Assignment,,Open Label,,Treatment,Efficacy Study
NCT00299546,Completed,Actual,Phase 3,Interventional,3,,Actual,461,Both,18 Years,0,,44,1506984474,Drug,431,151,431,365,0.001,0.001,10,,,1636,477,1159,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00300469,Completed,,Phase 3,Interventional,6,,Actual,613,Both,18 Years,0,,120,505410856,Drug,,12,,285,0.005,0.001,1,,,1636,477,1159,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00304031,"Active, not recruiting",,Phase 3,Interventional,3,,Actual,1173,Both,18 Years,0,,72,660508271,Drug,1114,367,1114,990,0.63,0.63,2,,,1636,477,1159,Parallel Assignment,,Open Label,,Treatment,
NCT00300482,Completed,,Phase 3,Interventional,6,,Actual,1445,Both,18 Years,0,,155,1990608606,Drug,,35,,637,0.001,0.001,1,,,1636,477,1159,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00300677,Completed,Actual,Phase 4,Interventional,1,,Actual,12,Male,18 Years,55 Years,,240,3381126066,Drug,,,12,11,,,1,,,1636,477,1159,Single Group Assignment,,Open Label,,Basic Science,Pharmacokinetics Study
NCT00300885,Terminated,Actual,Phase 3,Interventional,2,,Actual,926,Both,18 Years,0,,79,1922189326,Drug,922,467,922,904,0.1015,0.915,21,,,1636,477,1159,Parallel Assignment,,Double-Blind,,Treatment,Safety/Efficacy Study
NCT00301262,Completed,,Phase 4,Interventional,,,Actual,183,Male,18 Years,0,,237,2952165934,Drug,,,,,0.0001,0.0001,1,,,1636,477,1159,Parallel Assignment,,Double-Blind,,Treatment,Safety/Efficacy Study
NCT00301808,Completed,Actual,Phase 2,Interventional,1,,Actual,29,Both,18 Years,0,,271,2288821332,Drug,29,15,29,29,,,1,,,1636,477,1159,Single Group Assignment,,Open Label,,Treatment,Safety/Efficacy Study
NCT00301873,Completed,Actual,Phase 2,Interventional,1,,Actual,60,Both,18 Years,0,,71,780859460,Drug,59,16,59,31,0.0413,0.2212,1,,,1636,477,1159,Single Group Assignment,,Open Label,,Supportive Care,
NCT00302952,Completed,Actual,Phase 2,Interventional,2,,Actual,64,Both,18 Years,70 Years,,401,2326608903,Drug,64,2,64,48,0.19,0.91,1,,,1636,477,1159,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00303459,Completed,Actual,Phase 4,Interventional,2,,Actual,334,Both,12 Years,0,,383,3149469713,Drug,333,175,333,282,0.0003,1,12,,,1636,477,1159,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00304915,"Active, not recruiting",Anticipated,N/A,Interventional,2,,Actual,249,Both,18 Years,75 Years,,201,4148919742,Behavioral,,,,,0.003,0.003,1,,,1636,477,1159,Parallel Assignment,,Open Label,,Treatment,Efficacy Study
NCT00308711,Completed,Actual,Phase 3,Interventional,3,,Actual,1308,Female,18 Years,0,,88,1606603429,Drug,1307,357,1307,391,0.011,0.974,2,,,1636,477,1159,Parallel Assignment,,Double Blind,,Treatment,Efficacy Study
NCT00305565,Completed,Actual,Phase 4,Interventional,3,,Actual,331,Both,18 Years,0,,133,2194019288,Device,331,66,331,318,0.803,0.813,1,,,1636,477,1159,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00307151,"Active, not recruiting",Anticipated,Phase 2,Interventional,4,,Actual,452,Both,2 Months,36 Months,,199,2889579184,Drug,451,147,451,447,0.015,0.001,7,,,1636,477,1159,Parallel Assignment,,Open Label,,Treatment,Efficacy Study
NCT00307333,Completed,Actual,N/A,Interventional,2,,Actual,3003,Both,0,32 Weeks,,408,3534255774,Device,2989,274,,,0.08,0.47,1,,,1636,477,1159,Parallel Assignment,,Open Label,,Diagnostic,Efficacy Study
NCT00307437,Completed,Actual,Phase 3,Interventional,3,,Actual,1230,Both,18 Years,0,,381,1711367644,Drug,2438,256,2438,1361,0.014,0.001,7,,,1636,477,1159,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00307489,Completed,Actual,Phase 2,Interventional,2,,Actual,106,Both,18 Years,69 Years,,94,2307672194,Drug,,16,,91,0.544,0.999,4,,,1636,477,1159,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00307684,Completed,Actual,Phase 3,Interventional,3,,Actual,155,Both,18 Years,65 Years,,54,1600057117,Drug,200,13,200,141,0.2586,0.5458,7,,,1636,477,1159,Single Group Assignment,,Double Blind,,Treatment,Efficacy Study
NCT00307801,Completed,Actual,Phase 3,Interventional,2,,Actual,231,Female,18 Years,0,,298,811893236,Drug,226,4,226,65,0.0001,0.0001,10,,,1636,477,1159,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00308087,Terminated,Actual,Phase 2,Interventional,2,,Actual,75,Both,18 Years,0,,277,2133617614,Drug,75,12,75,71,0.5501,0.8217,2,,,1636,477,1159,Parallel Assignment,,Open Label,,Treatment,Safety/Efficacy Study
NCT00308308,Completed,Actual,Phase 3,Interventional,2,,Actual,589,Both,18 Years,80 Years,,147,1915134822,Drug,565,99,565,522,0.0052,0.0001,10,,,1636,477,1159,Parallel Assignment,,Open Label,,Treatment,Efficacy Study
NCT00312494,Completed,Actual,Phase 3,Interventional,3,,Actual,680,Both,18 Years,65 Years,,64,2594871937,Drug,656,13,656,315,0.0101,0.9049,1,,,1636,477,1159,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00308737,Completed,Actual,Phase 3,Interventional,3,,Actual,2053,Both,18 Years,70 Years,,146,3392498499,Drug,2035,188,2035,1078,0.112,0.112,8,,,1636,477,1159,Parallel Assignment,,Open Label,,Treatment,Safety Study
NCT00309465,Completed,Actual,Phase 4,Interventional,3,,Actual,402,Both,18 Years,0,,138,2883582343,Drug,401,1,401,3,0.031,0.332,1,,,1636,477,1159,Parallel Assignment,,Open Label,,Treatment,Safety/Efficacy Study
NCT00309608,Completed,,Phase 2,Interventional,5,,Actual,333,Both,21 Years,75 Years,,144,3633170488,Drug,333,10,333,34,0.001,0.0001,6,,,1636,477,1159,Parallel Assignment,,Double-Blind,,Treatment,Safety/Efficacy Study
NCT00310466,Completed,Actual,Phase 3,Interventional,2,,Actual,226,Both,18 Years,65 Years,,18,1090996619,Biological,226,6,226,168,0.04,0.87,1,,,1636,477,1159,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00310401,Completed,Actual,Phase 2,Interventional,2,,Actual,506,Both,14 Years,0,,69,480406809,Drug,,,,,0.98,0.98,1,,,1636,477,1159,Parallel Assignment,,Double Blind,,Treatment,Efficacy Study
NCT00311311,Terminated,Actual,Phase 3,Interventional,2,,Actual,72,Both,35 Years,0,,49,2002447835,Drug,72,38,72,69,0.0002,0.0001,2,,,1636,477,1159,Parallel Assignment,,Open Label,,Treatment,Efficacy Study
NCT00311402,Completed,,Phase 3,Interventional,2,,Actual,1295,Both,50 Years,0,,87,550104849,Drug,1294,345,1294,1238,0.043,0.998,1,,,1636,477,1159,Parallel Assignment,,,,Prevention,
NCT00312208,Completed,Actual,Phase 3,Interventional,2,,Actual,3299,Female,18 Years,70 Years,,73,1499605101,Drug,3269,851,3269,3263,0.371,0.978,37,,,1636,477,1159,Parallel Assignment,,Open Label,,Treatment,Safety/Efficacy Study
NCT00312221,Terminated,Actual,Phase 3,Interventional,3,,Actual,418,Both,40 Years,0,,334,3213715074,Drug,1070,25,1070,343,0.007,0.707,1,,,1636,477,1159,Parallel Assignment,,Double Blind,,Treatment,Efficacy Study
NCT00312845,Completed,Actual,Phase 3,Interventional,2,,Actual,676,Both,18 Years,0,,321,2973869801,Drug,673,96,673,520,0.039,0.001,32,,,1636,477,1159,Parallel Assignment,,Open Label,,Treatment,
NCT00315939,Completed,Actual,N/A,Interventional,2,,Actual,120,Both,18 Years,0,,143,2617365673,Device,,,,,0.001,0.001,1,,,1636,477,1159,Crossover Assignment,,Open Label,,,Efficacy Study
NCT00313014,Terminated,Actual,Phase 3,Interventional,3,,Actual,660,Both,18 Years,0,,60,3011469154,Drug,1820,32,1820,654,0.006,0.001,1,,,1636,477,1159,Parallel Assignment,,Double Blind,,Treatment,Efficacy Study
NCT00313144,Terminated,Actual,Phase 4,Interventional,1,,Actual,127,Both,18 Years,0,,19,2852224729,Drug,127,39,127,97,0.005,0.046,1,,,1636,477,1159,Single Group Assignment,,Open Label,,Treatment,Safety/Efficacy Study
NCT00313716,Completed,Actual,Phase 2/Phase 3,Interventional,6,,Actual,200,Both,15 Years,0,,29,1185043251,Drug,400,335,400,356,0.01,0.13,1,,,1636,477,1159,Factorial Assignment,,Double Blind,,Treatment,Efficacy Study
NCT00313846,Completed,Actual,Phase 3,Interventional,2,,Actual,529,Both,40 Years,75 Years,,334,3213715074,Drug,855,7,855,272,0.0026,0.0026,1,,,1636,477,1159,Parallel Assignment,,Double Blind,,Treatment,Efficacy Study
NCT00314249,Completed,,Phase 3,Interventional,2,,Actual,1025,Both,18 Years,70 Years,,180,3671355921,Drug,1025,17,1025,816,0.001,0.001,1,,,1636,477,1159,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00314951,Completed,Actual,Phase 3,Interventional,2,,Actual,629,Both,16 Years,0,,106,2853050698,Drug,623,153,623,382,0.007,0.008,2,,,1636,477,1159,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00315328,Completed,Actual,Phase 3,Interventional,2,,Actual,233,Both,7 Years,12 Years,,24,825550705,Drug,,,233,19,0.04,0.01,1,,,1636,477,1159,Parallel Assignment,,Open Label,,Treatment,Efficacy Study
NCT00315445,Completed,Actual,Phase 3,Interventional,3,,Actual,134,Both,18 Years,0,,59,4132948223,Drug,134,8,134,92,0.011,0.63,1,,,1636,477,1159,Parallel Assignment,,Double Blind,,Treatment,Efficacy Study
NCT00316004,Terminated,Actual,Phase 3,Interventional,3,,Actual,1331,Both,15 Years,0,,70,3572572513,Drug,1282,282,,,0.84,0.91,2,,,1636,477,1159,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00320385,Completed,Actual,Phase 3,Interventional,2,,Actual,296,Female,18 Years,0,,313,1776861857,Drug,295,64,295,272,0.008,0.46,13,,,1636,477,1159,Parallel Assignment,,Open Label,,Treatment,Safety/Efficacy Study
NCT00316017,Terminated,Actual,Phase 3,Interventional,3,,Actual,895,Both,15 Years,0,,409,3291828913,Drug,852,67,852,3,0.31,0.02,2,,,1636,477,1159,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00316173,Completed,Actual,Phase 2,Interventional,1,,Actual,77,Female,18 Years,0,,339,2909107598,Drug,77,18,77,74,,,2,,,1636,477,1159,Single Group Assignment,,Open Label,,Treatment,Efficacy Study
NCT00316303,Completed,Actual,Phase 2,Interventional,2,,Actual,236,Both,18 Years,65 Years,,199,2889579184,Drug,,,,,0.011,0.001,1,,,1636,477,1159,Parallel Assignment,,Open Label,,Treatment,Efficacy Study
NCT00317642,Completed,Actual,Phase 3,Interventional,2,,Actual,326,Both,55 Years,0,,4,3894681620,Drug,632,346,632,630,0.0001,0.0001,5,,,1636,477,1159,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00318565,Completed,Actual,Phase 4,Interventional,1,,Actual,291,Both,18 Years,0,,52,3316240768,Device,267,4,267,73,0.05,0.05,1,,,1636,477,1159,Single Group Assignment,,Open Label,,Treatment,Safety/Efficacy Study
NCT00319644,Completed,Actual,N/A,Interventional,2,,Actual,37,Both,18 Years,0,,460,3209578115,Device,,,37,2,0.26,0.26,1,,,1636,477,1159,Single Group Assignment,,Open Label,,Diagnostic,Efficacy Study
NCT00319982,Completed,Actual,Phase 2/Phase 3,Interventional,2,,Actual,39,Both,5 Years,39 Years,,234,4143189883,Drug,,,38,22,0.08,0.06,1,,,1636,477,1159,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00320112,Completed,Actual,Phase 3,Interventional,2,,Actual,244,Both,21 Years,0,,138,2883582343,Behavioral,244,3,,,0.91,0.1,1,,,1636,477,1159,Parallel Assignment,,Open Label,,,Efficacy Study
NCT00320489,Completed,Actual,Phase 3,Interventional,2,,Actual,524,Both,18 Years,65 Years,,405,2119471695,Drug,524,59,524,342,0.258,0.952,12,,,1636,477,1159,Parallel Assignment,,Open Label,,Treatment,Safety/Efficacy Study
NCT00322621,Completed,Actual,Phase 4,Interventional,1,,Actual,216,Both,18 Years,0,,150,1972684966,Drug,297,20,297,175,0.003,0.001,4,,,1636,477,1159,Single Group Assignment,,Open Label,,Treatment,Safety/Efficacy Study
NCT00320541,Completed,Actual,Phase 2,Interventional,2,,Actual,187,Female,18 Years,0,,73,1499605101,Drug,187,63,187,186,0.002,0.475,2,,,1636,477,1159,Parallel Assignment,,Open Label,,Treatment,Safety/Efficacy Study
NCT00320593,Completed,Actual,Phase 3,Interventional,2,,Actual,118,Both,8 Years,11 Years,,310,3204675572,Device,,,,,,,1,,,1636,477,1159,Parallel Assignment,,Double Blind,,Treatment,Efficacy Study
NCT00320606,"Active, not recruiting",Anticipated,Phase 1,Interventional,1,,Actual,20,Both,4 Years,18 Years,,268,1426884497,Procedure,20,11,20,19,,,1,,,1636,477,1159,Single Group Assignment,,Open Label,,Treatment,Safety Study
NCT00321737,Completed,Actual,Phase 3,Interventional,3,,Actual,445,Both,18 Years,0,,171,3175721293,Drug,,9,,72,0.0673,0.99999,8,,,1636,477,1159,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00321854,Completed,,Phase 4,Interventional,2,,Actual,535,Both,30 Years,79 Years,,345,3641618925,Drug,535,50,535,336,0.0001,0.0001,10,,,1636,477,1159,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00321984,Completed,Actual,Phase 3,Interventional,3,,Actual,947,Both,18 Years,0,,184,2110570532,Drug,,4,,111,0.3146,0.00001,1,,,1636,477,1159,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00322153,Completed,Actual,Phase 3,Interventional,2,,Actual,677,Both,50 Years,0,,130,3787324800,Drug,676,49,676,137,0.001,0.177,4,,,1636,477,1159,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00322465,Completed,Actual,Phase 2,Interventional,4,,Actual,305,Male,16 Years,45 Years,,453,448489118,Drug,,,305,78,0.005,0.001,1,,,1636,477,1159,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00324168,Completed,Actual,Phase 4,Interventional,2,,Actual,500,Both,16 Years,0,,117,2813729792,Drug,500,28,500,78,0.03,0.99,2,,,1636,477,1159,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00323193,Completed,Actual,N/A,Interventional,2,,Actual,109,Both,18 Years,75 Years,,292,2854748474,Behavioral,,,,,0.71,0.72,1,,,1636,477,1159,Parallel Assignment,,Open Label,,,Efficacy Study
NCT00323258,Completed,Actual,N/A,Interventional,2,,Actual,143,Both,18 Years,0,,83,2867382159,Behavioral,,,,,0.5,0.11,1,,,1636,477,1159,Parallel Assignment,,Single Blind,,,
NCT00323271,Completed,Actual,N/A,Interventional,2,,Actual,26,Both,21 Years,0,,304,3878017841,Other,,,,,0.911,0.32,1,,,1636,477,1159,Parallel Assignment,,Open Label,,Treatment,Efficacy Study
NCT00323297,Completed,Actual,Phase 4,Interventional,2,,Actual,105,Both,18 Years,0,,383,3149469713,Drug,103,45,103,71,0.5802,0.5802,10,,,1636,477,1159,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00323427,Completed,Actual,Phase 2,Interventional,2,,Actual,135,Both,18 Years,85 Years,,207,4057057403,Behavioral,,,,,0.42,0.97,1,,,1636,477,1159,Parallel Assignment,,Open Label,,Treatment,Efficacy Study
NCT00323492,Completed,Actual,Phase 4,Interventional,4,,Actual,92,Both,18 Years,0,,199,2889579184,Drug,164,17,164,37,0.009,0.001,1,,,1636,477,1159,Parallel Assignment,,Open Label,,Treatment,Safety Study
NCT00323622,Completed,Actual,Phase 2,Interventional,8,,Actual,1737,Both,33 Months,69 Months,,283,3780497230,Biological,1737,97,,,0.01,0.7,1,,,1636,477,1159,Parallel Assignment,,Open Label,,Prevention,Safety/Efficacy Study
NCT00324116,Completed,Actual,Phase 4,Interventional,1,,Actual,81,Both,50 Years,0,,278,377136507,Drug,,8,,28,,,1,,,1636,477,1159,Single Group Assignment,,Open Label,,Treatment,Safety/Efficacy Study
NCT00324155,Completed,Actual,Phase 3,Interventional,2,,Actual,681,Both,18 Years,0,,287,326450020,Drug,498,291,498,438,0.0009,0.4067,25,,,1636,477,1159,Parallel Assignment,,Double Blind,,Treatment,Efficacy Study
NCT00324350,Completed,Actual,Phase 3,Interventional,2,,Actual,7287,Both,40 Years,79 Years,,49,2002447835,Drug,,,,,0.49,0.854,2,,,1636,477,1159,Factorial Assignment,,Single Blind,,Prevention,Efficacy Study
NCT00328172,Completed,,Phase 2,Interventional,5,,Actual,302,Both,21 Years,75 Years,,144,3633170488,Drug,302,5,302,63,0.0012,0.0001,6,,,1636,477,1159,Parallel Assignment,,Double-Blind,,Treatment,Safety/Efficacy Study
NCT00324649,Completed,Actual,Phase 4,Interventional,2,,Actual,80,Both,18 Years,0,,202,3937948214,Drug,,7,,52,0.0006,0.9725,1,,,1636,477,1159,Parallel Assignment,,Open Label,,Treatment,Safety/Efficacy Study
NCT00325039,Completed,Actual,Phase 4,Interventional,2,,Actual,597,Female,21 Years,0,,454,3722636346,Procedure,597,60,597,199,0.14,0.47,1,,,1636,477,1159,Parallel Assignment,,Open Label,,Treatment,Efficacy Study
NCT00325403,Completed,Actual,Phase 3,Interventional,2,,Actual,349,Both,12 Years,75 Years,,386,1248981652,Drug,228,42,228,206,0.0001,1,13,,,1636,477,1159,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00325442,Completed,Actual,Phase 3,Interventional,2,,Actual,354,Both,12 Years,70 Years,,386,1248981652,Drug,350,65,350,330,0.011,0.966,14,,,1636,477,1159,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00325819,Completed,Actual,Phase 3,Interventional,2,,Actual,374,Both,6 Weeks,9 Months,,179,1502818448,Drug,,,,,0.001,1,1,,,1636,477,1159,Parallel Assignment,,Double Blind,,Prevention,Efficacy Study
NCT00326612,Completed,Actual,Phase 2,Interventional,2,,Actual,358,Both,0,17 Years,,407,3324862935,Drug,92,1,,,,,1,,,1636,477,1159,Parallel Assignment,,Open Label,,Treatment,Safety/Efficacy Study
NCT00327171,Completed,Actual,Phase 2,Interventional,2,,Actual,218,Female,18 Years,0,,77,4264060553,Drug,215,107,215,211,0.5043,0.5592,11,,,1636,477,1159,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00327717,Completed,Actual,Phase 3,Interventional,2,,Actual,240,Both,16 Years,70 Years,,347,2304842022,Drug,,,238,170,0.028,0.678,1,,,1636,477,1159,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00328627,Completed,Actual,Phase 3,Interventional,12,,Actual,1554,Both,18 Years,80 Years,,449,2402940714,Drug,1553,45,1553,521,0.001,0.001,19,,,1636,477,1159,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00330733,Completed,Actual,Phase 2/Phase 3,Interventional,2,,Actual,71,Both,21 Years,75 Years,,49,2002447835,Drug,,,70,19,0.05,0.05,1,,,1636,477,1159,Parallel Assignment,,Double Blind,,Prevention,Efficacy Study
NCT00329238,Completed,,Phase 3,Interventional,2,,Actual,2867,Both,18 Years,0,,440,1048045504,Drug,5635,525,5635,890,0.0137,0.0001,33,,,1636,477,1159,Parallel Assignment,,Double-Blind,,Treatment,Safety/Efficacy Study
NCT00329407,Completed,Actual,Phase 4,Interventional,1,,Actual,10,Both,18 Years,65 Years,,17,1576823743,Drug,,,10,2,0.001,0.0001,1,,,1636,477,1159,Single Group Assignment,,Open Label,,Treatment,Efficacy Study
NCT00329433,Completed,Actual,Phase 2/Phase 3,Interventional,2,,Actual,120,Both,18 Years,0,,128,2047748260,Drug,,,,,0.05,0.05,1,,,1636,477,1159,Parallel Assignment,,Double Blind,,Prevention,Efficacy Study
NCT00329524,Completed,Actual,N/A,Interventional,1,,Actual,5,Both,19 Years,65 Years,,442,2132296284,Device,,,,,0.05,0.05,1,,,1636,477,1159,Crossover Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00329602,Completed,Actual,Phase 4,Interventional,2,,Actual,404,Both,18 Years,79 Years,,398,2991482834,Drug,673,23,673,316,0.023,0.039,11,,,1636,477,1159,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00329849,Completed,Actual,Phase 3,Interventional,2,,Actual,1500,Both,2 Years,10 Years,,289,3770674851,Biological,1500,10,1500,680,,,1,,,1636,477,1159,Parallel Assignment,,Single Blind,,Prevention,Safety/Efficacy Study
NCT00330174,Completed,Actual,Phase 4,Interventional,2,,Actual,90,Both,18 Years,60 Years,,420,719201761,Drug,90,2,90,46,0.64,0.64,1,,,1636,477,1159,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00330382,Completed,Actual,Phase 2,Interventional,2,,Actual,325,Both,18 Years,0,,264,2512972782,Drug,132,5,132,55,0.66,0.45,1,,,1636,477,1159,Parallel Assignment,,Double Blind,,Prevention,Efficacy Study
NCT00334802,Completed,Actual,Phase 2,Interventional,1,,Actual,62,Female,20 Years,74 Years,,294,2238648170,Drug,,4,,62,0.001,0.169,1,,,1636,477,1159,Single Group Assignment,,Open Label,,Treatment,Safety/Efficacy Study
NCT00331006,Completed,Actual,Phase 2,Interventional,1,,Actual,23,Both,18 Months,0,,218,483804573,Drug,16,11,16,15,0.043,0.043,1,,,1636,477,1159,Single Group Assignment,,Open Label,,Treatment,Safety/Efficacy Study
NCT00331799,Completed,Actual,Phase 2,Interventional,1,,Actual,18,Both,18 Years,65 Years,,279,960571772,Drug,,,,,0.00365,0.00365,1,,,1636,477,1159,Single Group Assignment,,Open Label,,Treatment,Safety/Efficacy Study
NCT00332488,Completed,,Phase 3,Interventional,3,,Actual,547,Both,18 Years,80 Years,,144,3633170488,Drug,698,21,698,252,0.42,0.001,11,,,1636,477,1159,Crossover Assignment,,Open Label,,Treatment,Safety/Efficacy Study
NCT00332722,Completed,Actual,N/A,Interventional,2,,Actual,120,Both,18 Years,0,,312,1680332030,Procedure,120,0,,,0.05,0.05,1,,,1636,477,1159,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00333437,Completed,Actual,N/A,Interventional,1,,Actual,7,Both,21 Years,70 Years,,406,1958910089,Drug,7,1,7,1,0.0115,0.3652,1,,,1636,477,1159,Single Group Assignment,,Open Label,,Treatment,Safety/Efficacy Study
NCT00333619,Completed,Actual,N/A,Interventional,2,,Actual,219,Both,60 Years,0,,415,4259325252,Behavioral,,,,,0.1,0.12,1,,,1636,477,1159,Parallel Assignment,,Double Blind,,Treatment,Efficacy Study
NCT00333866,Completed,Actual,Phase 3,Interventional,4,,Actual,747,Both,18 Years,0,,180,3671355921,Drug,736,18,736,529,0.0002,0.0001,16,,,1636,477,1159,Parallel Assignment,,Double-Blind,,Treatment,Safety/Efficacy Study
NCT00333983,Completed,Actual,N/A,Interventional,2,,Actual,62,Both,18 Years,0,,433,678611600,Device,,,62,4,0.025,0.025,1,,,1636,477,1159,Parallel Assignment,,Open Label,,Treatment,Efficacy Study
NCT00334282,Completed,Actual,Phase 3,Interventional,2,,Actual,435,Both,18 Years,0,,81,1588592340,Drug,435,107,435,345,0.0000001,0.0000001,25,,,1636,477,1159,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00336544,Completed,Actual,Phase 3,Interventional,2,,Actual,522,Both,18 Years,0,,358,564386991,Drug,517,21,517,142,0.0769,0.0775,1,,,1636,477,1159,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00335153,Completed,Actual,Phase 3,Interventional,1,,Actual,354,Both,30 Years,0,,13,2626316786,Drug,354,108,354,278,0.023,0.001,16,,,1636,477,1159,Single Group Assignment,,Open Label,,Treatment,Safety/Efficacy Study
NCT00335283,Completed,Actual,Phase 3,Interventional,2,,Actual,75,Both,18 Years,0,,258,2462553535,Drug,,,,,0.001,0.97,1,,,1636,477,1159,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00335452,Completed,Actual,Phase 3,Interventional,4,,Actual,25086,Both,18 Years,0,,3,2150851199,Drug,25086,1355,,,0.0004,0.945,38,,,1636,477,1159,Factorial Assignment,,Double Blind,,Treatment,Efficacy Study
NCT00335777,Completed,Actual,Phase 4,Interventional,2,,Actual,64,Both,18 Years,65 Years,,299,3712179563,Drug,,,48,14,0.289,0.289,1,,,1636,477,1159,Crossover Assignment,,Open Label,,Treatment,Safety/Efficacy Study
NCT00336284,Completed,Actual,Phase 4,Interventional,2,,Actual,1450,Both,18 Years,0,,349,391138901,Other,1450,198,,,0.005,0.001,2,,,1636,477,1159,Parallel Assignment,,Open Label,,Treatment,Safety/Efficacy Study
NCT00336323,Completed,Actual,Phase 2,Interventional,5,,Actual,121,Both,18 Years,0,,151,3639286776,Procedure,109,29,109,91,0.003,0.001,1,,,1636,477,1159,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00336479,Completed,Actual,Phase 2,Interventional,4,,Actual,263,Both,18 Years,65 Years,,95,587377062,Drug,250,22,250,250,0.0014,0.0418,2,,,1636,477,1159,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00336505,Completed,Actual,Phase 3,Interventional,2,,Actual,584,Both,18 Years,0,,358,564386991,Drug,579,22,579,92,0.5667,0.9999,1,,,1636,477,1159,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00337129,Completed,Actual,Phase 2,Interventional,1,,Actual,42,Both,18 Years,0,,204,599964,Drug,40,5,40,36,,,1,,,1636,477,1159,Single Group Assignment,,Open Label,,Treatment,
NCT00345176,Completed,Actual,Phase 3,Interventional,4,,Actual,4203,Both,50 Years,85 Years,,15,2596109672,Dietary Supplement,4203,1987,4203,3058,0.013,0.05,1,,,1636,477,1159,Parallel Assignment,,Double Blind,,Treatment,Efficacy Study
NCT00337194,Completed,Actual,Phase 2,Interventional,2,,Actual,30,Both,18 Years,0,,12,3481824985,Biological,30,10,30,28,0.06,1,1,,,1636,477,1159,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00337285,Completed,Actual,Phase 3,Interventional,1,,Actual,349,Both,18 Years,55 Years,,55,933064736,Drug,,8,,306,0.0001,0.0001,1,,,1636,477,1159,Single Group Assignment,,Open Label,,Treatment,Safety/Efficacy Study
NCT00337350,Completed,Actual,Phase 4,Interventional,2,,Actual,20,Both,18 Years,65 Years,,405,2119471695,Drug,,,,,0.05,0.21,1,,,1636,477,1159,Single Group Assignment,,Double Blind,,Prevention,Efficacy Study
NCT00337467,Completed,Actual,Phase 3,Interventional,1,,Actual,61,Both,18 Years,0,,228,2548010696,Drug,61,12,61,25,,,1,,,1636,477,1159,Single Group Assignment,,Open Label,,Treatment,Efficacy Study
NCT00337662,Completed,Actual,Phase 4,Interventional,3,,Actual,628,Both,18 Years,65 Years,,405,2119471695,Drug,522,45,,280,0.015,0.05,3,,,1636,477,1159,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00339040,Completed,Actual,Phase 2,Interventional,2,,Actual,130,Both,7 Years,12 Years,,199,2889579184,Biological,126,7,126,123,1,1,2,,,1636,477,1159,Parallel Assignment,,Double Blind,,Prevention,Safety/Efficacy Study
NCT00343044,Completed,Actual,Phase 2,Interventional,1,,Actual,40,Female,18 Years,0,,355,1397078073,Drug,40,9,40,38,0.02,0.08,1,,,1636,477,1159,Single Group Assignment,,Open Label,,Treatment,Safety/Efficacy Study
NCT00343252,Completed,Actual,Phase 3,Interventional,2,,Actual,712,Female,45 Years,0,,338,310696855,Drug,710,121,710,550,0.353,0.986,13,,,1636,477,1159,Parallel Assignment,,Double Blind,,Treatment,Efficacy Study
NCT00343382,Completed,Actual,Phase 3,Interventional,4,,Actual,201,Female,18 Years,0,,73,1499605101,Drug,,,194,128,0.002,0.5974,1,,,1636,477,1159,Parallel Assignment,,Double Blind,,Supportive Care,Safety/Efficacy Study
NCT00345384,Completed,Actual,Phase 1/Phase 2,Interventional,2,,Actual,38,Both,18 Years,85 Years,,366,2679883384,Drug,,,38,15,0.02,0.04,1,,,1636,477,1159,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00348283,Completed,,Phase 3,Interventional,2,,Actual,135,Both,18 Years,75 Years,,123,2517084291,Biological,135,20,129,92,0.001,0.001,8,,,1636,477,1159,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00345592,Completed,Actual,Phase 4,Interventional,2,,Actual,420,Both,18 Years,0,,214,1697312720,Device,396,196,396,61,,,1,,,1636,477,1159,Parallel Assignment,,Open Label,,Treatment,
NCT00345605,Completed,Actual,Phase 2,Interventional,2,,Actual,12,Both,5 Years,0,,40,381504241,Drug,,,24,2,,,1,,,1636,477,1159,Crossover Assignment,,Double Blind,,Treatment,Efficacy Study
NCT00346151,Terminated,Actual,Phase 2,Interventional,1,,Actual,5,Both,18 Years,65 Years,,393,3508821678,Drug,5,4,5,5,,,1,,,1636,477,1159,Single Group Assignment,,Open Label,,Treatment,Safety/Efficacy Study
NCT00346333,Completed,Actual,Phase 3,Interventional,2,,Actual,240,Both,18 Years,60 Years,,399,1012520744,Drug,240,2,,,0.03,0.8,1,,,1636,477,1159,Parallel Assignment,,Double Blind,,Treatment,Efficacy Study
NCT00346398,Completed,Actual,Phase 2,Interventional,2,,Actual,51,Both,12 Months,30 Months,,48,2527395224,Biological,51,15,51,51,0.28,0.85,2,,,1636,477,1159,Parallel Assignment,,Double Blind,,Prevention,Safety/Efficacy Study
NCT00346697,Completed,Actual,Phase 4,Interventional,2,,Actual,48,Both,18 Years,0,,199,2889579184,Drug,,,48,12,0.8,0.96,1,,,1636,477,1159,Parallel Assignment,,Double Blind,,Treatment,Efficacy Study
NCT00347360,Completed,Actual,Phase 3,Interventional,2,,Actual,654,Both,18 Years,0,,233,2554888772,Drug,,13,,316,0.1,0.1,1,,,1636,477,1159,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00347919,"Active, not recruiting",Anticipated,Phase 2,Interventional,3,,Actual,189,Female,21 Years,0,,313,1776861857,Drug,189,34,189,170,0.2578,0.7488,16,,,1636,477,1159,Parallel Assignment,,Open Label,,Treatment,Safety/Efficacy Study
NCT00349466,Completed,Actual,Phase 2,Interventional,2,,Actual,80,Both,18 Years,0,,252,2241969754,Drug,,,76,28,0.006,0.006,1,,,1636,477,1159,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00354029,Completed,Actual,Phase 4,Interventional,2,,Actual,83,Both,18 Years,0,,219,120432252,Drug,,,,,0.05,0.05,1,,,1636,477,1159,Parallel Assignment,,Double Blind,,Treatment,Efficacy Study
NCT00349921,Completed,Actual,Phase 2,Interventional,4,,Actual,24,Both,0,0,,341,3299448680,Drug,,,,,0.05,0.05,1,,,1636,477,1159,Crossover Assignment,,Double Blind,,Treatment,
NCT00350142,Completed,Actual,Phase 2,Interventional,1,,Actual,20,Both,18 Years,90 Years,,343,3043072635,Radiation,20,1,20,6,,,1,,,1636,477,1159,Single Group Assignment,,Open Label,,Treatment,Safety Study
NCT00350402,Completed,Actual,Phase 2,Interventional,2,,Actual,44,Both,45 Years,80 Years,,346,4003884833,Behavioral,,,,,0.001,0.459,1,,,1636,477,1159,Parallel Assignment,,Double Blind,,Treatment,Efficacy Study
NCT00351533,Completed,Actual,Phase 2,Interventional,2,,Actual,90,Both,18 Years,0,,395,1332702445,Drug,90,22,90,51,0.002,0.89,2,,,1636,477,1159,Parallel Assignment,,Double Blind,,Treatment,
NCT00351936,Completed,Actual,Phase 4,Interventional,2,,Actual,16,Both,18 Years,65 Years,,405,2119471695,Drug,,,15,1,0.001,0.999,1,,,1636,477,1159,Crossover Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00352053,Completed,Actual,Phase 3,Interventional,2,,Actual,87,Both,12 Years,17 Years,,199,2889579184,Drug,168,33,168,155,0.22,1,2,,,1636,477,1159,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00352417,Completed,Actual,Phase 2,Interventional,2,,Actual,50,Both,30 Years,80 Years,,49,2002447835,Drug,50,5,50,27,0.37,0.01,1,,,1636,477,1159,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00353496,Completed,Actual,Phase 3,Interventional,2,,Actual,264,Both,18 Years,0,,162,1192638635,Drug,204,57,204,180,0.001,0.001,15,,,1636,477,1159,Parallel Assignment,,Double Blind,,Treatment,Efficacy Study
NCT00355147,Completed,Actual,N/A,Interventional,2,,Actual,174,Both,18 Years,0,,445,1019378447,Behavioral,,,,,0.0001,0.69,1,,,1636,477,1159,Parallel Assignment,,Double Blind,,Health Services Research,Efficacy Study
NCT00358215,Completed,Actual,Phase 3,Interventional,2,,Actual,2278,Both,18 Years,0,,213,3865579137,Drug,2273,1522,2273,1451,0.005,0.922,36,,,1636,477,1159,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00355394,Completed,Actual,Phase 2,Interventional,2,,Actual,31,Both,8 Years,18 Years,,300,3938495423,Drug,,,,,0.002,0.5,1,,,1636,477,1159,Parallel Assignment,,Double Blind,,Treatment,Efficacy Study
NCT00355706,Completed,Actual,N/A,Interventional,2,,Actual,100,Both,18 Years,0,,270,112942658,Procedure,,,,,0.56,0.964,1,,,1636,477,1159,Factorial Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00355797,Completed,Actual,Phase 4,Interventional,3,,Actual,1491,Both,18 Years,0,,68,3362919,Device,,,1491,86,0.004,0.552,1,,,1636,477,1159,Parallel Assignment,,Single Blind,,Treatment,Efficacy Study
NCT00356135,Completed,Actual,Phase 2,Interventional,3,,Actual,139,Both,18 Years,74 Years,,118,1856855603,Drug,139,3,139,52,0.0001,0.0001,1,,,1636,477,1159,Parallel Assignment,,Double Blind,,Treatment,Pharmacodynamics Study
NCT00356304,Completed,Actual,Phase 1,Interventional,2,,Actual,50,Both,18 Years,65 Years,,133,2194019288,Behavioral,,,,,0.05,0.05,1,,,1636,477,1159,Parallel Assignment,,Open Label,,Treatment,Efficacy Study
NCT00356811,Completed,Actual,Phase 2,Interventional,1,,Actual,57,Female,18 Years,0,,313,1776861857,Drug,57,11,57,56,,,4,,,1636,477,1159,Single Group Assignment,,Open Label,,Treatment,Safety/Efficacy Study
NCT00356915,Completed,Actual,Phase 3,Interventional,3,,Actual,1381,Both,16 Years,75 Years,,333,3683329912,Drug,2572,26,2572,104,0.001,0.001,7,,,1636,477,1159,Parallel Assignment,,Single Blind,,Treatment,Safety/Efficacy Study
NCT00357097,Completed,Actual,Phase 3,Interventional,,,Actual,240,Both,18 Years,79 Years,,398,2991482834,Drug,,4,,154,0.001,0.001,1,,,1636,477,1159,Parallel Assignment,,Double Blind,,Treatment,Efficacy Study
NCT00361335,Completed,Actual,Phase 3,Interventional,5,,Actual,643,Both,18 Years,0,,401,2326608903,Drug,1438,150,1438,625,0.001,0.001,15,,,1636,477,1159,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00358644,Completed,Actual,Phase 2,Interventional,1,,Actual,55,Both,60 Years,0,,5,1001156887,Drug,55,40,55,55,,,1,,,1636,477,1159,Single Group Assignment,,Open Label,,Treatment,Safety/Efficacy Study
NCT00358735,Completed,Actual,N/A,Interventional,2,,Actual,411,Both,18 Years,0,,127,4179641909,Device,392,13,392,191,0.0004,0.05,1,,,1636,477,1159,Parallel Assignment,,Single Blind,,Prevention,Safety/Efficacy Study
NCT00358826,Completed,Actual,Phase 2,Interventional,4,,Actual,191,Both,30 Years,80 Years,,119,2281658183,Drug,191,19,191,172,0.11,0.005,2,,,1636,477,1159,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00358917,Completed,Actual,Phase 3,Interventional,2,,Actual,599,Both,18 Years,0,,229,4253814299,Drug,599,64,599,381,0.222,0.413,1,,,1636,477,1159,Parallel Assignment,,Open Label,,Treatment,Safety/Efficacy Study
NCT00359424,Terminated,Actual,Phase 3,Interventional,2,,Actual,656,Both,18 Years,82 Years,,433,678611600,Drug,656,382,656,587,0.5241,0.8275,8,,,1636,477,1159,Parallel Assignment,,Open Label,,Treatment,Safety/Efficacy Study
NCT00359788,Completed,,Phase 4,Interventional,,,Actual,349,Both,40 Years,0,,385,1533570944,Drug,349,23,349,20,0.0001,0.0001,1,,,1636,477,1159,Parallel Assignment,,,,Treatment,Safety/Efficacy Study
NCT00360282,Completed,Actual,N/A,Interventional,4,,Actual,36,Both,21 Years,45 Years,,299,3712179563,Drug,,,53,1,0.549,0.007,1,,,1636,477,1159,Crossover Assignment,,Double Blind,,Basic Science,Pharmacokinetics/Dynamics Study
NCT00360334,Completed,Actual,Phase 3,Interventional,2,,Actual,235,Both,30 Years,0,,448,3563636584,Drug,,10,,199,0.001,0.001,1,,,1636,477,1159,Parallel Assignment,,Open Label,,Treatment,Safety/Efficacy Study
NCT00360698,Completed,Actual,Phase 4,Interventional,2,,Actual,106,Both,18 Years,75 Years,,144,3633170488,Drug,106,3,,,0.0109,0.958,3,,,1636,477,1159,Parallel Assignment,,Open Label,,Treatment,Safety/Efficacy Study
NCT00364130,Completed,Actual,N/A,Interventional,2,,Actual,138,Both,8 Years,21 Years,,122,240489291,Device,138,13,138,20,0.02,0.98,1,,,1636,477,1159,Parallel Assignment,,Double Blind,,Treatment,Efficacy Study
NCT00362115,Completed,Actual,Phase 2,Interventional,7,,Actual,449,Both,18 Years,0,,233,2554888772,Drug,445,5,445,56,0.0001,0.0001,4,,,1636,477,1159,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00362232,Completed,Actual,Phase 3,Interventional,2,,Actual,3148,Both,18 Years,0,,459,1680079989,Drug,3034,237,3034,2319,0.012,0.001,13,,,1636,477,1159,Parallel Assignment,,Double Blind,,Prevention,Safety/Efficacy Study
NCT00362297,Completed,Actual,Phase 4,Interventional,2,,Actual,31,Both,18 Years,0,,189,420947143,Drug,,,,,0.052,0.052,1,,,1636,477,1159,Crossover Assignment,,Open Label,,Treatment,Efficacy Study
NCT00362375,Completed,Actual,Phase 1/Phase 2,Interventional,2,,Actual,313,Female,18 Years,0,,199,2889579184,Behavioral,,,,,0.05,0.05,1,,,1636,477,1159,Parallel Assignment,,Open Label,,Prevention,Efficacy Study
NCT00362453,Completed,Actual,N/A,Interventional,2,,Actual,40,Both,55 Years,0,,257,4066368552,Behavioral,,,40,1,0.00005,1,1,,,1636,477,1159,Parallel Assignment,,Single Blind,,Treatment,Safety/Efficacy Study
NCT00363129,Completed,Actual,Phase 3,Interventional,2,,Actual,207,Both,18 Years,0,,318,4244454230,Dietary Supplement,,,189,51,0.43,1,1,,,1636,477,1159,Parallel Assignment,,Double Blind,,Supportive Care,Safety/Efficacy Study
NCT00363311,Completed,Actual,Phase 4,Interventional,2,,Actual,302,Male,50 Years,80 Years,,314,306685706,Drug,302,45,302,123,0.007,0.8,2,,,1636,477,1159,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00364533,Terminated,Actual,Phase 3,Interventional,4,,Actual,367,Both,18 Years,80 Years,,45,3020316824,Drug,365,6,365,230,0.001,0.001,8,,,1636,477,1159,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00364377,Completed,Actual,Phase 4,Interventional,2,,Actual,22,Both,35 Years,70 Years,,370,2544211151,Drug,,,22,0,0.05,0.05,1,,,1636,477,1159,Parallel Assignment,,Double Blind,,Treatment,Efficacy Study
NCT00364858,Completed,Actual,Phase 4,Interventional,2,,Actual,95,Both,18 Years,0,,187,4285183308,Drug,190,22,190,142,,,7,,,1636,477,1159,Parallel Assignment,,Open Label,,Treatment,Safety/Efficacy Study
NCT00367133,Completed,Actual,Phase 3,Interventional,3,,Actual,840,Both,18 Years,0,,148,4146875630,Procedure,840,258,840,330,0.002,0.001,1,,,1636,477,1159,Parallel Assignment,,Double Blind,,Treatment,Efficacy Study
NCT00365300,Completed,Actual,Phase 3,Interventional,2,,Actual,129,Both,0,11 Months,,183,1227007759,Drug,492,10,492,218,1,1,1,,,1636,477,1159,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00365456,Completed,Actual,Phase 3,Interventional,2,,Actual,407,Female,50 Years,0,,337,2339607719,Drug,687,65,687,460,0.01,0.01,1,,,1636,477,1159,Single Group Assignment,,Open Label,,Treatment,Safety Study
NCT00366249,Completed,Actual,Phase 3,Interventional,2,,Actual,1061,Both,18 Years,0,,61,1267336030,Drug,,141,,698,,,39,,,1636,477,1159,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00366301,Terminated,Actual,Phase 4,Interventional,4,,Actual,500,Both,18 Years,79 Years,,448,3563636584,Drug,500,13,500,68,0.05,0.05,1,,,1636,477,1159,Factorial Assignment,,Open Label,,Treatment,Efficacy Study
NCT00366340,Completed,Actual,Phase 3,Interventional,2,,Actual,604,Both,56 Days,112 Days,,457,1181752925,Biological,2412,98,2345,797,,,1,,,1636,477,1159,Parallel Assignment,,Double Blind,,Prevention,Safety Study
NCT00366548,Completed,Actual,Phase 3,Interventional,2,,Actual,500,Both,42 Days,98 Days,,457,1181752925,Biological,1980,108,1980,491,,,1,,,1636,477,1159,Parallel Assignment,,Double-Blind,,Prevention,Safety Study
NCT00366899,Completed,Actual,Phase 3,Interventional,2,,Actual,605,Both,75 Days,105 Days,,457,1181752925,Biological,2338,59,2338,893,,,1,,,1636,477,1159,Parallel Assignment,,Double Blind,,Prevention,Safety Study
NCT00368069,Completed,Actual,Phase 3,Interventional,2,,Actual,158,Both,12 Years,70 Years,,167,2963929165,Drug,156,8,156,44,0.003,0.07,6,,,1636,477,1159,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00369668,Completed,Actual,Phase 2,Interventional,3,,Actual,30,Both,44 Years,86 Years,,87,550104849,Behavioral,,,,,0.05,0.05,1,,,1636,477,1159,Parallel Assignment,,Double Blind,,Treatment,Efficacy Study
NCT00368459,Completed,Actual,Phase 2,Interventional,2,,Actual,42,Female,60 Years,0,,22,4102679792,Drug,42,3,42,29,0.01,0.1,1,,,1636,477,1159,Parallel Assignment,,Double Blind,,Treatment,Efficacy Study
NCT00368537,Completed,Actual,Phase 4,Interventional,2,,Actual,550,Both,18 Years,0,,412,638341672,Drug,531,67,531,637,0.444,0.444,12,,,1636,477,1159,Parallel Assignment,,Open Label,,Treatment,Safety/Efficacy Study
NCT00368745,Completed,Actual,Phase 3,Interventional,2,,Actual,108,Both,18 Years,65 Years,,188,1272109837,Drug,,,106,62,0.0001,0.9966,7,,,1636,477,1159,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00368849,Completed,Actual,Phase 2,Interventional,2,,Actual,20,Both,18 Years,65 Years,,230,2393214790,Drug,40,3,38,17,0.09,0.84,1,,,1636,477,1159,Crossover Assignment,,Double Blind,,Treatment,Efficacy Study
NCT00368927,Completed,Actual,Phase 2,Interventional,2,,Actual,61,Both,40 Years,79 Years,,371,1121935247,Drug,61,2,61,49,0.63,0.85,2,,,1636,477,1159,Parallel Assignment,,Double Blind,,Prevention,Efficacy Study
NCT00368966,Completed,Actual,Phase 3,Interventional,2,,Actual,619,Both,42 Days,98 Days,,457,1181752925,Biological,2414,77,2414,563,,,1,,,1636,477,1159,Parallel Assignment,,Double-Blind,,Prevention,Safety Study
NCT00368979,Completed,Actual,Phase 3,Interventional,2,,Actual,378,Male,50 Years,0,,379,3703198641,Drug,377,28,377,240,0.003,0.003,1,,,1636,477,1159,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00369343,Completed,Actual,Phase 3,Interventional,2,,Actual,381,Female,40 Years,70 Years,,133,2194019288,Drug,,19,,606,0.008,0.001,1,,,1636,477,1159,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00369382,Completed,Actual,Phase 4,Interventional,2,,Actual,121,Both,18 Years,0,,192,3144545399,Drug,114,43,114,94,0.001,0.001,7,,,1636,477,1159,Parallel Assignment,,Open Label,,Prevention,Efficacy Study
NCT00369928,Completed,Actual,Phase 2,Interventional,3,,Actual,254,Both,18 Years,70 Years,,401,2326608903,Drug,256,11,256,10,0.666,0.982,6,,,1636,477,1159,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00371865,Completed,Actual,N/A,Interventional,2,,Actual,114,Both,18 Years,0,,247,3604042324,Behavioral,,,,,0.13,0.9,1,,,1636,477,1159,Parallel Assignment,,Single Blind,,Treatment,Efficacy Study
NCT00370032,Completed,Actual,Phase 4,Interventional,,,Actual,49,Female,18 Years,49 Years,,248,2982263879,Drug,,,94,44,0.131,0.131,1,,,1636,477,1159,Crossover Assignment,,Double-Blind,,Treatment,Pharmacodynamics Study
NCT00370071,Completed,Actual,Phase 3,Interventional,1,,Actual,39,Both,16 Years,55 Years,,304,3878017841,Drug,,,39,34,0.0017,0.0001,1,,,1636,477,1159,Single Group Assignment,,Open Label,,Treatment,Safety/Efficacy Study
NCT00370292,Completed,Actual,Phase 2,Interventional,2,,Actual,19,Both,18 Years,0,,319,3940632058,Drug,19,5,19,19,0.03,0.001,1,,,1636,477,1159,Single Group Assignment,,Open Label,,Treatment,Safety/Efficacy Study
NCT00370331,Completed,Actual,Phase 3,Interventional,2,,Actual,197,Both,18 Years,0,,387,2054861079,Drug,196,27,196,176,0.001,0.001,24,,,1636,477,1159,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00371137,Completed,Actual,Phase 3,Interventional,2,,Actual,548,Both,18 Years,0,,180,3671355921,Drug,547,3,547,399,0.015,0.001,1,,,1636,477,1159,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00371267,Completed,Actual,N/A,Interventional,2,,Actual,101,Both,55 Years,0,,341,3299448680,Behavioral,,,,,0.39,0.74,1,,,1636,477,1159,Parallel Assignment,,Open Label,,Treatment,Efficacy Study
NCT00371397,Completed,Actual,N/A,Interventional,3,,Actual,52,Female,30 Years,65 Years,,205,2158746441,Behavioral,,,,,0.009,0.009,1,,,1636,477,1159,Crossover Assignment,,Single Blind,,Treatment,Efficacy Study
NCT00371566,Completed,Actual,Phase 2,Interventional,2,,Actual,107,Both,18 Years,0,,425,2771705880,Drug,105,28,105,105,0.394,0.394,5,,,1636,477,1159,Parallel Assignment,,Single Blind,,Treatment,Safety/Efficacy Study
NCT00375492,Completed,Actual,Phase 3,Interventional,2,,Actual,196,Both,18 Years,75 Years,,449,2402940714,Drug,,4,,169,0.003,0.0001,1,,,1636,477,1159,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00372385,Completed,Actual,Phase 2,Interventional,4,,Actual,334,Both,18 Years,65 Years,,95,587377062,Drug,323,44,323,321,0.0026,0.959,4,,,1636,477,1159,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00373113,Terminated,Actual,Phase 3,Interventional,2,,Actual,482,Female,18 Years,0,,74,3128271172,Drug,478,116,478,457,0.002,0.001,23,,,1636,477,1159,Parallel Assignment,,Open Label,,Treatment,Safety/Efficacy Study
NCT00373256,Completed,Actual,Phase 3,Interventional,2,,Actual,488,Both,18 Years,0,,74,3128271172,Drug,477,174,477,471,0.9986,0.9986,4,,,1636,477,1159,Parallel Assignment,,Open Label,,Treatment,Efficacy Study
NCT00373334,Completed,Actual,Phase 3,Interventional,3,,Actual,138,Both,0,1 Years,,184,2110570532,Drug,138,1,138,89,0.262,0.938,1,,,1636,477,1159,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00373360,Completed,Actual,Phase 4,Interventional,1,,Actual,10,Both,18 Years,70 Years,,386,1248981652,Drug,10,2,10,9,0,1,1,,,1636,477,1159,Single Group Assignment,,Open Label,,Treatment,Safety/Efficacy Study
NCT00373425,Completed,Actual,Phase 3,Interventional,2,,Actual,1252,Both,18 Years,0,,326,1982470504,Drug,1231,260,1231,1137,0.3235,0.562,19,,,1636,477,1159,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00373685,Completed,Actual,Phase 4,Interventional,2,,Actual,8067,Both,55 Years,0,,334,3213715074,Drug,7921,194,7921,2125,0.0001,0.0001,2,,,1636,477,1159,Parallel Assignment,,Open Label,,Treatment,Safety Study
NCT00373958,Completed,Actual,Phase 3,Interventional,2,,Actual,666,Both,42 Days,98 Days,,457,1181752925,Biological,2509,66,2509,962,,,1,,,1636,477,1159,Parallel Assignment,,Double-Blind,,Prevention,Safety Study
NCT00374322,Completed,Actual,Phase 3,Interventional,2,,Actual,3166,Female,18 Years,0,,313,1776861857,Drug,3147,177,3147,2618,0.286,0.286,33,,,1636,477,1159,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00000378,Completed,Actual,Phase 4,Interventional,2,,Actual,110,Both,60 Years,95 Years,,133,2194019288,Drug,,,110,6,0.05,0.05,1,1,,1636,477,279,Parallel Assignment,,Double Blind,,Treatment,Efficacy Study
NCT00001656,Completed,Actual,Phase 4,Interventional,2,,Actual,25,Both,7 Years,18 Years,,90,2188822896,Drug,25,3,25,25,0.04,0.96,1,1,,1636,477,279,Parallel Assignment,,Double Blind,,Treatment,Efficacy Study
NCT00001959,Completed,Actual,Phase 2,Interventional,1,,Actual,21,Both,18 Years,0,,181,1694915496,Drug,21,3,21,16,0.16,0.01,1,1,,1636,477,279,Single Group Assignment,,Open Label,,Treatment,Safety/Efficacy Study
NCT00003222,Completed,,Phase 2,Interventional,2,,Actual,40,Both,18 Years,79 Years,,288,3256609041,Biological,37,5,37,36,0.004,0.13,1,1,,1636,477,279,Parallel Assignment,,Open Label,,Treatment,Efficacy Study
NCT00003389,"Active, not recruiting",Anticipated,Phase 3,Interventional,2,,Actual,854,Both,16 Years,0,,276,1696214900,Drug,836,756,836,835,0.32,0.86,3,539,,1636,477,279,Parallel Assignment,,Open Label,,Treatment,Safety/Efficacy Study
NCT00004054,Completed,Actual,Phase 3,Interventional,2,,Actual,397,Male,18 Years,0,,378,3123971163,Drug,397,76,397,387,0.81,0.81,2,54,,1636,477,279,Parallel Assignment,,Open Label,,Treatment,
NCT00004228,"Active, not recruiting",,Phase 3,Interventional,7,,Actual,393,Both,1 Years,30 Years,,276,1696214900,Drug,374,51,374,370,0.63,0.97,5,176,,1636,477,279,Parallel Assignment,,Open Label,,Treatment,Efficacy Study
NCT00004412,Completed,Actual,Phase 2,Interventional,3,,Actual,23,Both,16 Years,60 Years,,414,1996600544,Other,26,14,26,1,0.05,0.05,1,4,,1636,477,279,Parallel Assignment,,Open Label,,Treatment,Efficacy Study
NCT00004732,"Active, not recruiting",Anticipated,Phase 3,Interventional,2,,Actual,2502,Both,18 Years,0,,49,2002447835,Procedure,2502,614,2502,425,,,2,116,,1636,477,279,Parallel Assignment,,Open Label,,Prevention,
NCT00004859,Terminated,Actual,Phase 3,Interventional,2,,Actual,589,Both,18 Years,0,,271,2288821332,Drug,577,471,577,567,0.99,0.99,2,236,,1636,477,279,Parallel Assignment,,Open Label,,Treatment,Efficacy Study
NCT00004888,Completed,Actual,Phase 2,Interventional,2,,Actual,84,Female,18 Years,0,,388,380129175,Drug,89,89,89,89,,,1,1,,1636,477,279,Parallel Assignment,,Open Label,,Treatment,Safety/Efficacy Study
NCT00004978,Completed,Actual,Phase 3,Interventional,2,,Actual,4150,Both,18 Years,0,,199,2889579184,Drug,4111,849,4111,225,0.003,0.97,25,248,,1636,477,279,Parallel Assignment,,Open Label,,Treatment,Efficacy Study
NCT00004980,Completed,Actual,Phase 2,Interventional,2,,Actual,50,Both,18 Years,60 Years,,405,2119471695,Device,,,50,19,0.001,0.01,1,1,,1636,477,279,Parallel Assignment,,Double Blind,,Treatment,Efficacy Study
NCT00005947,Completed,Actual,Phase 3,Interventional,2,,Actual,127,Male,18 Years,0,,378,3123971163,Biological,127,30,127,126,0.01,0.052,1,,,1636,477,279,,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00006011,Completed,,Phase 3,Interventional,2,,Actual,659,Female,0,0,,163,727628577,Biological,539,31,539,537,,,1,,,1636,477,279,Parallel Assignment,,Double Blind,,Treatment,Efficacy Study
NCT00006170,Completed,Actual,Phase 4,Interventional,2,,Actual,349,Female,18 Years,65 Years,,443,179058863,Drug,,,,,0.001,0.001,1,,,1636,477,279,Factorial Assignment,,Double Blind,,Treatment,Efficacy Study
NCT00006721,"Active, not recruiting",,Phase 3,Interventional,3,,Actual,571,Both,18 Years,0,,276,1696214900,Drug,539,19,539,536,0.08,0.11,1,,,1636,477,279,Parallel Assignment,,Open Label,,Treatment,Safety/Efficacy Study
NCT00010803,Completed,Actual,Phase 3,Interventional,2,,Actual,3069,Both,75 Years,0,,129,1878179548,Drug,3069,1961,3069,2973,0.65,0.98,1,,,1636,477,279,Parallel Assignment,,Double Blind,,Prevention,Safety/Efficacy Study
NCT00013611,Completed,Actual,Phase 3,Interventional,2,,Actual,1695,Both,18 Years,0,,198,3223041150,Drug,1695,389,,,0.1,0.001,1,,,1636,477,279,Parallel Assignment,,Open Label,,Treatment,Safety/Efficacy Study
NCT00014911,Completed,Actual,Phase 2,Interventional,1,,Actual,36,Both,18 Years,65 Years,,141,3520364124,Procedure,36,17,36,36,,,5,,,1636,477,279,Single Group Assignment,,Open Label,,Treatment,
NCT00023309,Completed,Actual,Phase 2,Interventional,2,,Actual,41,Both,18 Years,0,,196,2835725183,Drug,,,,,0.0049,0.0913,1,,,1636,477,279,Parallel Assignment,,Open Label,,Treatment,Safety/Efficacy Study
NCT00023452,Completed,Actual,Phase 3,Interventional,2,,Actual,8595,Both,2 Years,0,,446,3377839684,Drug,7799,162,7799,474,0.02,0.001,4,,,1636,477,279,Parallel Assignment,,Open Label,,Prevention,Safety/Efficacy Study
NCT00024102,Completed,Actual,Phase 3,Interventional,2,,Actual,633,Female,65 Years,0,,73,1499605101,Drug,611,58,611,568,0.02,0.001,3,,,1636,477,279,Parallel Assignment,,Open Label,,Treatment,Safety/Efficacy Study
NCT00027378,Completed,Actual,Phase 2,Interventional,2,,Actual,50,Both,15 Years,20 Years,,17,1576823743,Drug,,,,,0.05,0.05,1,,,1636,477,279,Parallel Assignment,,Double Blind,,Treatment,Efficacy Study
NCT00028093,Completed,Actual,Phase 4,Interventional,2,,Actual,50,Both,18 Years,0,,95,587377062,Drug,,,,,0.54,0.54,1,,,1636,477,279,Parallel Assignment,,Open Label,,Treatment,Safety/Efficacy Study
NCT00029146,Terminated,Actual,Phase 3,Interventional,2,,Actual,700,Both,18 Years,85 Years,,433,678611600,Procedure,195,16,,,0.33,0.85,1,,,1636,477,279,Parallel Assignment,,Single Blind,,Treatment,Efficacy Study
NCT00032591,Completed,Actual,Phase 4,Interventional,2,,Actual,2922,Both,18 Years,0,,51,734346743,Procedure,2922,497,2922,731,0.14,0.14,2,,,1636,477,279,Parallel Assignment,,Open Label,,Treatment,Safety/Efficacy Study
NCT00033657,Completed,Actual,Phase 2,Interventional,2,,Actual,97,Both,18 Years,0,,170,458737369,Drug,151,97,151,148,0.48,0.48,1,,,1636,477,279,Parallel Assignment,,Open Label,,Treatment,Efficacy Study
NCT00035815,Completed,Actual,Phase 3,Interventional,2,,Actual,330,Both,18 Years,80 Years,,27,40759743,Drug,330,30,330,195,0.321,0.529,2,,,1636,477,279,Parallel Assignment,,Double Blind,,Treatment,Efficacy Study
NCT00035932,Completed,Actual,Phase 3,Interventional,3,,Actual,571,Both,16 Years,0,,199,2889579184,Drug,347,63,347,300,0.05,0.05,1,,,1636,477,279,Parallel Assignment,,Open Label,,Treatment,Safety/Efficacy Study
NCT00036270,Completed,Actual,Phase 3,Interventional,2,,Actual,9779,Female,50 Years,0,,74,3128271172,Drug,9666,1615,9666,7118,0.118,0.951,1,,,1636,477,279,Parallel Assignment,,Open Label,,Treatment,Safety/Efficacy Study
NCT00037830,Completed,Actual,Phase 2,Interventional,3,,Actual,94,Both,39 Years,85 Years,,345,3641618925,Drug,94,3,94,77,0.0003,0.05,1,,,1636,477,279,Crossover Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00039741,Completed,Actual,Phase 2/Phase 3,Interventional,4,,Actual,266,Both,0,18 Years,,199,2889579184,Drug,263,48,,,0.26,0.56,2,,,1636,477,279,Factorial Assignment,,Open Label,,Treatment,Efficacy Study
NCT00040742,Completed,Actual,Phase 2/Phase 3,Interventional,4,,Actual,745,Both,18 Years,0,,311,1233291739,Other,745,1,745,23,0.017,0.738,1,,,1636,477,279,Parallel Assignment,,Double Blind,,Prevention,Efficacy Study
NCT00040937,"Active, not recruiting",Anticipated,Phase 2,Interventional,1,,Actual,147,Both,18 Years,65 Years,,303,1739707547,Biological,321,8,321,319,,,1,,,1636,477,279,Single Group Assignment,,Open Label,,Treatment,Efficacy Study
NCT00042991,Completed,Actual,Phase 1/Phase 2,Interventional,1,,Actual,69,Both,3 Years,21 Years,,452,3777646411,Other,69,30,69,69,0.0546,0.0001,1,,,1636,477,279,Single Group Assignment,,Open Label,,Treatment,Safety/Efficacy Study
NCT00044044,Completed,Actual,Phase 2,Interventional,5,,Actual,356,Both,18 Years,64 Years,,405,2119471695,Drug,353,28,353,259,0.05,0.05,1,,,1636,477,279,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00046475,Completed,Actual,Phase 4,Interventional,,,Actual,140,Both,18 Years,0,,235,1347978219,Drug,625,11,625,122,0.001,0.001,1,,,1636,477,279,Crossover Assignment,,Double-Blind,,Treatment,Safety/Efficacy Study
NCT00046891,Completed,Actual,Phase 3,Interventional,2,,Actual,226,Female,18 Years,0,,73,1499605101,Drug,205,7,205,183,0.84,0.84,1,,,1636,477,279,,,Double-Blind,,Supportive Care,
NCT00047008,"Active, not recruiting",,Phase 3,Interventional,2,,Actual,743,Both,18 Years,0,,204,599964,Procedure,721,572,721,716,0.18,0.18,1,,,1636,477,279,Parallel Assignment,,Open Label,,Treatment,
NCT00047385,Completed,Actual,Phase 3,Interventional,2,,Actual,53454,Both,55 Years,74 Years,,271,2288821332,Device,53454,2,,,0.004,0.02,1,,,1636,477,279,Parallel Assignment,,Open Label,,Screening,
NCT00047463,Completed,Actual,Phase 2,Interventional,2,,Actual,35,Both,18 Years,0,,167,2963929165,Device,,,35,7,0.26,0.26,1,,,1636,477,279,Parallel Assignment,,Double Blind,,Treatment,Safety Study
NCT00048542,Completed,Actual,Phase 3,Interventional,8,,Actual,171,Both,4 Years,17 Years,,42,2261255864,Biological,367,45,367,285,0.002,0.156,8,,,1636,477,279,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00048997,Completed,,Phase 3,Interventional,2,,Actual,356,Both,18 Years,0,,271,2288821332,Radiation,163,5,163,83,0.2853,0.2853,1,,,1636,477,279,Parallel Assignment,,Open Label,,Treatment,
NCT00049530,"Active, not recruiting",Anticipated,Phase 2,Interventional,1,,Actual,32,Both,18 Years,0,,288,3256609041,Biological,32,13,32,31,0.001,0.001,1,,,1636,477,279,Single Group Assignment,,Open Label,,Treatment,
NCT00050089,Completed,Actual,N/A,Interventional,4,,Actual,368,Both,18 Years,0,,0,3058073368,Other,339,214,,,0.49,0.92,2,,,1636,477,279,Factorial Assignment,,Open Label,,Treatment,Efficacy Study
NCT00050778,Completed,Actual,Phase 2,Interventional,3,,Actual,334,Both,18 Years,50 Years,,305,3529108695,Biological,539,155,539,538,0.0001,0.0001,5,,,1636,477,279,Parallel Assignment,,Single Blind,,Treatment,Safety/Efficacy Study
NCT00051558,Completed,Actual,Phase 3,Interventional,2,,Actual,428,Both,21 Years,0,,337,2339607719,Drug,,134,,367,0.002,0.001,6,,,1636,477,279,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00053703,Completed,Actual,Phase 4,Interventional,3,,Actual,116,Both,8 Years,19 Years,,405,2119471695,Drug,116,8,116,97,0.05,0.05,1,,,1636,477,279,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00054847,Completed,Actual,N/A,Interventional,2,,Actual,733,Both,0,0,,83,2867382159,Procedure,733,330,733,313,0.61,0.99,1,,,1636,477,279,Parallel Assignment,,Single Blind,,Treatment,Bio-equivalence Study
NCT00055237,Completed,Actual,Phase 2,Interventional,2,,Actual,19,Both,18 Years,0,,251,622266319,Biological,19,4,19,19,,,1,,,1636,477,279,Single Group Assignment,,Open Label,,Treatment,Safety/Efficacy Study
NCT00056472,Completed,Actual,Phase 3,Interventional,2,,Actual,259,Both,18 Years,0,,281,2438250757,Drug,259,12,259,74,0.02,0.001,2,,,1636,477,279,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00056498,Completed,Actual,Phase 4,Interventional,2,,Actual,65,Both,18 Years,65 Years,,405,2119471695,Drug,65,3,,,0.05,0.05,1,,,1636,477,279,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00056862,Completed,Actual,Phase 4,Interventional,2,,Actual,58,Both,18 Years,0,,222,1420832983,Drug,57,3,57,3,0.002,0.2,1,,,1636,477,279,Parallel Assignment,,Open Label,,Treatment,Safety/Efficacy Study
NCT00057577,Completed,Actual,Phase 4,Interventional,2,,Actual,452,Both,18 Years,0,,133,2194019288,Behavioral,452,141,,,0.01,0.038,1,,,1636,477,279,Parallel Assignment,,Single Blind,,Prevention,Efficacy Study
NCT00058019,Completed,Actual,Phase 2,Interventional,1,,Actual,51,Both,18 Years,0,,28,3991674064,Drug,51,11,51,48,0.022,1,1,,,1636,477,279,Single Group Assignment,,Open Label,,Treatment,Safety/Efficacy Study
NCT00059215,Completed,Actual,Phase 2,Interventional,4,,Actual,905,Both,18 Years,75 Years,,84,3416315868,Drug,904,66,904,691,0.26,1,2,,,1636,477,279,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00059332,Completed,Actual,Phase 3,Interventional,2,,Actual,1700,Both,40 Years,95 Years,,87,550104849,Drug,1700,861,1700,660,0.12,0.95,1,,,1636,477,279,Parallel Assignment,,Double Blind,,Treatment,Efficacy Study
NCT00060008,Terminated,Actual,N/A,Interventional,1,,Actual,18,Both,0,25 Years,,316,635999104,Radiation,,,,,0.016,0.016,1,,,1636,477,279,Single Group Assignment,,Open Label,,Diagnostic,
NCT00060944,Completed,Actual,Phase 2,Interventional,2,,Actual,271,Both,18 Years,0,,259,1049890625,Drug,260,89,260,257,0.0302,0.192,8,,,1636,477,279,Parallel Assignment,,Open Label,,Treatment,Safety/Efficacy Study
NCT00061633,Completed,Actual,Phase 2,Interventional,2,,Actual,169,Both,18 Years,0,,1,321984546,Drug,167,12,167,96,0.5289,0.5289,1,,,1636,477,279,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00062010,Completed,Actual,Phase 2,Interventional,1,,Actual,37,Both,18 Years,0,,271,2288821332,Drug,34,21,34,33,,,1,,,1636,477,279,Single Group Assignment,,Open Label,,Treatment,Safety/Efficacy Study
NCT00062764,Completed,Actual,Phase 2,Interventional,1,,Actual,18,Both,18 Years,0,,220,1949604403,Drug,18,0,18,14,0.004,0.004,1,,,1636,477,279,Single Group Assignment,,Open Label,,Treatment,Safety/Efficacy Study
NCT00063622,Completed,Actual,Phase 3,Interventional,3,,Actual,247,Both,18 Years,0,,266,2597930394,Drug,247,19,247,127,0.001,0.001,1,,,1636,477,279,Parallel Assignment,,Double Blind,,Treatment,Efficacy Study
NCT00064350,Completed,Actual,Phase 2,Interventional,3,,Actual,342,Both,18 Years,0,,271,2288821332,Drug,463,173,463,429,0.005,0.12,1,,,1636,477,279,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00064662,Completed,Actual,Phase 2/Phase 3,Interventional,2,,Actual,655,Female,21 Years,0,,454,3722636346,Procedure,655,74,655,362,0.01,0.001,1,,,1636,477,279,Parallel Assignment,,Open Label,,Treatment,Efficacy Study
NCT00064701,Completed,Actual,Phase 3,Interventional,3,,Actual,668,Both,12 Years,0,,256,3993050794,Drug,638,428,638,628,,,3,,,1636,477,279,Parallel Assignment,,Open Label,,Treatment,Safety/Efficacy Study
NCT00064844,Completed,Actual,Phase 4,Interventional,2,,Actual,96,Both,18 Years,0,,418,2521044459,Behavioral,,,96,8,0.01,0.01,1,,,1636,477,279,Parallel Assignment,,Double Blind,,Treatment,Efficacy Study
NCT00065442,Completed,Actual,Phase 3,Interventional,2,,Actual,512,Male,18 Years,0,,378,3123971163,Biological,506,122,506,496,0.023,0.628,2,,,1636,477,279,Parallel Assignment,,Double Blind,,Treatment,Efficacy Study
NCT00065468,Completed,Actual,Phase 3,Interventional,3,,Actual,626,Both,18 Years,0,,81,1588592340,Drug,616,303,616,610,0.0011,0.0001,25,,,1636,477,279,Parallel Assignment,,Open Label,,Treatment,Efficacy Study
NCT00065507,Completed,Actual,Phase 3,Interventional,2,,Actual,195,Both,16 Years,0,,221,3320253692,Drug,191,129,191,153,0.0193,0.0001,17,,,1636,477,279,Parallel Assignment,,Open Label,,Treatment,Safety/Efficacy Study
NCT00066066,Completed,Actual,Phase 2,Interventional,3,,Actual,146,Both,20 Years,0,,353,3595900821,Drug,146,9,146,36,0.05,0.05,1,,,1636,477,279,Parallel Assignment,,Double Blind,,Treatment,Efficacy Study
NCT00066963,Completed,Actual,Phase 3,Interventional,3,,Actual,376,Both,6 Months,36 Months,,132,387858106,Device,,,280,1,0.001,0.001,1,,,1636,477,279,Parallel Assignment,,Double Blind,,Prevention,Efficacy Study
NCT00067236,Completed,Actual,Phase 2,Interventional,2,,Actual,253,Both,18 Years,80 Years,,212,2224452751,Drug,253,142,253,248,0.4239,0.4239,3,,,1636,477,279,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00068107,Completed,Actual,Phase 2,Interventional,1,,Actual,13,Male,0,0,,174,3582084673,Drug,13,10,13,13,0.01,0.01,1,,,1636,477,279,Single Group Assignment,,Open Label,,Treatment,Safety/Efficacy Study
NCT00068770,Terminated,Actual,Phase 2,Interventional,2,,Actual,35,Both,18 Years,0,,72,660508271,Radiation,,,35,35,0.11,0.82,1,,,1636,477,279,Parallel Assignment,,Open Label,,Treatment,Safety/Efficacy Study
NCT00068822,Completed,Actual,Phase 3,Interventional,2,,Actual,131,Both,50 Years,0,,423,2635962032,Device,129,2,,,0.13,0.83,1,,,1636,477,279,Crossover Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00069160,Completed,Actual,Phase 2,Interventional,2,,Actual,48,Both,18 Years,0,,272,3968936251,Drug,48,14,48,48,0.05,0.05,1,,,1636,477,279,Single Group Assignment,,Open Label,,Treatment,Pharmacokinetics Study
NCT00069641,Completed,Actual,Phase 2/Phase 3,Interventional,3,,Actual,96,Male,5 Years,25 Years,,301,2453006443,Biological,96,26,96,96,0.0049,0.0049,4,,,1636,477,279,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00069784,Completed,Actual,Phase 3,Interventional,4,,Actual,12537,Both,50 Years,0,,142,765036385,Drug,12504,535,,,0.2692,0.6273,40,,,1636,477,279,Factorial Assignment,,Open Label,,Treatment,Efficacy Study
NCT00069823,Completed,Actual,Phase 3,Interventional,2,,Actual,403,Both,18 Years,0,,48,2527395224,Drug,402,26,,,0.04,0.87,1,,,1636,477,279,Parallel Assignment,,Double Blind,,Treatment,Efficacy Study
NCT00071032,Completed,Actual,Phase 3,Interventional,2,,Actual,2016,Both,50 Years,0,,29,1185043251,Biological,2016,142,,,,,1,,,1636,477,279,Parallel Assignment,,Single Blind,,Treatment,Safety/Efficacy Study
NCT00071110,Completed,Actual,Phase 2,Interventional,2,,Actual,57,Both,18 Years,80 Years,,133,2194019288,Procedure,,,57,48,0.09,0.32,1,,,1636,477,279,Parallel Assignment,,Single Blind,,Treatment,Safety/Efficacy Study
NCT00071487,Completed,Actual,Phase 2,Interventional,4,,Actual,449,Both,18 Years,65 Years,,273,2811241671,Drug,794,109,794,727,0.0882,0.9705,2,,,1636,477,279,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00071799,Completed,Actual,Phase 3,Interventional,2,,Actual,358,Both,18 Years,0,,307,1004845582,Drug,340,226,340,324,0.0001,0.0001,15,,,1636,477,279,Parallel Assignment,,Open Label,,,Safety/Efficacy Study
NCT00071812,Completed,Actual,Phase 2,Interventional,4,,Actual,283,Both,18 Years,65 Years,,44,1506984474,Drug,520,47,520,364,0.0051,0.9769,1,,,1636,477,279,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00071890,Completed,Actual,Phase 2,Interventional,2,,Actual,148,Both,18 Years,0,,199,2889579184,Drug,,,,,0.025,0.069,2,,,1636,477,279,Parallel Assignment,,Open Label,,Treatment,Efficacy Study
NCT00071981,"Active, not recruiting",Anticipated,Phase 2,Interventional,4,,Actual,175,Both,18 Years,0,,288,3256609041,Biological,167,25,167,125,0.532,0.001,1,,,1636,477,279,Parallel Assignment,,Open Label,,Treatment,Efficacy Study
NCT00073008,Terminated,Actual,Phase 2,Interventional,1,,Actual,131,Both,18 Years,0,,324,3756632883,Drug,131,32,131,127,,,2,,,1636,477,279,Single Group Assignment,,Open Label,,Treatment,Safety/Efficacy Study
NCT00073021,Completed,Actual,Phase 3,Interventional,2,,Actual,386,Both,18 Years,75 Years,,450,675069312,Drug,268,5,386,153,0.0357,0.0001,3,,,1636,477,279,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00073307,Completed,Actual,Phase 3,Interventional,2,,Actual,903,Both,18 Years,0,,81,1588592340,Drug,1570,633,1570,1378,0.0287,0.000001,19,,,1636,477,279,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00074412,Completed,Actual,Phase 3,Interventional,2,,Actual,2026,Both,0,0,,199,2889579184,Drug,1519,293,1519,1232,0.049,0.805,4,,,1636,477,279,Parallel Assignment,,Double Blind,,Prevention,Safety/Efficacy Study
NCT00074984,Completed,Actual,Phase 4,Interventional,2,,Actual,82,Both,16 Years,0,,174,3582084673,Biological,164,60,164,160,0.0577,0.5261,6,,,1636,477,279,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00075218,Completed,Actual,Phase 3,Interventional,2,,Actual,361,Both,18 Years,0,,185,2448023912,Drug,,232,,587,0.004,0.001,11,,,1636,477,279,Crossover Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00075270,Completed,Actual,Phase 3,Interventional,2,,Actual,580,Female,18 Years,0,,313,1776861857,Drug,579,166,579,565,0.094,0.142,25,,,1636,477,279,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00075946,"Active, not recruiting",Anticipated,Phase 3,Interventional,2,,Actual,545,Both,18 Years,0,,276,1696214900,Biological,846,38,846,55,0.0002,0.33,1,,,1636,477,279,Parallel Assignment,,Open Label,,Treatment,Efficacy Study
NCT00076024,Completed,Actual,Phase 1/Phase 2,Interventional,2,,Actual,174,Female,18 Years,0,,74,3128271172,Drug,189,74,189,185,0.038,0.156,8,,,1636,477,279,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00076804,Terminated,Actual,Phase 2,Interventional,2,,Actual,274,Both,18 Years,0,,199,2889579184,Behavioral,274,48,274,160,0.14,0.89,1,,,1636,477,279,Parallel Assignment,,Open Label,,Treatment,Efficacy Study
NCT00077675,Completed,Actual,Phase 2,Interventional,2,,Actual,201,Both,18 Years,0,,241,1933240641,Drug,195,10,195,110,0.5318,0.5318,1,,,1636,477,279,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00077974,Completed,Actual,Phase 2,Interventional,1,,Actual,106,Both,18 Years,0,,81,1588592340,Drug,106,46,106,106,,,1,,,1636,477,279,Single Group Assignment,,Open Label,,Treatment,Safety/Efficacy Study
NCT00078286,Completed,Actual,Phase 2/Phase 3,Interventional,2,,Actual,469,Both,45 Years,0,,214,1697312720,Drug,469,120,469,45,0.78,0.89,1,,,1636,477,279,Parallel Assignment,,Double Blind,,Treatment,Efficacy Study
NCT00078403,Completed,Actual,Phase 2,Interventional,3,,Actual,338,Both,18 Years,0,,199,2889579184,Drug,255,45,255,250,0.58,0.58,2,,,1636,477,279,Parallel Assignment,,Open Label,,Treatment,Efficacy Study
NCT00078559,Completed,Actual,Phase 1/Phase 2,Interventional,1,,Actual,10,Both,18 Years,65 Years,,256,3993050794,Drug,10,5,10,10,,,1,,,1636,477,279,Single Group Assignment,,Open Label,,Treatment,Safety/Efficacy Study
NCT00078715,Completed,Actual,Phase 2,Interventional,2,,Actual,11,Both,18 Years,65 Years,,134,2416318511,Drug,,,12,2,0.527,0.527,1,,,1636,477,279,Crossover Assignment,,Double Blind,,,Efficacy Study
NCT00078949,"Active, not recruiting",Anticipated,Phase 3,Interventional,4,,Actual,619,Both,16 Years,65 Years,,276,1696214900,Biological,834,86,834,768,0.005,0.55,3,,,1636,477,279,Parallel Assignment,,Open Label,,Treatment,
NCT00079001,Completed,Actual,Phase 3,Interventional,2,,Actual,645,Male,18 Years,0,,296,1868624750,Drug,618,121,618,535,0.22,0.385,2,,,1636,477,279,Parallel Assignment,,Double Blind,,Treatment,Efficacy Study
NCT00079040,Completed,Actual,Phase 2,Interventional,1,,Actual,65,Both,18 Years,0,,173,1454481731,Drug,64,49,64,63,,,1,,,1636,477,279,Single Group Assignment,,Open Label,,Treatment,Safety/Efficacy Study
NCT00080119,Terminated,Actual,Phase 2/Phase 3,Interventional,4,,Actual,1354,Both,91 Days,120 Days,,198,3223041150,Drug,1351,140,1351,1253,0.43,0.93,2,,,1636,477,279,Parallel Assignment,,Double Blind,,Prevention,Efficacy Study
NCT00080301,Completed,Actual,Phase 3,Interventional,2,,Actual,752,Female,18 Years,0,,73,1499605101,Drug,737,278,737,710,0.0002,0.0001,22,,,1636,477,279,Parallel Assignment,,Open Label,,Treatment,Safety/Efficacy Study
NCT00080912,Completed,Actual,Phase 3,Interventional,2,,Actual,850,Both,18 Years,0,,296,1868624750,Radiation,850,1,,,0.03,0.03,1,,,1636,477,279,Parallel Assignment,,Open Label,,Treatment,
NCT00081458,Completed,Actual,Phase 3,Interventional,3,,Actual,84,Both,18 Years,0,,410,984094672,Drug,83,29,83,79,0.005,0.007,9,,,1636,477,279,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00082381,Completed,Actual,Phase 3,Interventional,2,,Actual,551,Both,30 Years,75 Years,,144,3633170488,Drug,,18,,386,0.3002,0.0001,13,,,1636,477,279,Parallel Assignment,,Open Label,,Treatment,Safety/Efficacy Study
NCT00082407,Completed,Actual,Phase 3,Interventional,2,,Actual,505,Both,30 Years,75 Years,,144,3633170488,Drug,,30,,307,0.0001,0.7888,12,,,1636,477,279,Parallel Assignment,,Open Label,,Treatment,Safety/Efficacy Study
NCT00083759,Terminated,,Phase 2,Interventional,2,,Actual,299,Both,18 Years,75 Years,,401,2326608903,Drug,,,,,0.089,0.526,2,,,1636,477,279,Parallel Assignment,,Double-Blind,,Treatment,Safety/Efficacy Study
NCT00084266,Completed,Actual,Phase 4,Interventional,2,,Actual,1225,Both,18 Years,0,,297,2638998868,Drug,1184,286,1184,729,0.042,0.9344,23,,,1636,477,279,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00085202,"Active, not recruiting",Anticipated,Phase 3,Interventional,2,,Actual,416,Both,3 Years,21 Years,,72,660508271,Procedure,413,34,413,354,0.0206,0.8001,3,,,1636,477,279,Parallel Assignment,,Open Label,,Treatment,Safety/Efficacy Study
NCT00085644,Completed,Actual,Phase 3,Interventional,2,,Actual,315,Both,18 Years,0,,33,3267503137,Biological,311,96,311,279,0.985,0.001,1,,,1636,477,279,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00085709,Completed,Actual,Phase 3,Interventional,4,,Actual,637,Both,18 Years,60 Years,,260,180008924,Other,1039,88,1039,989,0.001,0.0025,3,,,1636,477,279,Parallel Assignment,,Open Label,,Treatment,Safety/Efficacy Study
NCT00086047,Completed,Actual,Phase 3,Interventional,2,,Actual,114,Both,11 Years,18 Years,,180,3671355921,Behavioral,,,,,0.007,0.007,1,,,1636,477,279,Parallel Assignment,,Single Blind,,Treatment,Efficacy Study
NCT00086281,Completed,Actual,Phase 4,Interventional,4,,Actual,60,Both,18 Years,0,,332,942388683,Drug,218,1,218,65,0.009,0.5055,2,,,1636,477,279,Crossover Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00086346,Terminated,Actual,Phase 3,Interventional,2,,Actual,607,Both,13 Years,0,,269,295097427,Drug,,272,599,587,0.017,0.05,12,,,1636,477,279,Parallel Assignment,,Open Label,,Treatment,Safety/Efficacy Study
NCT00086580,Completed,Actual,Phase 3,Interventional,2,,Actual,335,Both,18 Years,0,,57,2255890431,Biological,329,95,329,307,0.014,0.001,15,,,1636,477,279,Parallel Assignment,,Open Label,,Treatment,Safety/Efficacy Study
NCT00087438,Completed,,Phase 2,Interventional,1,,Actual,59,Both,18 Years,0,,271,2288821332,Radiation,55,16,55,50,0.013,0.013,1,,,1636,477,279,Single Group Assignment,,Open Label,,Treatment,
NCT00088153,Completed,Actual,Phase 2/Phase 3,Interventional,2,,Actual,110,Female,12 Years,18 Years,,34,1531614257,Drug,110,28,110,38,0.05,0.05,1,,,1636,477,279,Parallel Assignment,,Double Blind,,Treatment,Efficacy Study
NCT00088634,Completed,Actual,Phase 2,Interventional,2,,Actual,180,Both,18 Years,64 Years,,405,2119471695,Drug,180,5,180,90,0.05,0.05,1,,,1636,477,279,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00088907,Terminated,Actual,Phase 3,Interventional,2,,Actual,270,Both,18 Years,0,,389,308097561,Drug,272,127,272,43,0.19,0.6,1,,,1636,477,279,Parallel Assignment,,Double Blind,,Treatment,Efficacy Study
NCT00089141,Terminated,Actual,Phase 3,Interventional,2,,Actual,151,Both,4 Years,0,,76,3991381194,Drug,,,,,0.03,0.55,2,,,1636,477,279,Parallel Assignment,,Double Blind,,Treatment,Efficacy Study
NCT00089648,Completed,Actual,Phase 2,Interventional,1,,Actual,61,Both,18 Years,0,,81,1588592340,Drug,61,30,61,60,,,1,,,1636,477,279,Single Group Assignment,,Open Label,,Treatment,Safety/Efficacy Study
NCT00089843,Completed,Actual,Phase 2/Phase 3,Interventional,4,,Actual,77,Female,18 Years,45 Years,,34,1531614257,Drug,77,14,77,56,0.002,0.0001,1,,,1636,477,279,Factorial Assignment,,Double Blind,,Treatment,Efficacy Study
NCT00089999,Completed,Actual,Phase 2,Interventional,,,Actual,138,Female,18 Years,0,,313,1776861857,Drug,138,33,138,111,0.443,0.691,11,,,1636,477,279,Parallel Assignment,,Open Label,,Treatment,Safety/Efficacy Study
NCT00090051,Completed,Actual,Phase 3,Interventional,2,,Actual,552,Both,18 Years,0,,101,1706704250,Drug,546,270,546,483,0.0002,0.0001,17,,,1636,477,279,Parallel Assignment,,Open Label,,Treatment,Safety/Efficacy Study
NCT00090402,Completed,,Phase 1/Phase 2,Interventional,3,,Actual,39,Both,55 Years,0,,23,4032982200,Other,39,2,39,21,0.93,0.93,1,,,1636,477,279,Parallel Assignment,,Double-Blind,,Treatment,Safety/Efficacy Study
NCT00091026,Completed,Actual,Phase 2,Interventional,2,,Actual,143,Both,18 Years,0,,10,2799339370,Drug,139,38,139,101,0.22,0.95,1,,,1636,477,279,Parallel Assignment,,Open Label,,Treatment,Safety/Efficacy Study
NCT00091390,"Active, not recruiting",,Phase 2,Interventional,1,,Actual,129,Male,18 Years,0,,378,3123971163,Radiation,112,46,112,110,0.0001,0.0001,1,,,1636,477,279,Single Group Assignment,,Open Label,,Treatment,
NCT00091442,Completed,Actual,Phase 3,Interventional,2,,Actual,751,Female,18 Years,0,,73,1499605101,Drug,750,128,750,699,0.0085,0.0001,18,,,1636,477,279,Parallel Assignment,,Open Label,,Treatment,Safety/Efficacy Study
NCT00091507,Completed,Actual,Phase 3,Interventional,2,,Actual,911,Both,30 Years,0,,31,1678923890,Drug,871,69,871,494,0.01,0.28,1,,,1636,477,279,Parallel Assignment,,Double Blind,,Treatment,Efficacy Study
NCT00091819,Completed,Actual,Phase 3,Interventional,2,,Actual,862,Both,18 Years,0,,429,136073174,Drug,855,58,855,693,,,1,,,1636,477,279,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00094172,Completed,Actual,Phase 2,Interventional,2,,Actual,82,Both,18 Years,55 Years,,304,3878017841,Drug,83,4,83,80,0.208,0.929,2,,,1636,477,279,Parallel Assignment,,Double Blind,,Prevention,Efficacy Study
NCT00094458,Completed,Actual,Phase 3,Interventional,3,,Actual,508,Both,21 Years,0,,122,240489291,Biological,,90,,422,0.006,0.001,15,,,1636,477,279,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00095121,Completed,Actual,Phase 3,Interventional,2,,Actual,173,Both,2 Years,17 Years,,94,2307672194,Drug,335,25,335,261,0.051,0.001,1,,,1636,477,279,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00095199,Completed,Actual,Phase 3,Interventional,4,,Actual,939,Both,18 Years,0,,319,3940632058,Biological,889,349,889,876,0.091,0.887,2,,,1636,477,279,Parallel Assignment,,Open Label,,Treatment,Safety/Efficacy Study
NCT00095212,Completed,Actual,N/A,Interventional,2,,Actual,25,Female,18 Years,55 Years,,198,3223041150,Drug,25,2,25,15,0.01,0.94,1,,,1636,477,279,Parallel Assignment,,Double Blind,,Treatment,Efficacy Study
NCT00095238,Completed,Actual,Phase 3,Interventional,2,,Actual,4128,Both,60 Years,0,,114,2971302321,Drug,4126,2301,4126,2446,,,25,,,1636,477,279,Parallel Assignment,,Double Blind,,Treatment,Efficacy Study
NCT00096265,Terminated,Actual,Phase 3,Interventional,3,,Actual,126,Both,18 Years,0,,390,3735875245,Radiation,124,44,124,94,0.93,0.95,2,,,1636,477,279,Parallel Assignment,,Open Label,,Treatment,Efficacy Study
NCT00097253,Completed,Actual,Phase 1,Interventional,3,,Actual,56,Both,18 Years,44 Years,,431,1254644797,Behavioral,,,,,0.014,0.83,1,,,1636,477,279,Crossover Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00097500,Completed,Actual,Phase 3,Interventional,2,,Actual,69,Both,30 Years,75 Years,,449,2402940714,Drug,69,4,69,63,0.0001,0.0001,3,,,1636,477,279,Parallel Assignment,,Open Label,,Treatment,Safety/Efficacy Study
NCT00097591,Completed,Actual,Phase 3,Interventional,2,,Actual,13619,Both,18 Years,0,,118,1856855603,Drug,13457,3406,13457,10404,0.002,0.001,1,,,1636,477,279,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00097773,Completed,Actual,Phase 2,Interventional,4,,Actual,304,Both,1 Years,12 Years,,124,191177468,Drug,304,83,304,270,0.12,0.86,1,,,1636,477,279,Parallel Assignment,,Double Blind,,Prevention,Safety/Efficacy Study
NCT00097981,Completed,Actual,Phase 3,Interventional,2,,Actual,225,Both,18 Years,0,,303,1739707547,Drug,216,101,216,214,0.42,0.93,1,,,1636,477,279,Parallel Assignment,,Open Label,,Treatment,Safety/Efficacy Study
NCT00098293,Completed,Actual,Phase 3,Interventional,3,,Actual,916,Both,16 Years,0,,202,3937948214,Drug,1022,210,1022,797,0.002,0.0001,14,,,1636,477,279,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00098306,Completed,Actual,Phase 2/Phase 3,Interventional,3,,Actual,601,Both,16 Years,0,,199,2889579184,Drug,1305,148,1305,470,0.0006,0.0001,2,,,1636,477,279,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00098475,"Active, not recruiting",,Phase 3,Interventional,4,,Actual,452,Both,18 Years,0,,125,1513883386,Drug,468,265,468,463,,,1,,,1636,477,279,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00098748,Completed,Actual,Phase 2/Phase 3,Interventional,3,,Actual,190,Both,16 Years,0,,199,2889579184,Drug,186,40,186,139,0.254,0.8243,9,,,1636,477,279,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00099359,Completed,Actual,Phase 3,Interventional,3,,Actual,1735,Both,0,2 Days,,152,247033278,Drug,1735,682,1735,1454,0.0001,0.0001,5,,,1636,477,279,Parallel Assignment,,Open Label,,Prevention,Safety/Efficacy Study
NCT00099632,Completed,Actual,Phase 2,Interventional,6,,Actual,484,Female,13 Years,0,,199,2889579184,Drug,422,4,,,0.091,0.37,6,,,1636,477,279,Parallel Assignment,,Open Label,,Treatment,Efficacy Study
NCT00100698,Completed,Actual,N/A,Interventional,2,,Actual,56,Both,18 Years,60 Years,,0,3058073368,Drug,55,5,55,8,0.049,0.049,1,,,1636,477,279,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00101283,Completed,Actual,Phase 2,Interventional,2,,Actual,32,Both,18 Years,0,,293,1136820113,Drug,29,23,29,29,,,1,,,1636,477,279,Parallel Assignment,,Open Label,,Treatment,Safety/Efficacy Study
NCT00101361,Terminated,Actual,Phase 3,Interventional,2,,Actual,212,Both,18 Years,0,,374,2416978262,Drug,212,25,212,180,0.05,0.05,2,,,1636,477,279,Parallel Assignment,,Double Blind,,Treatment,Efficacy Study
NCT00101686,Completed,Actual,Phase 3,Interventional,5,,Actual,547,Both,18 Years,0,,109,254331034,Drug,530,220,530,526,0.0042,0.9364,4,,,1636,477,279,Parallel Assignment,,Open Label,,Treatment,Safety/Efficacy Study
NCT00103194,Completed,Actual,Phase 2,Interventional,1,,Actual,49,Male,18 Years,0,,391,2376027775,Drug,49,4,49,46,0.006,0.006,1,,,1636,477,279,Single Group Assignment,,Open Label,,Treatment,Efficacy Study
NCT00104247,Completed,Actual,Phase 3,Interventional,,,Actual,89,Both,8 Years,0,,356,1288876632,Drug,,,,55,0.001,0.001,1,,,1636,477,279,Parallel Assignment,,Double-Blind,,Treatment,Safety/Efficacy Study
NCT00104299,Completed,Actual,Phase 2/Phase 3,Interventional,2,,Actual,197,Both,15 Years,0,,458,264192817,Drug,197,107,197,194,0.133,0.001,2,,,1636,477,279,Parallel Assignment,,Double Blind,,Treatment,Efficacy Study
NCT00104416,Completed,Actual,Phase 3,Interventional,2,,Actual,153,Both,13 Years,0,,167,2963929165,Drug,314,8,314,116,0.0001,0.0001,9,,,1636,477,279,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00105001,"Active, not recruiting",,Phase 2,Interventional,3,,Actual,210,Both,0,0,,426,1987242768,Drug,210,27,210,109,0.004,0.96,3,,,1636,477,279,Parallel Assignment,,Open Label,,Treatment,Efficacy Study
NCT00105196,Completed,Actual,Phase 3,Interventional,2,,Actual,349,Both,18 Years,65 Years,,279,960571772,Drug,348,2,348,169,0.037,0.001,1,,,1636,477,279,Parallel Assignment,,Double Blind,,Diagnostic,Safety/Efficacy Study
NCT00105235,Completed,Actual,Phase 2,Interventional,1,,Actual,27,Both,18 Years,0,,265,1428429816,Procedure,27,27,27,26,,,2,,,1636,477,279,Single Group Assignment,,Open Label,,Treatment,Safety/Efficacy Study
NCT00105443,Completed,Actual,Phase 3,Interventional,2,,Actual,602,Both,18 Years,0,,78,343272651,Drug,1245,719,1245,1129,0.000007,0.7676,23,,,1636,477,279,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00105989,Completed,Actual,Phase 3,Interventional,2,,Actual,514,Both,18 Years,0,,136,1049032054,Drug,,17,,218,0.003,0.001,6,,,1636,477,279,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00106028,Completed,Actual,Phase 3,Interventional,2,,Actual,143,Both,4 Years,15 Years,,336,1524497998,Drug,279,48,279,258,0.003,0.0001,13,,,1636,477,279,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00106080,Completed,Actual,N/A,Interventional,2,,Actual,376,Both,18 Years,0,,160,523876482,Behavioral,,,,,0.03,0.03,1,,,1636,477,279,Parallel Assignment,,Double Blind,,,Efficacy Study
NCT00106392,Completed,Actual,Phase 4,Interventional,2,,Actual,131,Male,0,65 Years,,169,2214996678,Drug,124,1,124,12,0.099,0.879,1,,,1636,477,279,Parallel Assignment,,Double Blind,,Prevention,Safety/Efficacy Study
NCT00106535,Completed,Actual,Phase 3,Interventional,3,,Actual,1196,Both,18 Years,0,,401,2326608903,Drug,2045,351,2045,1307,0.0001,0.0001,16,,,1636,477,279,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00106964,Completed,Actual,Phase 4,Interventional,3,,Actual,371,Both,12 Years,24 Years,,198,3223041150,Biological,,,371,78,0.0157,0.8698,3,,,1636,477,279,Parallel Assignment,,Open Label,,Prevention,Safety/Efficacy Study
NCT00107575,Completed,Actual,Phase 2,Interventional,2,,Actual,236,Both,18 Years,95 Years,,443,179058863,Other,236,2,,,0.027,0.05,1,,,1636,477,279,Factorial Assignment,,Double Blind,,Treatment,Efficacy Study
NCT00107900,Completed,Actual,Phase 2,Interventional,6,,Actual,606,Both,18 Years,0,,46,2804796376,Drug,606,40,606,264,0.238,0.238,1,,,1636,477,279,Parallel Assignment,,Open Label,,Prevention,Safety/Efficacy Study
NCT00107978,Completed,Actual,Phase 3,Interventional,2,,Actual,1035,Both,18 Years,0,,429,136073174,Drug,1012,53,1012,718,,,1,,,1636,477,279,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00108082,Completed,Actual,Phase 3,Interventional,1,,Actual,287,Both,18 Years,80 Years,,233,2554888772,Drug,,22,,167,0.1711,0.7651,1,,,1636,477,279,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00108160,Completed,Actual,Phase 4,Interventional,2,,Actual,146,Both,18 Years,0,,428,3411817248,Drug,146,3,,,0.356,0.356,1,,,1636,477,279,Parallel Assignment,,Double Blind,,Prevention,Efficacy Study
NCT00108550,Completed,Actual,Phase 2,Interventional,2,,Actual,108,Both,21 Years,70 Years,,99,3964941165,Drug,,,108,63,0.4237,0.458,1,,,1636,477,279,Parallel Assignment,,Double Blind,,Treatment,Efficacy Study
NCT00108732,Completed,Actual,Phase 2,Interventional,1,,Actual,50,Male,18 Years,0,,392,3524331487,Biological,50,2,50,44,0.003,0.02,1,,,1636,477,279,Single Group Assignment,,Open Label,,Treatment,Efficacy Study
NCT00108862,Completed,Actual,Phase 4,Interventional,2,,Actual,809,Both,13 Years,0,,198,3223041150,Other,806,99,806,780,0.02,0.67,13,,,1636,477,279,Parallel Assignment,,Open Label,,Treatment,Safety/Efficacy Study
NCT00108953,Completed,Actual,Phase 2,Interventional,2,,Actual,96,Both,18 Years,0,,78,343272651,Drug,95,39,95,95,0.007,0.038,6,,,1636,477,279,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00109590,Completed,Actual,Phase 2,Interventional,3,,Actual,175,Female,18 Years,0,,199,2889579184,Drug,339,102,339,269,0.009,0.048,1,,,1636,477,279,Parallel Assignment,,Open Label,,Treatment,Pharmacokinetics/Dynamics Study
NCT00109733,Completed,Actual,Phase 3,Interventional,2,,Actual,31,Both,13 Years,25 Years,,91,2613333871,Biological,31,1,31,27,0.002,0.001,1,,,1636,477,279,Parallel Assignment,,Open Label,,Treatment,Efficacy Study
NCT00109772,Terminated,Actual,Phase 2,Interventional,2,,Actual,184,Both,18 Years,0,,111,2671661174,Drug,180,28,180,149,0.894,0.894,1,,,1636,477,279,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00109837,Completed,Actual,Phase 2,Interventional,1,,Actual,79,Both,18 Years,64 Years,,260,180008924,Drug,176,5,176,169,,,1,,,1636,477,279,Single Group Assignment,,Open Label,,Treatment,
NCT00110019,"Active, not recruiting",,Phase 3,Interventional,2,,Actual,823,Both,18 Years,0,,302,4061726511,Other,790,643,790,769,0.092,0.863,2,,,1636,477,279,Parallel Assignment,,Double Blind,,Treatment,Efficacy Study
NCT00110084,Completed,Actual,Phase 2,Interventional,1,,Actual,50,Female,18 Years,0,,73,1499605101,Drug,50,11,50,50,,,1,,,1636,477,279,Single Group Assignment,,Open Label,,Treatment,
NCT00110136,Terminated,Actual,Phase 2,Interventional,1,,Actual,9,Female,18 Years,0,,73,1499605101,Drug,,,9,6,0.1042,0.9995,1,,,1636,477,279,Single Group Assignment,,Open Label,,Supportive Care,
NCT00110214,Completed,Actual,Phase 3,Interventional,2,,Actual,1050,Male,18 Years,0,,227,3208547707,Biological,1009,415,1009,783,0.181,0.001,1,,,1636,477,279,Parallel Assignment,,Double Blind,,Treatment,Efficacy Study
NCT00110461,Completed,Actual,Phase 3,Interventional,3,,Actual,296,Both,10 Years,17 Years,,64,2594871937,Drug,294,18,294,226,0.0001,0.0001,1,,,1636,477,279,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00110812,Completed,Actual,Phase 2,Interventional,3,,Actual,267,Both,18 Years,0,,199,2889579184,Drug,267,15,267,13,0.003,0.001,11,,,1636,477,279,Parallel Assignment,,Open Label,,Treatment,Safety/Efficacy Study
NCT00110994,Completed,Actual,Phase 2,Interventional,2,,Actual,101,Both,18 Years,0,,76,3991381194,Drug,101,36,101,94,0.039,0.973,1,,,1636,477,279,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00111007,Completed,Actual,Phase 3,Interventional,2,,Actual,270,Both,18 Years,0,,287,326450020,Drug,268,131,268,266,0.146,0.979,7,,,1636,477,279,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00112047,Completed,Actual,Phase 3,Interventional,2,,Actual,517,Both,18 Years,0,,199,2889579184,Drug,957,102,957,797,0.001,0.001,1,,,1636,477,279,Parallel Assignment,,Open Label,,Treatment,Safety/Efficacy Study
NCT00112294,Completed,Actual,Phase 3,Interventional,2,,Actual,755,Both,18 Years,0,,325,3552216531,Drug,645,304,645,639,0.0066,0.26,1,,,1636,477,279,Parallel Assignment,,Open Label,,Treatment,Efficacy Study
NCT00112359,Completed,Actual,Phase 3,Interventional,2,,Actual,166,Both,6 Years,0,,124,191177468,Drug,164,17,164,130,0.0005,0.0001,4,,,1636,477,279,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00112918,Completed,Actual,Phase 3,Interventional,3,,Actual,3451,Both,18 Years,0,,108,1696863024,Drug,3406,807,3406,3356,0.2024,0.2024,1,,,1636,477,279,Parallel Assignment,,Open Label,,Treatment,
NCT00113022,Terminated,Actual,Phase 2,Interventional,2,,Actual,9,Both,21 Years,70 Years,,133,2194019288,Drug,9,1,9,5,0.919,0.919,1,,,1636,477,279,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00113087,Completed,Actual,Phase 3,Interventional,2,,Actual,230,Both,0,45 Days,,209,2903305172,Drug,230,175,230,147,0.81,1,2,,,1636,477,279,Parallel Assignment,,Double Blind,,Treatment,Efficacy Study
NCT00113269,Completed,Actual,Phase 4,Interventional,4,,Actual,501,Both,18 Years,0,,256,3993050794,Drug,474,245,474,435,0.001,0.0001,1,,,1636,477,279,Parallel Assignment,,Open Label,,Treatment,Safety/Efficacy Study
NCT00113516,Completed,Actual,Phase 2,Interventional,1,,Actual,84,Both,18 Years,0,,326,1982470504,Drug,150,58,150,142,0.0074,0.929,3,,,1636,477,279,Single Group Assignment,,Open Label,,Treatment,Safety/Efficacy Study
NCT00113607,Completed,Actual,Phase 3,Interventional,2,,Actual,672,Female,18 Years,0,,339,2909107598,Drug,663,235,663,651,0.008,0.8203,20,,,1636,477,279,Parallel Assignment,,Open Label,,Treatment,Safety/Efficacy Study
NCT00113841,Completed,Actual,N/A,Interventional,2,,Actual,42,Both,0,0,,303,1739707547,Drug,,,33,18,0.16,0.16,1,,,1636,477,279,Parallel Assignment,,Open Label,,Treatment,Safety/Efficacy Study
NCT00113880,Completed,Actual,N/A,Observational,,3,Actual,63061,Both,5 Years,49 Years,,205,2158746441,Biological,63061,202,,,0.01,0.05,1,,,1636,477,279,,Cohort,,Prospective,,
NCT00114101,"Active, not recruiting",,Phase 3,Interventional,2,,Actual,460,Both,18 Years,70 Years,,125,1513883386,Other,460,85,460,361,0.7,0.001,1,,,1636,477,279,Parallel Assignment,,Double Blind,,Treatment,Efficacy Study
NCT00114127,Completed,Actual,Phase 3,Interventional,3,,Actual,28,Both,18 Years,0,,35,2074914426,Drug,28,2,28,2,0.292,0.132,1,,,1636,477,279,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00114634,Completed,Actual,Phase 2,Interventional,2,,Actual,13,Both,4 Years,17 Years,,417,4274467713,Drug,,,,,1,1,1,,,1636,477,279,Crossover Assignment,,Double Blind,,Treatment,Efficacy Study
NCT00115063,Terminated,Actual,Phase 4,Interventional,2,,Actual,390,Both,20 Years,60 Years,,329,1330809903,Behavioral,390,28,,,0.001,0.001,1,,,1636,477,279,Parallel Assignment,,Open Label,,Treatment,Safety/Efficacy Study
NCT00115349,Terminated,Actual,Phase 2,Interventional,2,,Actual,20,Both,18 Years,0,,84,3416315868,Drug,20,9,20,14,0.89,0.89,1,,,1636,477,279,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00115934,Completed,Actual,Phase 3,Interventional,2,,Actual,555,Both,0,0,,209,2903305172,Procedure,549,258,549,500,0.001,0.001,2,,,1636,477,279,Parallel Assignment,,Open Label,,Treatment,Safety/Efficacy Study
NCT00116272,Completed,Actual,N/A,Observational,,3,Actual,830,Both,0,0,,372,629356050,Drug,1032,126,,,,,1,,,1636,477,279,,Cohort,,,,
NCT00116428,Completed,Actual,Phase 3,Interventional,2,,Actual,167,Both,18 Years,0,,211,2189995785,Drug,164,25,164,23,0.001,0.001,5,,,1636,477,279,Parallel Assignment,,Open Label,,Treatment,Safety/Efficacy Study
NCT00116753,Completed,Actual,Phase 2,Interventional,3,,Actual,460,Male,18 Years,0,,378,3123971163,Drug,447,72,447,334,0.1557,0.9587,11,,,1636,477,279,Parallel Assignment,,Open Label,,Treatment,Safety/Efficacy Study
NCT00116779,Completed,Actual,Phase 2,Interventional,2,,Actual,127,Male,18 Years,0,,378,3123971163,Drug,,15,,107,0.778,0.8413,2,,,1636,477,279,Parallel Assignment,,Open Label,,Treatment,Safety/Efficacy Study
NCT00116805,"Active, not recruiting",Anticipated,Phase 3,Interventional,2,,Actual,266,Both,18 Years,69 Years,,94,2307672194,Drug,504,56,504,408,0.018,0.001,15,,,1636,477,279,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00116831,Completed,Actual,Phase 3,Interventional,2,,Actual,672,Both,30 Years,80 Years,,322,3904661288,Drug,668,142,668,215,0.1221,0.1221,20,,,1636,477,279,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00117559,Completed,Actual,N/A,Interventional,2,,Actual,19,Both,18 Years,0,,133,2194019288,Behavioral,,,,,0.05,0.05,1,,,1636,477,279,Parallel Assignment,,Open Label,,Treatment,Efficacy Study
NCT00117598,Completed,Actual,Phase 3,Interventional,3,,Actual,169,Both,18 Years,0,,276,1696214900,Drug,174,84,174,172,0.0004,0.0001,18,,,1636,477,279,Parallel Assignment,,Open Label,,Treatment,Safety/Efficacy Study
NCT00117637,Completed,Actual,Phase 2,Interventional,2,,Actual,189,Both,18 Years,0,,81,1588592340,Drug,297,127,297,272,0.0004,0.5,7,,,1636,477,279,Parallel Assignment,,Open Label,,Treatment,Safety/Efficacy Study
NCT00117793,Completed,Actual,N/A,Interventional,2,,Actual,20,Both,18 Years,70 Years,,26,3762057219,Device,,,17,1,0.0021,0.05,1,,,1636,477,279,Crossover Assignment,,Single Blind,,Treatment,Efficacy Study
NCT00117806,"Active, not recruiting",Anticipated,N/A,Interventional,2,,Actual,249,Both,18 Years,65 Years,,421,2393866971,Behavioral,,,,,0.008,0.008,1,,,1636,477,279,Parallel Assignment,,Open Label,,Treatment,Efficacy Study
NCT00117949,Completed,Actual,Phase 2,Interventional,4,,Actual,82,Male,18 Years,0,,378,3123971163,Drug,,2,,57,0.003,0.001,1,,,1636,477,279,Parallel Assignment,,Open Label,,Treatment,Safety/Efficacy Study
NCT00118378,Completed,Actual,Phase 4,Interventional,2,,Actual,115,Both,18 Years,75 Years,,199,2889579184,Drug,,,,,0.052,0.24,1,,,1636,477,279,Parallel Assignment,,Double Blind,,Treatment,Efficacy Study
NCT00118404,Completed,Actual,Phase 3,Interventional,3,,Actual,523,Both,18 Years,70 Years,,133,2194019288,Behavioral,,,,,0.01,0.61,1,,,1636,477,279,Parallel Assignment,,Double Blind,,Treatment,Efficacy Study
NCT00118534,Completed,Actual,N/A,Interventional,2,,Actual,943,Both,18 Years,80 Years,,291,2540811761,Behavioral,943,438,943,82,0.007,0.001,1,,,1636,477,279,Parallel Assignment,,Open Label,,Treatment,Efficacy Study
NCT00118742,Completed,Actual,Phase 4,Interventional,2,,Actual,293,Both,18 Years,74 Years,,269,295097427,Drug,294,132,294,275,0.0006,0.0001,2,,,1636,477,279,Parallel Assignment,,Open Label,,Treatment,Safety/Efficacy Study
NCT00118911,Completed,Actual,N/A,Interventional,2,,Actual,86,Both,18 Years,65 Years,,54,1600057117,Behavioral,,,,,0.03,0.05,1,,,1636,477,279,Parallel Assignment,,Open Label,,Treatment,Efficacy Study
NCT00119041,Completed,Actual,N/A,Interventional,3,,Actual,304,Both,18 Years,0,,140,2231272133,Behavioral,,,,,0.153,0.25,1,,,1636,477,279,Parallel Assignment,,Open Label,,Health Services Research,Efficacy Study
NCT00119158,Completed,Actual,Phase 4,Interventional,2,,Actual,90,Both,2 Years,65 Years,,50,3422213208,Drug,,,,,0.05,0.05,1,,,1636,477,279,Parallel Assignment,,Double Blind,,Treatment,Efficacy Study
NCT00119262,Completed,Actual,Phase 2,Interventional,2,,Actual,226,Both,18 Years,0,,284,3838063299,Biological,223,136,223,223,0.12,0.32,1,,,1636,477,279,Parallel Assignment,,Open Label,,Treatment,Efficacy Study
NCT00120042,Completed,Actual,N/A,Interventional,3,,Actual,251,Female,16 Years,50 Years,,357,3765223373,Drug,,,,,0.05,0.05,1,,,1636,477,279,Parallel Assignment,,Open Label,,Prevention,Safety/Efficacy Study
NCT00120289,Terminated,Actual,Phase 3,Interventional,2,,Actual,3414,Both,45 Years,0,,87,550104849,Drug,3414,1138,3414,2758,0.3,0.8,2,,,1636,477,279,Parallel Assignment,,Double Blind,,Prevention,Efficacy Study
NCT00120406,Completed,Actual,N/A,Interventional,2,,Actual,474,Both,18 Years,0,,354,911035767,Device,471,58,471,153,0.01,0.01,3,,,1636,477,279,Parallel Assignment,,Open Label,,Treatment,Safety/Efficacy Study
NCT00120627,Completed,Actual,N/A,Interventional,2,,Actual,146,Both,18 Years,0,,432,1538451997,Behavioral,,,,,0.01,0.66,1,,,1636,477,279,Parallel Assignment,,Single Blind,,Treatment,Efficacy Study
NCT00121641,Completed,Actual,Phase 3,Interventional,5,,Actual,1035,Both,18 Years,77 Years,,144,3633170488,Drug,467,55,467,320,0.0002,0.0001,6,,,1636,477,279,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00121667,Completed,Actual,Phase 3,Interventional,4,,Actual,1462,Both,18 Years,77 Years,,144,3633170488,Drug,743,87,743,534,0.0001,0.0001,9,,,1636,477,279,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00121810,Completed,Actual,Phase 4,Interventional,2,,Actual,305,Both,18 Years,75 Years,,256,3993050794,Drug,301,124,301,295,0.003,0.001,1,,,1636,477,279,Parallel Assignment,,Open Label,,Treatment,Safety/Efficacy Study
NCT00122382,Completed,Actual,Phase 3,Interventional,2,,Actual,1052,Both,18 Years,0,,401,2326608903,Drug,509,40,509,305,0.005,0.04,18,,,1636,477,279,Parallel Assignment,,Double Blind,,Treatment,Efficacy Study
NCT00122460,Completed,Actual,Phase 3,Interventional,2,,Actual,442,Both,18 Years,0,,204,599964,Drug,434,212,434,412,0.0001,0.0001,17,,,1636,477,279,Parallel Assignment,,Open Label,,Treatment,Efficacy Study
NCT00122980,Terminated,Actual,Phase 3,Interventional,2,,Actual,134,Both,5 Years,18 Years,,217,143551650,Procedure,133,43,133,130,0.033,0.05,1,,,1636,477,279,Parallel Assignment,,Open Label,,Prevention,Efficacy Study
NCT00123123,Completed,Actual,Phase 2,Interventional,3,,Actual,175,Both,18 Years,0,,358,564386991,Drug,,,,,0.675,0.675,1,,,1636,477,279,Parallel Assignment,,Double Blind,,,Efficacy Study
NCT00123422,Completed,Actual,N/A,Interventional,3,,Actual,103,Both,40 Years,0,,384,1255276805,Behavioral,103,6,103,4,0.015,0.05,1,,,1636,477,279,Parallel Assignment,,Single Blind,,Treatment,Efficacy Study
NCT00123474,Completed,Actual,Phase 3,Interventional,4,,Actual,724,Both,18 Years,90 Years,,309,1375871599,Drug,662,334,662,640,,,31,,,1636,477,279,Parallel Assignment,,Open Label,,Treatment,Safety/Efficacy Study
NCT00123487,Completed,Actual,Phase 3,Interventional,2,,Actual,638,Both,18 Years,0,,308,1799455519,Drug,609,464,609,579,,,32,,,1636,477,279,Parallel Assignment,,Open Label,,Treatment,Safety/Efficacy Study
NCT00124657,Completed,Actual,Phase 1/Phase 2,Interventional,1,,Actual,62,Both,3 Years,21 Years,,72,660508271,Drug,67,37,67,66,,,1,,,1636,477,279,Single Group Assignment,,Open Label,,Treatment,Safety/Efficacy Study
NCT00124709,Terminated,Actual,Phase 4,Interventional,2,,Actual,1091,Both,3 Months,18 Months,,50,3422213208,Drug,1087,79,1087,949,0.7901,0.7901,1,,,1636,477,279,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00125138,Completed,Actual,Phase 2,Interventional,4,,Actual,90,Both,0,0,,346,4003884833,Drug,89,6,89,30,0.1519,0.9212,3,,,1636,477,279,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00125242,Completed,Actual,N/A,Interventional,2,,Actual,110,Both,21 Years,80 Years,,37,2281125483,Behavioral,,,,,,,1,,,1636,477,279,Parallel Assignment,,Open Label,,Treatment,Efficacy Study
NCT00125593,Completed,Actual,Phase 4,Interventional,3,,Actual,9438,Both,40 Years,0,,253,518539727,Drug,9270,2257,9270,1952,0.001,0.41,1,,,1636,477,279,Parallel Assignment,,Double Blind,,Prevention,Safety/Efficacy Study
NCT00125957,Completed,Actual,Phase 3,Interventional,2,,Actual,32,Both,18 Years,70 Years,,451,3681315025,Drug,,,,,0.04,0.09,1,,,1636,477,279,Crossover Assignment,,Double Blind,,Treatment,Efficacy Study
NCT00126737,Completed,Actual,N/A,Interventional,4,,Actual,110,Both,50 Years,0,,93,3095176967,Other,,,110,22,0.0002,0.0535,1,,,1636,477,279,Factorial Assignment,,Single Blind,,Treatment,Efficacy Study
NCT00126776,Completed,Actual,N/A,Interventional,2,,Actual,743,Both,0,0,,102,2661081659,Behavioral,,,,,0.001,0.001,1,,,1636,477,279,Parallel Assignment,,Single Blind,,Prevention,Efficacy Study
NCT00127712,Completed,Actual,Phase 4,Interventional,2,,Actual,130,Both,40 Years,0,,51,734346743,Drug,130,3,130,43,0.001,0.79,1,,,1636,477,279,Parallel Assignment,,Open Label,,Prevention,Safety/Efficacy Study
NCT00127790,Completed,Actual,N/A,Interventional,4,,Actual,28,Both,35 Years,75 Years,,245,4173685762,Behavioral,,,,,0.01,0.786,1,,,1636,477,279,Parallel Assignment,,Open Label,,Treatment,Efficacy Study
NCT00128180,Completed,Actual,Phase 2,Interventional,2,,Actual,66,Both,2 Years,0,,203,4075247975,Drug,66,39,66,34,0.18,0.18,1,,,1636,477,279,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00128219,Completed,Actual,Phase 2,Interventional,2,,Actual,667,Female,18 Years,40 Years,,62,3463638132,Biological,663,36,663,624,0.044,0.256,1,,,1636,477,279,Parallel Assignment,,Double Blind,,Prevention,Efficacy Study
NCT00128713,Completed,Actual,Phase 3,Interventional,3,,Actual,1351,Both,0,0,,439,631942930,Procedure,1351,101,1351,582,0.02,0.001,1,,,1636,477,279,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00129220,Completed,Actual,Phase 3,Interventional,3,,Actual,224,Both,20 Years,65 Years,,64,2594871937,Drug,221,4,221,156,0.003,0.001,1,,,1636,477,279,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00129441,Completed,Actual,Phase 2,Interventional,2,,Actual,16,Male,18 Years,50 Years,,405,2119471695,Drug,,,16,4,0.01,0.05,1,,,1636,477,279,Parallel Assignment,,Double Blind,,Treatment,Efficacy Study
NCT00129766,Completed,Actual,Phase 3,Interventional,2,,Actual,6635,Both,0,24 Months,,397,493705133,Biological,6613,991,6613,5561,0.005,0.652,24,,,1636,477,279,Parallel Assignment,,Double Blind,,Prevention,Safety/Efficacy Study
NCT00129961,Completed,Actual,Phase 4,Interventional,2,,Actual,86,Both,18 Years,0,,413,389013820,Drug,86,36,86,78,0.004,0.999,4,,,1636,477,279,Parallel Assignment,,Open Label,,Prevention,Efficacy Study
NCT00130247,Completed,Actual,Phase 3,Interventional,2,,Actual,394,Both,18 Years,60 Years,,446,3377839684,Drug,394,41,394,334,,,3,,,1636,477,279,Parallel Assignment,,Open Label,,Treatment,Efficacy Study
NCT00131352,Completed,Actual,Phase 3,Interventional,2,,Actual,253,Both,40 Years,0,,335,399641608,Device,413,10,413,167,0.005,0.679,6,,,1636,477,279,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00131456,Completed,Actual,Phase 2,Interventional,2,,Actual,123,Both,18 Years,60 Years,,133,2194019288,Drug,,,103,57,0.01,0.01,1,,,1636,477,279,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00131508,Terminated,Actual,Phase 2,Interventional,2,,Actual,27,Both,5 Years,18 Years,,30,1181951473,Drug,,,,,0.14,1,1,,,1636,477,279,Parallel Assignment,,Double Blind,,Prevention,Efficacy Study
NCT00132132,Completed,Actual,N/A,Interventional,2,,Actual,30,Both,10 Years,20 Years,,329,1330809903,Behavioral,,,,,0.006,0.14,1,,,1636,477,279,Parallel Assignment,,Open Label,,Prevention,Efficacy Study
NCT00132314,Completed,Actual,Phase 3,Interventional,2,,Actual,382,Both,18 Years,0,,404,2348241859,Drug,369,187,369,255,0.39,0.39,1,,,1636,477,279,Parallel Assignment,,Open Label,,Treatment,Efficacy Study
NCT00132691,Completed,Actual,Phase 4,Interventional,2,,Actual,255,Both,13 Years,0,,456,2253127107,Drug,255,122,255,226,0.0008,0.0001,3,,,1636,477,279,Parallel Assignment,,Open Label,,Treatment,Efficacy Study
NCT00134563,Completed,Actual,Phase 3,Interventional,3,,Actual,1088,Both,18 Years,55 Years,,304,3878017841,Drug,1086,155,1086,795,0.0002,0.8271,21,,,1636,477,279,Parallel Assignment,,Double Blind,,Treatment,Efficacy Study
NCT00135330,Completed,Actual,Phase 3,Interventional,3,,Actual,137,Both,18 Years,75 Years,,144,3633170488,Drug,,11,,109,0.004,0.001,1,,,1636,477,279,Parallel Assignment,,Open Label,,Treatment,Safety/Efficacy Study
NCT00135798,Completed,Actual,Phase 2,Interventional,3,,Actual,79,Both,18 Years,0,,222,1420832983,Drug,79,51,,,0.0153,0.9513,1,,,1636,477,279,Parallel Assignment,,Open Label,,Treatment,Safety/Efficacy Study
NCT00136084,Completed,Actual,Phase 3,Interventional,2,,Actual,238,Both,0,21 Years,,262,3413094094,Drug,223,42,223,219,0.1559,0.6,1,,,1636,477,279,Parallel Assignment,,Open Label,,Treatment,Efficacy Study
NCT00136916,Terminated,Actual,Phase 3,Interventional,2,,Actual,635,Both,35 Years,75 Years,,139,1050540193,Drug,627,152,627,609,,,4,,,1636,477,279,Parallel Assignment,,Open Label,,Treatment,Safety/Efficacy Study
NCT00137046,Terminated,Actual,Phase 3,Interventional,2,,Actual,582,Both,18 Years,65 Years,,143,2617365673,Drug,580,115,580,579,,,5,,,1636,477,279,Parallel Assignment,,Open Label,,Treatment,Safety/Efficacy Study
NCT00137111,"Active, not recruiting",Anticipated,Phase 3,Interventional,2,,Actual,501,Both,12 Months,18 Years,,275,3825896021,Drug,498,74,498,468,0.0062,0.15,1,,,1636,477,279,Parallel Assignment,,Open Label,,Treatment,Safety/Efficacy Study
NCT00137267,Completed,Actual,N/A,Interventional,2,,Actual,102,Both,18 Years,0,,405,2119471695,Behavioral,,,,,0.152,0.001,1,,,1636,477,279,Parallel Assignment,,Open Label,,Prevention,Efficacy Study
NCT00137280,Completed,Actual,N/A,Interventional,2,,Actual,1067,Both,18 Years,0,,97,667092360,Behavioral,,,,,0.03,0.01,1,,,1636,477,279,Factorial Assignment,,Open Label,,Health Services Research,Safety/Efficacy Study
NCT00137423,Completed,Actual,Phase 2,Interventional,1,,Actual,107,Both,18 Years,0,,82,2078448118,Drug,,41,,107,,,7,,,1636,477,279,Single Group Assignment,,Open Label,,Treatment,Safety/Efficacy Study
NCT00137436,Completed,Actual,Phase 1/Phase 2,Interventional,1,,Actual,93,Male,18 Years,0,,380,2035633480,Drug,55,28,55,55,0.164,1,1,,,1636,477,279,Single Group Assignment,,Open Label,,Treatment,Safety/Efficacy Study
NCT00137449,Completed,Actual,Phase 2,Interventional,1,,Actual,60,Both,18 Years,0,,186,1634903594,Drug,,25,,60,,,3,,,1636,477,279,Single Group Assignment,,Open Label,,Treatment,Safety/Efficacy Study
NCT00138424,Terminated,Actual,Phase 1/Phase 2,Interventional,2,,Actual,22,Both,18 Years,0,,58,2972785372,Drug,22,2,22,15,0.05,0.87,1,,,1636,477,279,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00138671,Terminated,Actual,Phase 3,Interventional,2,,Actual,105,Both,30 Years,77 Years,,139,1050540193,Drug,,31,,97,,,5,,,1636,477,279,Parallel Assignment,,Open Label,,Treatment,Safety/Efficacy Study
NCT00139776,Completed,Actual,Phase 4,Interventional,2,,Actual,875,Both,18 Years,80 Years,,335,399641608,Drug,,16,,488,0.001,0.001,8,,,1636,477,279,Parallel Assignment,,Double Blind,,Treatment,Efficacy Study
NCT00141037,Completed,Actual,Phase 1/Phase 2,Interventional,2,,Actual,130,Both,0,21 Years,,254,3371916612,Drug,130,112,130,120,0.79,0.85,1,,,1636,477,279,Parallel Assignment,,Open Label,,Treatment,Safety/Efficacy Study
NCT00141102,Completed,Actual,Phase 4,Interventional,2,,Actual,4484,Both,18 Years,0,,334,3213715074,Drug,4460,122,4460,1199,0.0006,0.0001,32,,,1636,477,279,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00141219,Completed,Actual,Phase 3,Interventional,2,,Actual,241,Both,18 Years,0,,150,1972684966,Drug,240,3,240,91,0.504,0.979,1,,,1636,477,279,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00141271,Completed,Actual,Phase 3,Interventional,3,,Actual,536,Both,18 Years,0,,64,2594871937,Drug,,16,,216,0.0082,0.9855,1,,,1636,477,279,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00141453,Completed,Actual,Phase 3,Interventional,2,,Actual,577,Both,30 Years,70 Years,,149,4168899067,Drug,575,318,575,529,0.039,0.79,2,,,1636,477,279,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00141778,Completed,Actual,Phase 2/Phase 3,Interventional,3,,Actual,455,Both,18 Years,80 Years,,51,734346743,Drug,445,19,445,53,0.006,0.95,1,,,1636,477,279,Parallel Assignment,,Double Blind,,Prevention,Efficacy Study
NCT00142935,Completed,Actual,N/A,Interventional,3,,Actual,87,Both,18 Years,0,,200,3492718500,Behavioral,87,3,69,26,0.02,0.001,1,,,1636,477,279,Parallel Assignment,,Open Label,,Prevention,Efficacy Study
NCT00143312,Completed,Actual,Phase 4,Interventional,1,,Actual,45,Both,18 Years,0,,377,151271015,Drug,45,23,45,42,,,8,,,1636,477,279,Single Group Assignment,,Open Label,,Prevention,Safety/Efficacy Study
NCT00143390,Completed,Actual,Phase 3,Interventional,2,,Actual,298,Female,20 Years,0,,74,3128271172,Drug,298,38,298,239,,,1,,,1636,477,279,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00143403,Completed,Actual,Phase 3,Interventional,2,,Actual,321,Both,18 Years,75 Years,,109,254331034,Drug,306,47,306,296,0.468,0.468,16,,,1636,477,279,Parallel Assignment,,Open Label,,Treatment,Efficacy Study
NCT00143455,Completed,Actual,Phase 3,Interventional,2,,Actual,485,Both,18 Years,75 Years,,416,1143266442,Drug,482,87,482,482,0.011,0.7544,13,,,1636,477,279,Parallel Assignment,,Open Label,,Treatment,Efficacy Study
NCT00144027,Completed,Actual,N/A,Interventional,2,,Actual,75,Both,18 Years,70 Years,,405,2119471695,Behavioral,,,,,0.03,0.03,1,,,1636,477,279,Parallel Assignment,,Single Blind,,,Efficacy Study
NCT00144300,Completed,,Phase 4,Interventional,2,,Actual,246,Both,30 Years,0,,345,3641618925,Drug,246,43,246,198,,,1,,,1636,477,279,Parallel Assignment,,Open Label,,Diagnostic,Safety Study
NCT00144339,Completed,,Phase 3,Interventional,,,Actual,5993,Both,40 Years,0,,385,1533570944,Drug,,3049,,5265,0.0001,0.0001,37,,,1636,477,279,Parallel Assignment,,,,Treatment,Safety/Efficacy Study
NCT00145574,Completed,Actual,Phase 4,Interventional,3,,Actual,194,Both,10 Years,17 Years,,231,1565522294,Drug,378,6,378,130,0.0002,0.0001,8,,,1636,477,279,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00145600,"Active, not recruiting",Anticipated,Phase 2,Interventional,4,,Actual,296,Both,0,21 Years,,226,3732200463,Drug,296,1,293,221,0.0001,0.0001,1,,,1636,477,279,Single Group Assignment,,Open Label,,Treatment,Efficacy Study
NCT00145795,Completed,Actual,Phase 4,Interventional,2,,Actual,20,Both,18 Years,75 Years,,199,2889579184,Drug,,,20,1,0.03,0.81,1,,,1636,477,279,Parallel Assignment,,Single Blind,,Treatment,Efficacy Study
NCT00146848,Completed,Actual,Phase 4,Interventional,3,,Actual,1742,Both,18 Years,0,,213,3865579137,Device,,,1433,360,0.04,0.86,1,,,1636,477,279,Parallel Assignment,,Single Blind,,Treatment,Efficacy Study
NCT00147199,Completed,Actual,Phase 3,Interventional,2,,Actual,235,Both,18 Years,75 Years,,386,1248981652,Drug,235,22,235,201,0.0003,0.807,10,,,1636,477,279,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00147446,Completed,Actual,Phase 2,Interventional,2,,Actual,121,Both,18 Years,0,,304,3878017841,Behavioral,,,,,0.005,0.04,1,,,1636,477,279,Parallel Assignment,,Single Blind,,Prevention,Efficacy Study
NCT00147537,Completed,Actual,Phase 1/Phase 2,Interventional,2,,Actual,282,Both,18 Years,0,,80,4164722591,Drug,300,124,300,298,0.027,0.121,4,,,1636,477,279,Parallel Assignment,,Open Label,,Treatment,Efficacy Study
NCT00148109,Completed,Actual,Phase 2,Interventional,2,,Actual,36,Both,16 Years,0,,402,2142848470,Drug,36,19,36,21,0.05,0.05,1,,,1636,477,279,Parallel Assignment,,Open Label,,Treatment,
NCT00148798,Completed,Actual,Phase 3,Interventional,2,,Actual,1861,Both,18 Years,0,,320,3433929639,Drug,1110,569,1110,1069,0.0101,0.6801,28,,,1636,477,279,Parallel Assignment,,Open Label,,Treatment,Efficacy Study
NCT00148954,Completed,Actual,Phase 4,Interventional,2,,Actual,1962,Both,18 Years,0,,437,3478470100,Device,,,1962,1043,0.003,0.003,1,,,1636,477,279,Parallel Assignment,,Open Label,,Prevention,Efficacy Study
NCT00149227,Completed,Actual,Phase 4,Interventional,2,,Actual,3031,Both,20 Years,79 Years,,233,2554888772,Drug,,,,,0.05,0.05,1,,,1636,477,279,Parallel Assignment,,Open Label,,Diagnostic,Safety/Efficacy Study
NCT00149643,Completed,Actual,Phase 2,Interventional,2,,Actual,70,Both,14 Years,25 Years,,136,1049032054,Drug,,,,,0.05,0.05,1,,,1636,477,279,Parallel Assignment,,Double Blind,,Treatment,Efficacy Study
NCT00149799,Completed,Actual,Phase 3,Interventional,2,,Actual,100,Both,18 Years,0,,36,3102921191,Drug,,,158,132,0.048,0.048,1,,,1636,477,279,Parallel Assignment,,Double Blind,,Treatment,Efficacy Study
NCT00149825,Completed,Actual,Phase 2,Interventional,2,,Actual,30,Both,18 Years,75 Years,,279,960571772,Drug,,,,,0.05,0.13,1,,,1636,477,279,Parallel Assignment,,Double Blind,,Treatment,Efficacy Study
NCT00150345,Completed,Actual,Phase 3,Interventional,2,,Actual,147,Both,18 Years,0,,363,968260693,Drug,147,16,147,96,0.049,0.955,1,,,1636,477,279,Parallel Assignment,,Double Blind,,Treatment,Efficacy Study
NCT00150969,Completed,Actual,Phase 3,Interventional,2,,Actual,440,Female,0,0,,365,526887464,Dietary Supplement,440,40,440,21,0.05,0.05,1,,,1636,477,279,Parallel Assignment,,Double Blind,,Prevention,Efficacy Study
NCT00151775,Completed,Actual,Phase 2/Phase 3,Interventional,3,,Actual,362,Both,1 Years,16 Years,,233,2554888772,Drug,1048,37,1045,522,0.0008,0.0001,11,,,1636,477,279,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00151892,Completed,Actual,Phase 3,Interventional,2,,Actual,829,Both,18 Years,0,,107,310117854,Drug,826,9,,,,,28,,,1636,477,279,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00152971,Completed,,Phase 3,Interventional,3,,Actual,2615,Both,18 Years,0,,47,2338741005,Drug,2596,161,2596,2153,0.0004,1,4,,,1636,477,279,Parallel Assignment,,Double-Blind,,Prevention,Safety/Efficacy Study
NCT00153062,Completed,,Phase 4,Interventional,4,,Actual,20332,Both,50 Years,0,,433,678611600,Drug,,4657,,5342,0.1007,0.8292,36,,,1636,477,279,Parallel Assignment,,Double-Blind,,Prevention,Safety/Efficacy Study
NCT00153101,Completed,,Phase 4,Interventional,,,Actual,31546,Both,55 Years,0,,84,3416315868,Drug,31546,19760,,,0.0004,0.9563,41,,,1636,477,279,Parallel Assignment,,,,Prevention,
NCT00154102,Completed,Actual,Phase 3,Interventional,2,,Actual,1221,Both,18 Years,0,,166,324608979,Drug,1202,467,1202,1184,0.0012,0.0001,30,,,1636,477,279,Parallel Assignment,,Open Label,,Treatment,Safety/Efficacy Study
NCT00157014,Completed,Actual,Phase 3,Interventional,4,,Actual,111,Both,0,0,,215,3640311864,Drug,109,53,109,109,0.4725,0.8373,2,,,1636,477,279,Parallel Assignment,,Open Label,,Treatment,Safety/Efficacy Study
NCT00158197,Completed,Actual,N/A,Interventional,4,,Actual,119,Both,18 Years,65 Years,,25,2236239595,Behavioral,476,10,476,10,0.02,0.01,1,,,1636,477,279,Parallel Assignment,,Open Label,,Treatment,Efficacy Study
NCT00158600,Completed,Actual,Phase 3,Interventional,2,,Actual,90,Both,8 Years,0,,361,1454328214,Drug,180,38,180,180,0.0055,0.8333,3,,,1636,477,279,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00159861,Completed,Actual,Phase 3,Interventional,,,Actual,267,Both,16 Years,0,,386,1248981652,Drug,265,204,265,264,,,11,,,1636,477,279,Parallel Assignment,,Double Blind,,Treatment,Efficacy Study
NCT00159965,Completed,Actual,Phase 4,Interventional,2,,Actual,38,Both,18 Years,95 Years,,116,2268400135,Drug,,,38,5,0.03,0.05,1,,,1636,477,279,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00161616,Completed,Actual,Phase 4,Interventional,2,,Actual,277,Both,18 Years,0,,441,745428858,Drug,,56,,250,0.0541,0.8961,12,,,1636,477,279,Single Group Assignment,,Single Blind,,Treatment,Efficacy Study
NCT00162942,Completed,Actual,Phase 3,Interventional,2,,Actual,235,Both,18 Years,75 Years,,123,2517084291,Device,,,,,0.858,1,2,,,1636,477,279,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00162981,Completed,Actual,Phase 2,Interventional,2,,Actual,68,Both,2 Years,30 Years,,167,2963929165,Drug,68,4,68,58,0.0001,0.0182,1,,,1636,477,279,Parallel Assignment,,Double Blind,,Treatment,Efficacy Study
NCT00163293,Completed,Actual,Phase 3,Interventional,3,,Actual,240,Both,4 Years,11 Years,,48,2527395224,Drug,239,6,239,167,0.0145,0.7303,3,,,1636,477,279,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00165841,Completed,Actual,Phase 2,Interventional,2,,Actual,200,Both,18 Years,65 Years,,184,2110570532,Drug,,4,,74,0.0001,0.0001,1,,,1636,477,279,Parallel Assignment,,Double-Blind,,Treatment,Efficacy Study
NCT00166205,Completed,Actual,Phase 3,Interventional,1,,Actual,276,Both,18 Years,60 Years,,330,3336604758,Device,276,78,276,266,0.001,0.001,1,,,1636,477,279,Single Group Assignment,,Open Label,,Treatment,Safety/Efficacy Study
NCT00166296,Completed,Actual,Phase 2,Interventional,2,,Actual,133,Both,18 Years,65 Years,,282,3300006449,Drug,,,132,118,0.441,0.05,1,,,1636,477,279,Parallel Assignment,,Double Blind,,Prevention,Safety/Efficacy Study
NCT00167245,Completed,Actual,Phase 2,Interventional,2,,Actual,170,Both,18 Years,0,,17,1576823743,Drug,,,170,70,0.01,0.45,1,,,1636,477,279,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00168064,Completed,Actual,Phase 2,Interventional,2,,Actual,260,Both,0,0,,306,3486115913,Drug,,,255,207,,,1,,,1636,477,279,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00168103,Completed,Actual,Phase 2/Phase 3,Interventional,3,,Actual,126,Both,6 Years,0,,224,2322988993,Biological,,,126,38,0.0014,0.0329,15,,,1636,477,279,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00168805,Completed,,Phase 3,Interventional,3,,Actual,2101,Both,18 Years,0,,47,2338741005,Drug,2076,118,2076,1269,0.0385,1,15,,,1636,477,279,Parallel Assignment,,Double-Blind,,Prevention,Safety/Efficacy Study
NCT00168818,Completed,,Phase 3,Interventional,3,,Actual,3494,Both,18 Years,0,,440,1048045504,Drug,3463,262,3463,1910,0.0212,0.7052,16,,,1636,477,279,Parallel Assignment,,Double-Blind,,Prevention,Efficacy Study
NCT00168831,Completed,,Phase 3,Interventional,3,,Actual,1007,Both,40 Years,0,,385,1533570944,Drug,,191,,533,0.0002,0.0001,15,,,1636,477,279,Parallel Assignment,,Double-Blind,,Treatment,
NCT00170846,Completed,Actual,Phase 4,Interventional,3,,Actual,394,Both,18 Years,0,,394,1913707372,Drug,394,202,394,339,0.6332,0.7943,1,,,1636,477,279,Parallel Assignment,,Open Label,,Treatment,Safety/Efficacy Study
NCT00174252,Completed,Actual,Phase 3,Interventional,1,,Actual,57,Both,4 Years,9 Years,,178,2905656074,Drug,57,6,57,30,0.002,0.708,1,,,1636,477,279,Single Group Assignment,,Open Label,,Treatment,Safety/Efficacy Study
NCT00174382,Terminated,Actual,Phase 3,Interventional,1,,Actual,149,Both,50 Years,0,,131,106232196,Drug,,24,,53,0.004,0.906,1,,,1636,477,279,Single Group Assignment,,Open Label,,Treatment,Safety/Efficacy Study
NCT00174460,Completed,Actual,Phase 2,Interventional,2,,Actual,33,Both,4 Years,10 Years,,195,3045026739,Drug,33,6,33,24,0.007,0.001,1,,,1636,477,279,Parallel Assignment,,Open Label,,Treatment,Safety/Efficacy Study
NCT00177294,Completed,Actual,Phase 4,Interventional,2,,Actual,319,Both,60 Years,0,,133,2194019288,Drug,,,,,0.14,0.14,1,,,1636,477,279,Parallel Assignment,,Single Blind,,Treatment,Efficacy Study
NCT00178503,Completed,Actual,Phase 2/Phase 3,Interventional,4,,Actual,24,Both,7 Years,12 Years,,56,4055640828,Drug,,,96,60,0.005,0.001,1,,,1636,477,279,Single Group Assignment,,Double Blind,,Treatment,Efficacy Study
NCT00178633,Completed,Actual,N/A,Observational,,1,Actual,43,Both,18 Years,70 Years,,145,3054233798,Procedure,,,,,0.0001,0.0001,1,,,1636,477,279,,Cohort,,Prospective,,
NCT00180271,Completed,Actual,Phase 2/Phase 3,Interventional,2,,Actual,1820,Both,21 Years,0,,437,3478470100,Device,1791,219,1791,126,0.05,0.05,1,,,1636,477,279,Parallel Assignment,,Open Label,,Treatment,Safety/Efficacy Study
NCT00180479,Completed,Actual,Phase 3,Interventional,2,,Actual,1002,Both,18 Years,0,,430,527538929,Device,,345,,126,0.0001,0.0001,1,,,1636,477,279,Parallel Assignment,,Single Blind,,Treatment,Safety/Efficacy Study
NCT00182078,Completed,Actual,Phase 4,Interventional,2,,Actual,26,Both,6 Years,20 Years,,369,1929858239,Drug,,,26,1,0.001,0.65,1,,,1636,477,279,Parallel Assignment,,Double Blind,,Prevention,Safety/Efficacy Study
NCT00183092,Completed,Actual,Phase 2,Interventional,2,,Actual,69,Both,18 Years,0,,121,1154335332,Drug,75,41,75,34,0.01,0.92,1,,,1636,477,279,Parallel Assignment,,Double Blind,,Treatment,Efficacy Study
NCT00183456,Completed,Actual,Phase 2,Interventional,4,,Actual,746,Both,18 Years,74 Years,,199,2889579184,Behavioral,,,,,0.01,0.01,1,,,1636,477,279,Parallel Assignment,,Double Blind,,Prevention,Efficacy Study
NCT00183625,Completed,Actual,Phase 4,Interventional,4,,Actual,107,Both,18 Years,60 Years,,405,2119471695,Drug,107,28,,,0.0176,0.66,1,,,1636,477,279,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00184548,Terminated,Actual,Phase 3,Interventional,4,,Actual,554,Both,18 Years,70 Years,,2,2465663586,Drug,560,362,560,283,0.03,0.934,14,,,1636,477,279,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00185211,Completed,Actual,Phase 3,Interventional,2,,Actual,468,Both,18 Years,48 Years,,304,3878017841,Drug,468,103,468,452,0.000006,0.000001,20,,,1636,477,279,Parallel Assignment,,Open Label,,Treatment,Safety/Efficacy Study
NCT00185458,Completed,Actual,Phase 3,Interventional,1,,Actual,394,Female,46 Years,51 Years,,290,121024348,Drug,394,25,394,357,0.027,0.001,4,,,1636,477,279,Single Group Assignment,,Open Label,,Treatment,Safety/Efficacy Study
NCT00186888,"Active, not recruiting",Anticipated,Phase 3,Interventional,3,,Actual,107,Both,0,0,,400,2039344290,Procedure,105,11,105,68,0.106,0.844,1,,,1636,477,279,Parallel Assignment,,Open Label,,Treatment,Efficacy Study
NCT00187889,Completed,Actual,Phase 4,Interventional,2,,Actual,70,Female,21 Years,75 Years,,249,2806977916,Drug,50,1,50,6,0.15,0.92,1,,,1636,477,279,Parallel Assignment,,Double Blind,,Treatment,Efficacy Study
NCT00189098,Completed,Actual,N/A,Interventional,2,,Actual,101,Both,1 Years,12 Years,,104,3825874814,Drug,101,2,101,5,,,1,,,1636,477,279,Parallel Assignment,,Double Blind,,Treatment,Efficacy Study
NCT00189423,Terminated,Actual,N/A,Interventional,2,,Actual,1653,Both,18 Years,0,,208,2481567300,Device,1653,1553,,,0.0001,0.681,1,,,1636,477,279,Parallel Assignment,,Single Blind,,Treatment,Safety/Efficacy Study
NCT00189540,Completed,Actual,Phase 2,Interventional,2,,Actual,27,Both,40 Years,0,,41,3133420132,Genetic,27,20,27,25,0.04,1,1,,,1636,477,279,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00190775,Completed,Actual,Phase 4,Interventional,2,,Actual,502,Both,18 Years,0,,55,933064736,Drug,500,7,500,439,0.792,0.001,2,,,1636,477,279,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00191139,Completed,Actual,Phase 2,Interventional,2,,Actual,64,Both,18 Years,0,,326,1982470504,Drug,64,31,64,64,0.08,0.38,4,,,1636,477,279,Parallel Assignment,,Open Label,,Treatment,Efficacy Study
NCT00191152,Completed,Actual,Phase 3,Interventional,2,,Actual,475,Both,18 Years,0,,73,1499605101,Drug,463,127,463,454,0.117,0.99,8,,,1636,477,279,Crossover Assignment,,Open Label,,Treatment,Efficacy Study
NCT00191165,Completed,Actual,Phase 3,Interventional,2,,Actual,27,Both,0,14 Years,,194,1177800271,Drug,,1,,18,0.061,0.388,1,,,1636,477,279,Parallel Assignment,,Open Label,,Treatment,Safety/Efficacy Study
NCT00191282,Completed,Actual,Phase 4,Interventional,2,,Actual,1116,Both,30 Years,0,,144,3633170488,Drug,,287,,702,0.086,0.982,17,,,1636,477,279,Parallel Assignment,,Open Label,,Treatment,Safety/Efficacy Study
NCT00191386,Completed,Actual,Phase 3,Interventional,1,,Actual,228,Both,6 Years,17 Years,,55,933064736,Drug,228,6,228,222,0.001,0.001,1,,,1636,477,279,Single Group Assignment,,Open Label,,Treatment,Safety Study
NCT00191477,Terminated,Actual,Phase 3,Interventional,2,,Actual,355,Both,18 Years,0,,67,2486064534,Drug,328,27,328,74,0.777,0.777,1,,,1636,477,279,Parallel Assignment,,Double Blind,,Treatment,Efficacy Study
NCT00191646,Completed,Actual,Phase 3,Interventional,2,,Actual,919,Female,18 Years,0,,190,2982276392,Drug,1327,210,1327,1274,0.013,0.784,2,,,1636,477,279,Crossover Assignment,,Open Label,,Treatment,Safety/Efficacy Study
NCT00191724,Completed,Actual,Phase 2,Interventional,5,,Actual,47,Both,18 Years,80 Years,,435,576207025,Drug,,7,,36,0.018,0.985,1,,,1636,477,279,Parallel Assignment,,Double Blind,,Treatment,Safety Study
NCT00191906,Completed,Actual,Phase 4,Interventional,4,,Actual,121,Both,8 Years,12 Years,,55,933064736,Drug,,,175,87,0.003,0.001,2,,,1636,477,279,Crossover Assignment,,Double Blind,,Treatment,Efficacy Study
NCT00191945,Completed,Actual,Phase 3,Interventional,2,,Actual,151,Both,6 Years,15 Years,,55,933064736,Drug,151,1,151,118,0.0009,0.001,1,,,1636,477,279,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00192023,Completed,Actual,Phase 3,Interventional,2,,Actual,139,Both,6 Years,15 Years,,55,933064736,Drug,,,139,91,0.001,0.001,1,,,1636,477,279,Parallel Assignment,,Double Blind,,Treatment,Efficacy Study
NCT00194025,Completed,Actual,Phase 4,Interventional,1,,Actual,20,Both,50 Years,0,,405,2119471695,Drug,,,,,0.017,0.001,1,,,1636,477,279,Single Group Assignment,,Open Label,,Treatment,Safety/Efficacy Study
NCT00195273,Completed,Actual,Phase 3,Interventional,2,,Actual,61,Both,18 Years,0,,193,4053992763,Drug,,50,,61,0.4662,0.6081,2,,,1636,477,279,Parallel Assignment,,Open Label,,Treatment,Safety/Efficacy Study
NCT00195351,Completed,Actual,Phase 4,Interventional,2,,Actual,467,Both,18 Years,0,,39,3118204704,Drug,,100,,384,0.009,0.02,6,,,1636,477,279,Single Group Assignment,,Open Label,,Treatment,Safety/Efficacy Study
NCT00195403,Completed,Actual,N/A,Observational,,1,Actual,1014,Both,4 Years,0,,401,2326608903,Drug,998,3,998,142,0.0001,0.0001,1,,,1636,477,279,,Case-Only,,Prospective,,
NCT00195429,Completed,Actual,Phase 4,Interventional,2,,Actual,47,Both,13 Years,0,,255,2427876087,Drug,,,47,45,0.361,1,1,,,1636,477,279,Parallel Assignment,,Open Label,,Treatment,Safety/Efficacy Study
NCT00195494,Completed,Actual,Phase 4,Interventional,4,,Actual,542,Both,18 Years,0,,401,2326608903,Drug,,108,,817,0.001,0.001,1,,,1636,477,279,Parallel Assignment,,Double Blind,,Treatment,Efficacy Study
NCT00195663,Completed,Actual,Phase 3,Interventional,3,,Actual,799,Both,18 Years,0,,157,120873158,Biological,1496,488,1496,1329,0.5402,0.001,19,,,1636,477,279,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00195702,Completed,Actual,Phase 3,Interventional,6,,Actual,619,Both,18 Years,0,,401,2326608903,Biological,1172,352,1172,975,0.001,0.01,2,,,1636,477,279,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00195819,Completed,Actual,Phase 3,Interventional,2,,Actual,82,Both,18 Years,0,,33,3267503137,Biological,82,20,82,78,0.06,0.387,1,,,1636,477,279,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00196105,Completed,Actual,N/A,Interventional,3,,Actual,241,Both,21 Years,0,,63,2512545532,Device,,,,,0.007,0.69,1,,,1636,477,279,Parallel Assignment,,Open Label,,Treatment,Efficacy Study
NCT00197106,Completed,Actual,Phase 4,Interventional,1,,Actual,176,Both,6 Years,12 Years,,48,2527395224,Drug,158,5,158,84,0.63,0.63,1,,,1636,477,279,Parallel Assignment,,Double Blind,,Treatment,Efficacy Study
NCT00198822,Completed,Actual,Phase 3,Interventional,3,,Actual,59666,Female,15 Years,49 Years,,461,2825133744,Dietary Supplement,,,,,0.05,0.05,2,,,1636,477,279,Parallel Assignment,,Double Blind,,Prevention,Efficacy Study
NCT00200057,Completed,Actual,N/A,Interventional,1,,Actual,285,Both,18 Years,0,,177,3043226755,Device,120,41,120,88,0.0001,0.0001,2,,,1636,477,279,Single Group Assignment,,Open Label,,Treatment,Safety/Efficacy Study
NCT00200967,Completed,Actual,Phase 3,Interventional,2,,Actual,87,Both,18 Years,90 Years,,48,2527395224,Drug,87,5,87,40,0.004,0.99,1,,,1636,477,279,Crossover Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00201201,Completed,Actual,N/A,Interventional,2,,Actual,160,Both,60 Years,0,,84,3416315868,Other,,,,,0.0001,0.1,1,,,1636,477,279,Parallel Assignment,,Open Label,,,
NCT00201643,Completed,Actual,Phase 4,Interventional,2,,Actual,437,Female,18 Years,60 Years,,375,3505650681,Drug,1014,81,,,0.002,0.002,1,,,1636,477,279,Parallel Assignment,,Double Blind,,Prevention,Safety/Efficacy Study
NCT00203268,Completed,Actual,N/A,Interventional,1,,Actual,13,Both,18 Years,65 Years,,299,3712179563,Drug,,,18,6,0.3025,0.3025,1,,,1636,477,279,Single Group Assignment,,Open Label,,Treatment,Efficacy Study
NCT00203294,Completed,Actual,N/A,Interventional,2,,Actual,45,Both,18 Years,65 Years,,299,3712179563,Drug,,,,,0.01,0.01,1,,,1636,477,279,Parallel Assignment,,Single Blind,,Treatment,Safety/Efficacy Study
NCT00203892,Completed,Actual,Phase 1/Phase 2,Interventional,3,,Actual,23,Both,18 Years,0,,342,1476279783,Biological,,,19,7,0.028,0.99,1,,,1636,477,279,Parallel Assignment,,Open Label,,Treatment,Safety/Efficacy Study
NCT00203931,Terminated,Actual,Phase 2,Interventional,2,,Actual,55,Both,18 Years,0,,326,1982470504,Drug,43,18,43,32,0.029,0.91,1,,,1636,477,279,Parallel Assignment,,Open Label,,Treatment,Safety/Efficacy Study
NCT00204932,Completed,Actual,Phase 2,Interventional,2,,Actual,53,Both,18 Years,44 Years,,329,1330809903,Drug,,,48,3,0.05,0.05,1,,,1636,477,279,Parallel Assignment,,Double Blind,,Treatment,Efficacy Study
NCT00205777,Completed,Actual,Phase 3,Interventional,2,,Actual,7609,Female,55 Years,80 Years,,337,2339607719,Drug,7492,1847,7492,7216,0.001,0.001,30,,,1636,477,279,Single Group Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00205803,Completed,Actual,Phase 1/Phase 2,Interventional,2,,Actual,249,Both,42 Days,98 Days,,206,4045688794,Biological,624,24,624,351,,,1,,,1636,477,279,Parallel Assignment,,Double-Blind,,Prevention,Safety Study
NCT00206726,Completed,Actual,Phase 2,Interventional,1,,Actual,60,Both,18 Years,0,,261,651820616,Drug,57,41,57,55,0.014,0.014,1,,,1636,477,279,Single Group Assignment,,Open Label,,Treatment,Safety/Efficacy Study
NCT00207090,Completed,Actual,Phase 1,Interventional,1,,Actual,19,Both,18 Years,0,,14,2822688266,Drug,15,4,15,14,,,1,,,1636,477,279,Single Group Assignment,,Open Label,,Treatment,Pharmacokinetics Study
NCT00207142,Completed,Actual,Phase 4,Interventional,3,,Actual,252,Both,18 Years,0,,199,2889579184,Drug,252,23,252,199,,,10,,,1636,477,279,Parallel Assignment,,Open Label,,Treatment,Efficacy Study
NCT00207740,Completed,Actual,Phase 2,Interventional,2,,Actual,309,Both,18 Years,0,,48,2527395224,Drug,309,86,309,293,0.021,0.986,11,,,1636,477,279,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00208091,Completed,Actual,Phase 4,Interventional,1,,Actual,16,Both,25 Years,69 Years,,182,719727155,Drug,,,,,0.06,0.23,1,,,1636,477,279,Single Group Assignment,,Open Label,,Treatment,Efficacy Study
NCT00208507,Completed,Actual,N/A,Interventional,2,,Actual,264,Both,20 Years,75 Years,,250,1724926904,Device,264,41,264,124,0.001,0.001,1,,,1636,477,279,Parallel Assignment,,Single Blind,,Treatment,Safety/Efficacy Study
NCT00209131,Terminated,Actual,N/A,Interventional,2,,Actual,24,Both,18 Years,0,,455,2640149670,Drug,,,,,0.05,0.05,1,,,1636,477,279,Parallel Assignment,,Open Label,,Treatment,Efficacy Study
NCT00210626,Terminated,Actual,Phase 2,Interventional,2,,Actual,192,Both,18 Years,55 Years,,29,1185043251,Drug,188,37,188,164,0.3807,0.7038,1,,,1636,477,279,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00211536,Completed,Actual,Phase 3,Interventional,2,,Actual,107,Both,18 Years,65 Years,,447,3017351476,Drug,107,16,107,78,0.05,0.05,1,,,1636,477,279,Parallel Assignment,,Open Label,,Treatment,Efficacy Study
NCT00212134,Completed,Actual,Phase 3,Interventional,2,,Actual,114,Both,0,210 Days,,113,2209951279,Device,,,114,78,0.008,0.05,1,,,1636,477,279,Parallel Assignment,,Open Label,,Treatment,Efficacy Study
NCT00215137,Completed,Actual,Phase 2,Interventional,3,,Actual,14,Both,18 Years,0,,328,429793797,Drug,,,,,0.0417,0.0002,1,,,1636,477,279,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00215150,Completed,Actual,Phase 2,Interventional,3,,Actual,51,Both,18 Years,65 Years,,420,719201761,Drug,,,,,0.001,0.05,1,,,1636,477,279,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00215540,Terminated,Actual,Phase 2,Interventional,3,,Actual,136,Both,0,10 Days,,396,154706622,Drug,136,104,136,136,0.006,0.944,1,,,1636,477,279,Parallel Assignment,,Double Blind,,Prevention,Safety/Efficacy Study
NCT00215553,Terminated,Actual,Phase 2,Interventional,7,,Actual,124,Both,16 Years,75 Years,,7,3391465483,Drug,124,49,124,114,0.028,0.964,1,,,1636,477,279,Parallel Assignment,,Open Label,,Treatment,Safety/Efficacy Study
NCT00216320,Completed,Actual,N/A,Interventional,3,,Actual,121,Both,18 Years,0,,433,678611600,Device,112,3,112,13,0.001,0.001,1,,,1636,477,279,Crossover Assignment,,Open Label,,Treatment,Efficacy Study
NCT00216476,Completed,Actual,Phase 3,Interventional,3,,Actual,753,Both,18 Years,0,,405,2119471695,Drug,711,147,711,442,0.0446,0.0001,24,,,1636,477,279,Parallel Assignment,,Open Label,,Treatment,Safety/Efficacy Study
NCT00216671,Completed,Actual,Phase 4,Interventional,2,,Actual,220,Both,18 Years,65 Years,,405,2119471695,Drug,220,40,220,124,0.519,0.001,10,,,1636,477,279,Parallel Assignment,,Open Label,,Treatment,Safety/Efficacy Study
NCT00217087,Completed,Actual,Phase 2,Interventional,2,,Actual,73,Both,18 Years,0,,158,1639129743,Procedure,73,5,73,24,0.0098,0.34,1,,,1636,477,279,Parallel Assignment,,Open Label,,Treatment,Efficacy Study
NCT00218296,Completed,Actual,Phase 2,Interventional,2,,Actual,332,Both,18 Years,70 Years,,443,179058863,Drug,,,199,71,0.002,0.056,1,,,1636,477,279,Parallel Assignment,,Open Label,,Treatment,Efficacy Study
NCT00218439,Completed,Actual,N/A,Interventional,2,,Actual,105,Both,18 Years,65 Years,,443,179058863,Drug,,,124,69,0.006,0.001,1,,,1636,477,279,Crossover Assignment,,Double Blind,,Treatment,Pharmacodynamics Study
NCT00218634,Completed,Actual,N/A,Interventional,2,,Actual,89,Both,18 Years,65 Years,,11,3704993648,Behavioral,,,,,0.05,0.05,1,,,1636,477,279,Parallel Assignment,,Single Blind,,Treatment,Efficacy Study
NCT00219544,Completed,Actual,Phase 3,Interventional,4,,Actual,158,Both,18 Years,0,,317,2211147477,Drug,,1,,258,0.0003,0.0001,1,,,1636,477,279,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00219557,Completed,Actual,Phase 2,Interventional,2,,Actual,111,Both,18 Years,0,,344,1385352340,Drug,107,48,107,100,0.1026,0.661,8,,,1636,477,279,Parallel Assignment,,Open Label,,Treatment,Safety/Efficacy Study
NCT00220636,Completed,Actual,Phase 4,Interventional,1,,Actual,15,Both,18 Years,70 Years,,136,1049032054,Drug,,,15,8,0.008,0.001,1,,,1636,477,279,Single Group Assignment,,Open Label,,Treatment,Efficacy Study
NCT00220740,Completed,Actual,Phase 3,Interventional,2,,Actual,117,Both,18 Years,0,,360,3280533209,Drug,208,14,208,106,0.001,0.001,10,,,1636,477,279,Parallel Assignment,,Double Blind,,Treatment,Efficacy Study
NCT00220779,Completed,Actual,Phase 2,Interventional,3,,Actual,128,Both,18 Years,55 Years,,305,3529108695,Drug,128,5,128,87,0.221,0.471,12,,,1636,477,279,Parallel Assignment,,Double Blind,,Treatment,Efficacy Study
NCT00223236,Completed,Actual,Phase 3,Interventional,2,,Actual,44,Both,18 Years,70 Years,,286,3805192690,Drug,44,3,,,0.4637,0.4637,1,,,1636,477,279,Parallel Assignment,,Double Blind,,Treatment,Efficacy Study
NCT00223652,Completed,Actual,Phase 2,Interventional,2,,Actual,85,Both,18 Years,0,,135,1716088513,Behavioral,,,,,0.07,0.37,1,,,1636,477,279,Parallel Assignment,,Single Blind,,Treatment,Efficacy Study
NCT00224770,Completed,Actual,Phase 2,Interventional,3,,Actual,141,Both,18 Years,80 Years,,246,4065823762,Drug,110,57,110,73,0.156,0.0001,4,,,1636,477,279,Parallel Assignment,,Open Label,,Treatment,Safety/Efficacy Study
NCT00225017,Completed,Actual,Phase 3,Interventional,2,,Actual,50,Both,18 Years,0,,198,3223041150,Drug,,,,,0.141,0.009,3,,,1636,477,279,Parallel Assignment,,Open Label,,Treatment,Safety/Efficacy Study
NCT00225147,Completed,Actual,Phase 2/Phase 3,Interventional,3,,Actual,77,Both,12 Years,0,,32,1706155871,Drug,100,4,100,25,0.001,0.001,1,,,1636,477,279,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00225251,Completed,Actual,Phase 4,Interventional,2,,Actual,18,Both,18 Years,65 Years,,156,3252367856,Drug,,,18,9,0.05,0.05,1,,,1636,477,279,Parallel Assignment,,Double Blind,,Treatment,Efficacy Study
NCT00227266,Completed,Actual,Phase 2,Interventional,3,,Actual,94,Both,2 Years,17 Years,,424,1686373220,Drug,94,9,94,69,0.001,0.001,2,,,1636,477,279,Crossover Assignment,,Double Blind,,Treatment,Efficacy Study
NCT00227903,Completed,Actual,Phase 2,Interventional,2,,Actual,168,Female,16 Years,45 Years,,16,2154971641,Behavioral,,,,,0.01,0.05,1,,,1636,477,279,Parallel Assignment,,Open Label,,Treatment,Efficacy Study
NCT00228566,Completed,Actual,Phase 3,Interventional,,,Actual,247,Both,18 Years,65 Years,,172,2180414515,Drug,246,6,246,134,,,1,,,1636,477,279,Single Group Assignment,,Open Label,,Treatment,
NCT00230971,Completed,Actual,Phase 4,Interventional,2,,Actual,473,Both,18 Years,0,,39,3118204704,Drug,467,75,467,328,0.001,0.75,19,,,1636,477,279,Parallel Assignment,,Open Label,,Treatment,Safety/Efficacy Study
NCT00231153,Completed,Actual,Phase 3,Interventional,2,,Actual,1859,Both,13 Years,0,,239,385418706,Drug,,,,,0.002,0.001,4,,,1636,477,279,Parallel Assignment,,Open Label,,Prevention,Safety/Efficacy Study
NCT00231179,Completed,Actual,Phase 3,Interventional,2,,Actual,302,Both,4 Years,5 Years,,89,3175281679,Behavioral,,,,,0.59,0.05,1,,,1636,477,279,Parallel Assignment,,Single Blind,,Prevention,Efficacy Study
NCT00231283,Completed,Actual,Phase 3,Interventional,1,,Actual,100,Both,18 Years,0,,119,2281658183,Device,95,1,96,12,,,1,,,1636,477,279,Single Group Assignment,,Open Label,,Treatment,Safety/Efficacy Study
NCT00232141,Completed,Actual,Phase 3,Interventional,2,,Actual,302,Both,18 Years,0,,199,2889579184,Drug,,,,,0.004,0.9964,2,,,1636,477,279,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00232180,Completed,Actual,Phase 3,Interventional,1,,Actual,2743,Both,55 Years,0,,213,3865579137,Drug,6710,2646,6710,2673,0.0081,0.0001,29,,,1636,477,279,Single Group Assignment,,Open Label,,Treatment,Safety Study
NCT00232596,Completed,Actual,Phase 3,Interventional,2,,Actual,306,Both,18 Years,75 Years,,348,2794048920,Drug,520,38,520,311,0.001,0.001,5,,,1636,477,279,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00232739,Completed,Actual,Phase 3,Interventional,1,,Actual,100,Both,18 Years,0,,119,2281658183,Device,91,5,96,39,N/A,N/A,1,,,1636,477,279,Single Group Assignment,,Open Label,,Treatment,Safety/Efficacy Study
NCT00233064,Completed,Actual,Phase 4,Interventional,2,,Actual,417,Both,0,24 Months,,100,609893392,Biological,413,30,,,,,1,,,1636,477,279,Parallel Assignment,,Double Blind,,Treatment,Safety Study
NCT00234065,Completed,Actual,Phase 4,Interventional,2,,Actual,2800,Both,20 Years,80 Years,,85,3646913257,Drug,2672,805,2672,2527,0.0004,0.86,1,,,1636,477,279,Parallel Assignment,,Double Blind,,Prevention,Safety/Efficacy Study
NCT00234078,Completed,Actual,Phase 2,Interventional,4,,Actual,290,Both,20 Years,0,,154,136942581,Drug,290,5,290,127,0.004,0.601,1,,,1636,477,279,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00234104,Completed,Actual,Phase 2,Interventional,,,Actual,122,Both,20 Years,80 Years,,214,1697312720,Drug,118,7,118,81,0.001,0.0459,1,,,1636,477,279,Parallel Assignment,,Double-Blind,,Treatment,Safety/Efficacy Study
NCT00234286,Completed,Actual,N/A,Interventional,1,,Actual,78,Both,0,0,,126,2245485319,Behavioral,,,,,0.003,0.86,1,,,1636,477,279,Single Group Assignment,,Open Label,,Health Services Research,Efficacy Study
NCT00234832,Completed,Actual,Phase 3,Interventional,3,,Actual,10777,Both,55 Years,0,,329,1330809903,Drug,20529,4465,,,0.015,0.948,1,,,1636,477,279,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00235716,Completed,Actual,Phase 3,Interventional,4,,Actual,613,Both,40 Years,0,,23,4032982200,Drug,613,344,613,367,0.03,0.94,2,,,1636,477,279,Factorial Assignment,,Double Blind,,Treatment,Efficacy Study
NCT00235755,Completed,Actual,Phase 3,Interventional,3,,Actual,539,Both,18 Years,75 Years,,348,2794048920,Drug,931,44,931,350,0.007,0.001,13,,,1636,477,279,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00236080,Completed,,Phase 3,Interventional,5,,Actual,136,Both,18 Years,65 Years,,105,912304318,Drug,,,134,29,0.0945,0.1236,1,,,1636,477,279,Parallel Assignment,,Double-Blind,,Treatment,Efficacy Study
NCT00236184,Completed,Actual,Phase 3,Interventional,2,,Actual,629,Both,19 Years,0,,216,1501901890,Drug,629,3,629,11,0.001,0.001,1,,,1636,477,279,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00236899,Completed,Actual,Phase 3,Interventional,4,,Actual,241,Female,18 Years,0,,295,377576721,Drug,238,37,238,224,0.0028,0.976,1,,,1636,477,279,Factorial Assignment,,Open Label,,Treatment,Safety/Efficacy Study
NCT00237042,Completed,Actual,N/A,Interventional,3,,Actual,252,Female,18 Years,45 Years,,438,836342297,Behavioral,,,140,23,0.003,0.27,1,,,1636,477,279,Parallel Assignment,,Single Blind,,Treatment,Efficacy Study
NCT00237666,Completed,Actual,Phase 4,Interventional,1,,Actual,30,Both,18 Years,0,,65,758287255,Drug,30,1,30,20,0.0001,0.0001,1,,,1636,477,279,Single Group Assignment,,Open Label,,Treatment,Safety/Efficacy Study
NCT00237718,Completed,Actual,Phase 2,Interventional,2,,Actual,385,Both,18 Years,0,,161,1124500464,Drug,325,96,325,176,0.05,0.05,1,,,1636,477,279,Parallel Assignment,,Double Blind,,Treatment,Efficacy Study
NCT00238615,Terminated,Actual,Phase 2,Interventional,1,,Actual,13,Both,18 Years,0,,271,2288821332,Drug,13,8,13,10,,,1,,,1636,477,279,Single Group Assignment,,Open Label,,Treatment,Efficacy Study
NCT00239226,Completed,Actual,Phase 4,Interventional,4,,Actual,102,Both,18 Years,0,,411,791024063,Procedure,97,3,,,0.047,0.047,1,,,1636,477,279,Parallel Assignment,,Single Blind,,Prevention,Efficacy Study
NCT00239681,Terminated,Actual,Phase 3,Interventional,2,,Actual,17802,Both,50 Years,0,,159,1744629141,Drug,17733,2421,17733,6398,0.018,0.172,27,,,1636,477,279,Parallel Assignment,,Double Blind,,Prevention,Safety/Efficacy Study
NCT00240487,Completed,Actual,Phase 3,Interventional,2,,Actual,52,Both,1 Months,18 Years,,7,3391465483,Drug,,,,,0.05,0.05,1,,,1636,477,279,Parallel Assignment,,Open Label,,Treatment,Safety/Efficacy Study
NCT00241176,Completed,Actual,Phase 4,Interventional,1,,Actual,11,Both,7 Years,18 Years,,444,3453728878,Drug,,,11,11,0.05,0.05,1,,,1636,477,279,Single Group Assignment,,Open Label,,Treatment,Safety/Efficacy Study
NCT00242385,Completed,Actual,Phase 1,Interventional,2,,Actual,25,Both,18 Years,0,,20,1595060059,Biological,,,50,42,,,2,,,1636,477,279,Crossover Assignment,,Double-Blind,,Treatment,Pharmacokinetics Study
NCT00242710,Completed,Actual,Phase 3,Interventional,4,,Actual,1083,Female,40 Years,65 Years,,164,1069563061,Drug,1061,55,1061,948,0.003,0.001,1,,,1636,477,279,Parallel Assignment,,Double Blind,,Prevention,Safety/Efficacy Study
NCT00243022,Terminated,Actual,Phase 2,Interventional,2,,Actual,12,Both,18 Years,0,,72,660508271,Drug,12,2,12,6,0.12,0.9,1,,,1636,477,279,Parallel Assignment,,Open Label,,Treatment,Efficacy Study
NCT00243269,Completed,Actual,Phase 1/Phase 2,Interventional,4,,Actual,83,Female,18 Years,0,,311,1233291739,Behavioral,,,,,0.84,0.932,1,,,1636,477,279,Parallel Assignment,,Double Blind,,Supportive Care,Efficacy Study
NCT00243386,Completed,Actual,Phase 4,Interventional,2,,Actual,82,Both,7 Years,65 Years,,218,483804573,Drug,140,13,140,29,0.0002,0.0001,10,,,1636,477,279,Parallel Assignment,,Open Label,,Treatment,Efficacy Study
NCT00244140,Completed,Actual,Phase 3,Interventional,2,,Actual,435,Both,18 Years,0,,112,2653119705,Drug,434,2,434,33,,,4,,,1636,477,279,Parallel Assignment,,Open Label,,Diagnostic,Safety/Efficacy Study
NCT00244712,Completed,Actual,Phase 4,Interventional,2,,Actual,688,Both,18 Years,0,,198,3223041150,Drug,,87,,364,0.913,0.913,2,,,1636,477,279,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00244764,Completed,Actual,Phase 2,Interventional,2,,Actual,225,Both,21 Years,0,,81,1588592340,Drug,225,80,225,215,,,9,,,1636,477,279,Single Group Assignment,,Open Label,,Treatment,Safety/Efficacy Study
NCT00245050,Completed,Actual,Phase 3,Interventional,2,,Actual,34,Female,0,0,,73,1499605101,Drug,29,14,29,23,0.916,0.05,1,,,1636,477,279,Parallel Assignment,,Double Blind,,Supportive Care,Efficacy Study
NCT00246025,Completed,,Phase 2,Interventional,4,,Actual,512,Both,20 Years,0,,47,2338741005,Drug,512,10,512,224,0.0006,0.0001,1,,,1636,477,279,Parallel Assignment,,Double-Blind,,Prevention,Efficacy Study
NCT00246571,Completed,Actual,Phase 2,Interventional,2,,Actual,217,Both,18 Years,0,,74,3128271172,Drug,213,61,213,207,0.814,0.9624,12,,,1636,477,279,Parallel Assignment,,Open Label,,Treatment,Safety/Efficacy Study
NCT00247273,Completed,Actual,Phase 3,Interventional,2,,Actual,1294,Female,50 Years,0,,367,1461450240,Drug,1292,128,1292,1132,1,1,14,,,1636,477,279,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00247611,Completed,Actual,Phase 2,Interventional,2,,Actual,594,Both,18 Years,0,,197,2709160825,Behavioral,,,,,0.024,0.5,1,,,1636,477,279,Parallel Assignment,,Open Label,,Treatment,Efficacy Study
NCT00247676,Completed,Actual,Phase 2,Interventional,1,,Actual,37,Both,18 Years,0,,267,683971202,Drug,37,24,37,37,,,3,,,1636,477,279,Single Group Assignment,,Open Label,,Treatment,Efficacy Study
NCT00247962,Completed,Actual,Phase 4,Interventional,2,,Actual,566,Both,18 Years,0,,33,3267503137,Drug,,11,,313,0.01,0.001,18,,,1636,477,279,Parallel Assignment,,Double Blind,,Treatment,Efficacy Study
NCT00248547,Completed,Actual,N/A,Interventional,2,,Actual,40,Both,18 Years,0,,76,3991381194,Drug,40,2,,,0.041,0.041,1,,,1636,477,279,Parallel Assignment,,Double Blind,,Supportive Care,Safety/Efficacy Study
NCT00249288,Completed,Actual,Phase 4,Interventional,2,,Actual,46,Both,18 Years,68 Years,,405,2119471695,Drug,,,,,0.37,0.37,1,,,1636,477,279,Parallel Assignment,,Double Blind,,Treatment,Efficacy Study
NCT00249613,Completed,Actual,N/A,Interventional,2,,Actual,291,Female,18 Years,75 Years,,436,1195930968,Behavioral,,,,,0.01,0.33,1,,,1636,477,279,Parallel Assignment,,Open Label,,Treatment,Efficacy Study
NCT00249873,Completed,Actual,Phase 3,Interventional,2,,Actual,7554,Both,18 Years,0,,51,734346743,Drug,7554,2223,7554,5044,0.0133,0.001,30,,,1636,477,279,Parallel Assignment,,Double Blind,,Prevention,Efficacy Study
NCT00251303,Completed,Actual,Phase 2,Interventional,2,,Actual,78,Both,7 Years,17 Years,,331,1244656958,Drug,60,1,60,56,0.959,0.959,1,,,1636,477,279,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00251693,Completed,Actual,Phase 3,Interventional,3,,Actual,2038,Both,18 Years,0,,171,3175721293,Drug,2038,13,2038,166,0.001,0.927,15,,,1636,477,279,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00251719,Completed,Actual,Phase 3,Interventional,3,,Actual,2054,Both,18 Years,0,,171,3175721293,Drug,2054,10,2054,84,0.019,0.993,16,,,1636,477,279,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00251745,Completed,Actual,Phase 3,Interventional,3,,Actual,908,Both,18 Years,0,,184,2110570532,Drug,,3,,146,0.00001,0.00001,1,,,1636,477,279,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00251758,Completed,Actual,Phase 3,Interventional,3,,Actual,908,Both,18 Years,0,,184,2110570532,Drug,,3,,146,0.00001,0.00001,1,,,1636,477,279,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00251862,Completed,Actual,N/A,Interventional,3,,Actual,825,Both,50 Years,75 Years,,108,1696863024,Behavioral,,,,,0.046,0.001,1,,,1636,477,279,Parallel Assignment,,Single Blind,,Prevention,Efficacy Study
NCT00252187,Completed,Actual,Phase 1/Phase 2,Interventional,2,,Actual,45,Both,18 Years,0,,114,2971302321,Drug,45,4,45,37,0.001,0.14,1,,,1636,477,279,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00252629,Completed,Actual,N/A,Interventional,2,,Actual,29,Male,32 Years,52 Years,,38,633347903,Other,,,,,0.0001,0.004,1,,,1636,477,279,Parallel Assignment,,Single Blind,,Treatment,Efficacy Study
NCT00253370,Completed,Actual,Phase 2,Interventional,1,,Actual,44,Both,18 Years,0,,9,3114325493,Drug,44,40,44,44,0.0012,0.0012,1,,,1636,477,279,Single Group Assignment,,Open Label,,Treatment,Efficacy Study
NCT00253890,Completed,Actual,Phase 3,Interventional,2,,Actual,137,Both,18 Years,75 Years,,362,1867826490,Drug,,,,,0.05,0.05,1,,,1636,477,279,Parallel Assignment,,Double Blind,,Treatment,Efficacy Study
NCT00254540,Completed,Actual,Phase 2,Interventional,1,,Actual,51,Both,20 Years,0,,81,1588592340,Drug,51,28,51,51,,,1,,,1636,477,279,Single Group Assignment,,Open Label,,Treatment,Safety/Efficacy Study
NCT00254566,Completed,Actual,Phase 3,Interventional,2,,Actual,398,Both,50 Years,0,,92,2668162075,Other,,13,,51,0.159,0.87,6,,,1636,477,279,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00255151,Completed,Actual,Phase 3,Interventional,3,,Actual,451,Both,18 Years,0,,171,3175721293,Drug,,7,,65,0.37161,0.00001,1,,,1636,477,279,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00255164,Completed,Actual,Phase 3,Interventional,3,,Actual,451,Both,18 Years,0,,171,3175721293,Drug,,7,,65,0.37161,0.00001,1,,,1636,477,279,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00255190,Completed,Actual,Phase 3,Interventional,2,,Actual,591,Both,18 Years,0,,184,2110570532,Drug,,30,,228,0.005,0.001,1,,,1636,477,279,Parallel Assignment,,Open Label,,Treatment,Safety Study
NCT00255970,Completed,Actual,Phase 2/Phase 3,Interventional,2,,Actual,40,Both,18 Years,0,,352,3703859271,Other,,,,,0.05,0.05,1,,,1636,477,279,Parallel Assignment,,Double Blind,,Prevention,Safety/Efficacy Study
NCT00256997,Terminated,Actual,Phase 4,Interventional,2,,Actual,167,Both,18 Years,65 Years,,405,2119471695,Drug,167,20,167,139,0.5498,0.5498,4,,,1636,477,279,Parallel Assignment,,Open Label,,Treatment,Safety/Efficacy Study
NCT00257192,Terminated,Actual,Phase 3,Interventional,2,,Actual,284,Both,13 Years,17 Years,,405,2119471695,Drug,283,10,283,137,0.0412,0.4661,9,,,1636,477,279,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00257556,Completed,Actual,Phase 4,Interventional,2,,Actual,80,Female,20 Years,35 Years,,242,1134102512,Drug,76,13,76,39,,,2,,,1636,477,279,Parallel Assignment,,Open Label,,Treatment,Safety/Efficacy Study
NCT00257920,Completed,,Phase 4,Interventional,2,,Actual,41,Both,20 Years,0,,98,1111248481,Drug,,6,,33,0.573,0.67,1,,,1636,477,279,Crossover Assignment,,Open Label,,Treatment,Safety/Efficacy Study
NCT00258310,Completed,Actual,Phase 2,Interventional,1,,Actual,35,Both,18 Years,0,,204,599964,Drug,35,2,35,3,,,1,,,1636,477,279,Single Group Assignment,,Open Label,,Treatment,Safety/Efficacy Study
NCT00258674,Completed,Actual,N/A,Interventional,3,,Actual,1891,Both,65 Years,0,,139,1050540193,Other,,,,,0.307,0.996,1,,,1636,477,279,Parallel Assignment,,Open Label,,Health Services Research,Efficacy Study
NCT00259012,Completed,Actual,Phase 3,Interventional,2,,Actual,67,Both,1 Months,11 Months,,183,1227007759,Drug,,5,,30,0.003,0.982,8,,,1636,477,279,Parallel Assignment,,Open Label,,Treatment,Pharmacokinetics/Dynamics Study
NCT00259298,Completed,Actual,Phase 4,Interventional,1,,Actual,12,Female,50 Years,85 Years,,337,2339607719,Drug,12,1,12,12,0.002,1,1,,,1636,477,279,Single Group Assignment,,Open Label,,Treatment,Safety/Efficacy Study
NCT00260832,Completed,Actual,Phase 3,Interventional,2,,Actual,485,Both,65 Years,0,,5,1001156887,Drug,475,352,475,468,0.1079,0.1079,15,,,1636,477,279,Parallel Assignment,,Open Label,,Treatment,Safety/Efficacy Study
NCT00261443,Completed,Actual,Phase 4,Interventional,2,,Actual,1270,Both,18 Years,0,,64,2594871937,Drug,1057,34,1057,542,0.003,0.001,9,,,1636,477,279,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00261495,Completed,Actual,Phase 3,Interventional,2,,Actual,504,Both,18 Years,0,,341,3299448680,Drug,504,46,504,418,0.01,0.001,10,,,1636,477,279,Parallel Assignment,,Open Label,,Treatment,Safety/Efficacy Study
NCT00261833,Completed,Actual,Phase 4,Interventional,2,,Actual,180,Both,18 Years,65 Years,,21,2117749679,Biological,180,56,180,174,0.017,0.115,13,,,1636,477,279,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00262041,Completed,,Phase 2,Interventional,3,,Actual,524,Both,11 Years,17 Years,,376,3128510237,Biological,524,13,524,408,0.003,0.001,1,,,1636,477,279,Parallel Assignment,,Single Blind,,Prevention,Safety/Efficacy Study
NCT00262301,Completed,Actual,Phase 3,Interventional,2,,Actual,75,Both,16 Years,0,,224,2322988993,Drug,89,2,89,13,0.003,0.005,2,,,1636,477,279,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00262522,Completed,Actual,Phase 3,Interventional,4,,Actual,664,Both,18 Years,0,,229,4253814299,Drug,664,87,664,579,0.249,0.1,19,,,1636,477,279,Parallel Assignment,,Open Label,,Treatment,Safety/Efficacy Study
NCT00262730,Completed,Actual,Phase 2,Interventional,1,,Actual,97,Both,18 Years,0,,191,2999136560,Drug,,,97,5,0.1,0.1,1,,,1636,477,279,Single Group Assignment,,Open Label,,Treatment,Safety/Efficacy Study
NCT00262834,Completed,Actual,N/A,Interventional,1,,Actual,54,Female,18 Years,0,,73,1499605101,Drug,,,25,17,0.42,0.5,1,,,1636,477,279,Single Group Assignment,,Open Label,,Treatment,Safety Study
NCT00262847,Completed,Actual,Phase 3,Interventional,3,,Actual,1873,Female,18 Years,0,,427,1924775213,Other,1864,783,1864,1770,0.131,0.001,4,,,1636,477,279,Parallel Assignment,,Double Blind,,Treatment,Efficacy Study
NCT00263887,Completed,Actual,Phase 2,Interventional,2,,Actual,77,Both,18 Years,0,,20,1595060059,Drug,77,24,77,75,0.049,0.049,3,,,1636,477,279,Parallel Assignment,,Double Blind,,Treatment,Efficacy Study
NCT00264303,Completed,Actual,Phase 4,Interventional,2,,Actual,886,Both,18 Years,0,,96,1153606,Drug,886,2,886,157,0.002,0.001,9,,,1636,477,279,Parallel Assignment,,Double-Blind,,Treatment,Safety/Efficacy Study
NCT00264550,Completed,Actual,Phase 3,Interventional,4,,Actual,444,Both,18 Years,0,,401,2326608903,Drug,434,172,434,374,0.001,0.001,12,,,1636,477,279,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00264576,Completed,Actual,Phase 2,Interventional,2,,Actual,613,Both,18 Years,49 Years,,244,1679987934,Biological,613,8,613,473,,,1,,,1636,477,279,Parallel Assignment,,Single Blind,,Prevention,Safety/Efficacy Study
NCT00265096,Completed,Actual,Phase 3,Interventional,3,,Actual,407,Both,18 Years,0,,43,760806292,Biological,394,83,394,311,0.011,0.001,6,,,1636,477,279,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00265122,Completed,Actual,Phase 2,Interventional,6,,Actual,131,Both,18 Years,0,,122,240489291,Drug,120,10,120,98,0.292,0.337,3,,,1636,477,279,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00265317,Completed,Actual,Phase 2,Interventional,2,,Actual,162,Both,18 Years,0,,80,4164722591,Drug,158,69,158,149,0.0091,0.0001,8,,,1636,477,279,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00266032,Completed,Actual,Phase 3,Interventional,3,,Actual,1166,Female,18 Years,35 Years,,115,1291749007,Drug,1067,29,1067,547,0.0001,0.0001,3,,,1636,477,279,Parallel Assignment,,Open Label,,Prevention,Safety/Efficacy Study
NCT00266409,Completed,Actual,Phase 4,Interventional,4,,Actual,418,Both,18 Years,0,,188,1272109837,Drug,414,7,414,47,0.0001,0.9988,1,,,1636,477,279,Parallel Assignment,,Open Label,,Treatment,Efficacy Study
NCT00266864,Completed,Actual,Phase 2/Phase 3,Interventional,2,,Actual,31,Male,18 Years,49 Years,,422,2839930689,Drug,18,1,18,11,0.051,0.01,1,,,1636,477,279,Parallel Assignment,,Open Label,,Treatment,Safety/Efficacy Study
NCT00267046,Completed,Actual,Phase 2,Interventional,2,,Actual,49,Both,15 Years,65 Years,,402,2142848470,Drug,,,48,39,0.001,0.001,1,,,1636,477,279,Parallel Assignment,,Double Blind,,Prevention,Safety/Efficacy Study
NCT00267098,Completed,Actual,N/A,Interventional,2,,Actual,918,Both,18 Years,0,,53,371147933,Device,918,491,918,398,0.189,0.9999,2,,,1636,477,279,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00267111,Completed,Actual,Phase 2,Interventional,2,,Actual,110,Both,0,0,,341,3299448680,Drug,,,107,12,0.05,0.05,1,,,1636,477,279,Parallel Assignment,,Double Blind,,Treatment,Efficacy Study
NCT00267293,Completed,Actual,Phase 4,Interventional,3,,Actual,60,Both,6 Months,7 Years,,179,1502818448,Drug,,,,,0.0001,0.001,1,,,1636,477,279,Parallel Assignment,,Open Label,,Treatment,Efficacy Study
NCT00267670,Completed,Actual,Phase 2/Phase 3,Interventional,2,,Actual,26,Both,18 Years,65 Years,,327,431973634,Drug,,,,,0.16,0.94,1,,,1636,477,279,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00267748,Completed,Actual,Phase 2,Interventional,2,,Actual,317,Both,18 Years,0,,81,1588592340,Drug,314,111,314,311,0.075,0.866,1,,,1636,477,279,Parallel Assignment,,Open Label,,Treatment,Safety/Efficacy Study
NCT00267956,Completed,Actual,Phase 2,Interventional,2,,Actual,146,Both,18 Years,0,,382,3318947731,Drug,277,9,277,91,0.004,0.001,5,,,1636,477,279,Crossover Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00267969,Completed,Actual,Phase 3,Interventional,3,,Actual,766,Both,18 Years,0,,381,1711367644,Drug,1514,117,1514,893,0.001,0.001,3,,,1636,477,279,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00269113,Completed,Actual,Phase 3,Interventional,2,,Actual,360,Both,18 Years,75 Years,,321,2973869801,Drug,360,38,360,309,0.0002,0.0001,1,,,1636,477,279,Parallel Assignment,,Open Label,,Treatment,Safety/Efficacy Study
NCT00269152,Completed,Actual,Phase 2,Interventional,2,,Actual,122,Both,18 Years,0,,323,3115687674,Drug,118,23,118,113,,,3,,,1636,477,279,Parallel Assignment,,Open Label,,Treatment,Safety Study
NCT00271154,Completed,Actual,N/A,Interventional,2,,Actual,684,Both,18 Years,0,,213,3865579137,Device,648,403,648,203,0.1,0.0001,15,,,1636,477,279,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00271544,Completed,Actual,N/A,Interventional,1,,Actual,190,Both,18 Years,0,,213,3865579137,Device,,,,,,,2,,,1636,477,279,Single Group Assignment,,Open Label,,Treatment,Safety/Efficacy Study
NCT00272779,Completed,Actual,Phase 3,Interventional,2,,Actual,1057,Both,18 Years,0,,199,2889579184,Drug,878,109,878,725,0.0058,0.1847,29,,,1636,477,279,Parallel Assignment,,Open Label,,Treatment,Safety/Efficacy Study
NCT00272792,Completed,Actual,Phase 3,Interventional,2,,Actual,45,Both,4 Years,12 Years,,356,1288876632,Drug,,,,34,0.009,0.001,1,,,1636,477,279,Parallel Assignment,,Double-Blind,,Treatment,Safety/Efficacy Study
NCT00273182,Completed,Actual,N/A,Observational,,1,Actual,1999,Both,18 Years,0,,213,3865579137,Device,1999,450,1999,175,,,1,,,1636,477,279,,Cohort,,Prospective,,
NCT00274456,Completed,Actual,Phase 2,Interventional,4,,Actual,302,Female,18 Years,0,,294,2238648170,Drug,300,93,300,296,0.001,0.05,1,,,1636,477,279,Parallel Assignment,,Open Label,,Treatment,Safety/Efficacy Study
NCT00274625,Completed,Actual,N/A,Interventional,2,,Actual,402,Both,18 Years,0,,225,3427550757,Device,,,380,149,0.6,0.6,1,,,1636,477,279,Parallel Assignment,,Open Label,,Treatment,Efficacy Study
NCT00275340,Completed,Actual,Phase 1,Interventional,,,Actual,101,Both,0,0,,119,2281658183,Other,,,,,0.2,0.2,1,,,1636,477,279,Single Group Assignment,,Single Blind,,Treatment,Safety/Efficacy Study
NCT00275392,Completed,Actual,N/A,Interventional,2,,Actual,39,Both,60 Years,0,,153,151272800,Behavioral,,,,,0.016,0.05,1,,,1636,477,279,Parallel Assignment,,Single Blind,,Treatment,Efficacy Study
NCT00275561,Completed,Actual,Phase 2,Interventional,2,,Actual,42,Both,18 Years,60 Years,,165,2383553813,Drug,,,34,13,0.49,0.001,1,,,1636,477,279,Single Group Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00277212,Completed,Actual,Phase 4,Interventional,2,,Actual,1169,Both,18 Years,0,,64,2594871937,Drug,1128,46,1128,680,0.001,0.971,2,,,1636,477,279,Parallel Assignment,,Open Label,,Treatment,Safety/Efficacy Study
NCT00277446,Completed,Actual,N/A,Interventional,1,,Actual,13,Both,18 Years,50 Years,,48,2527395224,Drug,,,,,0.02,0.03,1,,,1636,477,279,Single Group Assignment,,Open Label,,Treatment,Safety/Efficacy Study
NCT00279201,Completed,Actual,Phase 4,Interventional,6,,Actual,2091,Both,30 Years,79 Years,,144,3633170488,Drug,3727,241,3667,2855,0.001,0.001,12,,,1636,477,279,Parallel Assignment,,Open Label,,Treatment,Safety/Efficacy Study
NCT00279591,Terminated,Actual,N/A,Interventional,2,,Actual,94,Both,1 Years,17 Years,,350,2715128815,Device,,,,,0.03,0.03,1,,,1636,477,279,Parallel Assignment,,Double Blind,,Treatment,Efficacy Study
NCT00280059,Completed,Actual,Phase 3,Interventional,2,,Actual,660,Both,16 Years,0,,168,1819384088,Drug,660,76,660,357,0.0003,0.8047,29,,,1636,477,279,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00280566,Completed,Actual,Phase 3,Interventional,2,,Actual,584,Both,18 Years,0,,66,1752722647,Drug,,20,,408,0.0003,0.9972,13,,,1636,477,279,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00281099,Terminated,Actual,N/A,Interventional,2,,Actual,1031,Both,18 Years,0,,210,2419787588,Device,1031,249,1031,229,0.0053,0.1,12,,,1636,477,279,Parallel Assignment,,Single Blind,,Prevention,Safety/Efficacy Study
NCT00281632,Completed,Actual,Phase 2,Interventional,1,,Actual,35,Female,21 Years,0,,285,2762284701,Drug,36,6,36,35,,,3,,,1636,477,279,Single Group Assignment,,Open Label,,Treatment,Safety/Efficacy Study
NCT00281918,Completed,Actual,Phase 3,Interventional,2,,Actual,817,Both,18 Years,0,,260,180008924,Drug,800,350,800,307,0.001,0.0001,11,,,1636,477,279,Parallel Assignment,,Open Label,,Treatment,
NCT00282087,Completed,Actual,Phase 2,Interventional,1,,Actual,47,Female,18 Years,0,,259,1049890625,Drug,47,9,47,14,0.15,0.15,1,,,1636,477,279,Single Group Assignment,,Open Label,,Treatment,Safety/Efficacy Study
NCT00282113,Completed,Actual,N/A,Interventional,3,,Actual,90,Both,0,7 Days,,373,234682948,Dietary Supplement,,,,,0.06,0.5,1,,,1636,477,279,Parallel Assignment,,Double Blind,,Prevention,Safety/Efficacy Study
NCT00282243,Completed,Actual,Phase 2,Interventional,1,,Actual,70,Both,18 Years,65 Years,,269,295097427,Drug,69,37,69,51,,,1,,,1636,477,279,Single Group Assignment,,Open Label,,Prevention,Safety/Efficacy Study
NCT00282256,Completed,Actual,Phase 2,Interventional,1,,Actual,19,Both,0,12 Years,,269,295097427,Drug,18,6,18,11,,,1,,,1636,477,279,Single Group Assignment,,Open Label,,Prevention,Safety/Efficacy Study
NCT00282464,Completed,Actual,Phase 3,Interventional,2,,Actual,392,Both,18 Years,0,,64,2594871937,Drug,,7,,166,0.0005,0.9863,1,,,1636,477,279,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00282568,Completed,Actual,Phase 2,Interventional,1,,Actual,70,Both,18 Years,65 Years,,256,3993050794,Drug,67,39,67,48,,,2,,,1636,477,279,Single Group Assignment,,Open Label,,Prevention,Safety/Efficacy Study
NCT00282984,Completed,Actual,Phase 3,Interventional,2,,Actual,714,Both,35 Years,75 Years,,419,3898843642,Drug,,44,,432,0.0001,0.0001,15,,,1636,477,279,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00283387,Completed,Actual,Phase 2,Interventional,2,,Actual,15,Both,6 Years,70 Years,,232,3322263591,Drug,,,26,19,0.007,0.007,1,,,1636,477,279,Crossover Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00283400,Terminated,Actual,N/A,Interventional,4,,Actual,47,Both,18 Years,79 Years,,434,1822793203,Drug,47,11,,,0.05,0.05,2,,,1636,477,279,Parallel Assignment,,Open Label,,Treatment,
NCT00283712,Completed,Actual,Phase 2,Interventional,2,,Actual,20,Both,18 Years,0,,351,3857742708,Drug,20,3,20,19,0.65,1,1,,,1636,477,279,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00283842,Terminated,Actual,Phase 3,Interventional,5,,Actual,408,Both,18 Years,0,,150,1972684966,Drug,,12,,325,0.001,0.375,1,,,1636,477,279,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00285012,Completed,Actual,Phase 3,Interventional,2,,Actual,504,Both,35 Years,0,,419,3898843642,Drug,499,17,499,278,0.0002,0.0001,4,,,1636,477,279,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00285779,Terminated,Actual,Phase 2,Interventional,2,,Actual,27,Both,18 Years,0,,263,2503015782,Drug,38,1,38,18,0.0978,0.0978,1,,,1636,477,279,Crossover Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00286156,Completed,Actual,Phase 1/Phase 2,Interventional,3,,Actual,30,Both,18 Years,75 Years,,359,2752214730,Drug,30,4,30,24,0.01,0.01,1,,,1636,477,279,Factorial Assignment,,Open Label,,Treatment,Efficacy Study
NCT00286325,Completed,Actual,Phase 1/Phase 2,Interventional,1,,Actual,8,Both,18 Years,0,,75,1559062851,Drug,,,,,0.0078,0.0156,1,,,1636,477,279,Single Group Assignment,,Open Label,,Treatment,Safety/Efficacy Study
NCT00286429,Completed,Actual,Phase 3,Interventional,3,,Actual,390,Both,18 Years,80 Years,,139,1050540193,Drug,389,21,389,162,0.001,0.001,16,,,1636,477,279,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00286442,Completed,Actual,Phase 3,Interventional,3,,Actual,527,Both,18 Years,80 Years,,139,1050540193,Drug,524,18,524,140,0.002,0.001,17,,,1636,477,279,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00286455,Completed,Actual,Phase 3,Interventional,3,,Actual,329,Both,18 Years,80 Years,,139,1050540193,Drug,329,8,329,119,0.001,0.001,18,,,1636,477,279,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00286741,Completed,Actual,Phase 3,Interventional,2,,Actual,239,Both,0,0,,138,2883582343,Other,239,96,239,207,0.03,0.15,1,,,1636,477,279,Parallel Assignment,,Single Blind,,Treatment,Efficacy Study
NCT00286754,Completed,Actual,N/A,Interventional,3,,Actual,533,Both,21 Years,0,,233,2554888772,Behavioral,533,7,533,30,0.001,0.009,1,,,1636,477,279,Parallel Assignment,,Single Blind,,Treatment,Efficacy Study
NCT00287222,Completed,Actual,Phase 2,Interventional,1,,Actual,21,Both,18 Years,0,,223,4057390872,Drug,21,11,,,0.0006,0.0006,1,,,1636,477,279,Single Group Assignment,,Open Label,,Treatment,Efficacy Study
NCT00288704,Completed,Actual,Phase 3,Interventional,3,,Actual,104,Both,7 Years,0,,175,2987399814,Drug,128,7,47,30,0.0001,0.01,1,,,1636,477,279,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00288912,Completed,Actual,N/A,Interventional,3,,Actual,523,Both,0,0,,334,3213715074,Behavioral,523,31,523,94,0.007,0.79,1,,,1636,477,279,Single Group Assignment,,Single Blind,,Health Services Research,Efficacy Study
NCT00289289,Completed,Actual,N/A,Interventional,3,,Actual,400,Both,0,0,,51,734346743,Device,400,19,,,0.165,0.629,2,,,1636,477,279,Crossover Assignment,,Single Blind,,Prevention,Efficacy Study
NCT00289341,Completed,Actual,Phase 1/Phase 2,Interventional,2,,Actual,24,Male,18 Years,0,,378,3123971163,Biological,60,2,60,58,0.001,0.2,1,,,1636,477,279,Crossover Assignment,,Single Blind,,Treatment,Safety/Efficacy Study
NCT00290186,Terminated,Actual,N/A,Interventional,2,,Actual,49,Both,3 Years,8 Years,,86,3979658093,Device,49,2,49,15,0.051,0.945,1,,,1636,477,279,Parallel Assignment,,Double Blind,,Treatment,Efficacy Study
NCT00290290,Completed,Actual,Phase 3,Interventional,2,,Actual,849,Both,18 Years,0,,368,3328686844,Drug,849,7,849,6,0.004,0.004,1,,,1636,477,279,Single Group Assignment,,Double Blind,,Prevention,Safety/Efficacy Study
NCT00291187,Completed,Actual,Phase 3,Interventional,4,,Actual,411,Both,21 Years,50 Years,,245,4173685762,Drug,,,411,23,0.001,0.001,1,,,1636,477,279,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00291330,Completed,,Phase 3,Interventional,2,,Actual,2564,Both,18 Years,0,,440,1048045504,Drug,2539,315,2539,372,0.0002,0.0001,29,,,1636,477,279,Parallel Assignment,,Double-Blind,,Treatment,Safety/Efficacy Study
NCT00291577,Completed,Actual,Phase 1,Interventional,1,,Actual,22,Female,18 Years,0,,74,3128271172,Drug,22,11,22,21,,,3,,,1636,477,279,Single Group Assignment,,Open Label,,Treatment,Safety/Efficacy Study
NCT00292188,Completed,Actual,Phase 4,Interventional,2,,Actual,255,Both,18 Years,80 Years,,315,2797596796,Drug,,8,,259,0,0.846,11,,,1636,477,279,Parallel Assignment,,Double Blind,,Treatment,Efficacy Study
NCT00292370,Completed,Actual,Phase 4,Interventional,3,,Actual,124,Both,18 Years,65 Years,,110,3054614311,Drug,174,7,174,33,0.05,0.05,1,,,1636,477,279,Parallel Assignment,,Double Blind,,Treatment,Efficacy Study
NCT00293241,Completed,Actual,Phase 4,Interventional,2,,Actual,630,Both,18 Years,0,,84,3416315868,Device,605,157,605,63,0.03,0.0001,1,,,1636,477,279,Parallel Assignment,,Single Blind,,Treatment,Efficacy Study
NCT00293384,Completed,Actual,N/A,Interventional,1,,Actual,40,Both,18 Years,0,,73,1499605101,Drug,35,10,35,33,0.1,0.1,1,,,1636,477,279,Single Group Assignment,,Open Label,,Supportive Care,
NCT00293462,Completed,Actual,N/A,Interventional,3,,Actual,91,Both,18 Years,0,,204,599964,Biological,85,6,85,71,0.09,0.92,1,,,1636,477,279,Crossover Assignment,,Double Blind,,Supportive Care,Efficacy Study
NCT00294645,Completed,Actual,N/A,Interventional,2,,Actual,980,Both,0,0,,68,3362919,Other,,,,,0.0001,0.0001,1,,,1636,477,279,Parallel Assignment,,Open Label,,Treatment,Efficacy Study
NCT00294723,Terminated,Actual,Phase 3,Interventional,4,,Actual,746,Both,18 Years,80 Years,,138,2883582343,Drug,888,73,888,602,0.0003,0.0001,3,,,1636,477,279,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00295061,Completed,Actual,Phase 3,Interventional,2,,Actual,24,Both,18 Years,0,,20,1595060059,Drug,48,1,48,8,,,1,,,1636,477,279,Crossover Assignment,,Double Blind,,Treatment,Pharmacokinetics Study
NCT00295750,Completed,Actual,Phase 3,Interventional,3,,Actual,620,Male,18 Years,0,,378,3123971163,Drug,,73,,480,0.0001,0.0001,12,,,1636,477,279,Parallel Assignment,,Open Label,,Treatment,Safety/Efficacy Study
NCT00296231,Completed,Actual,Phase 1,Interventional,1,,Actual,14,Both,0,3 Months,,238,2108073750,Other,,,,,0.011,0.011,1,,,1636,477,279,Crossover Assignment,,Open Label,,Treatment,Efficacy Study
NCT00296517,Completed,Actual,Phase 3,Interventional,2,,Actual,325,Both,18 Years,65 Years,,280,3624825644,Drug,,5,,249,0.036,0.805,1,,,1636,477,279,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00297102,Completed,Actual,Phase 3,Interventional,2,,Actual,1523,Both,40 Years,0,,103,3445665167,Drug,1524,297,1524,368,0.0003,0.0001,11,,,1636,477,279,Parallel Assignment,,Double Blind,,Treatment,
NCT00297115,Completed,Actual,Phase 3,Interventional,2,,Actual,1568,Both,40 Years,0,,103,3445665167,Drug,1568,340,1568,226,0.0035,0.0001,8,,,1636,477,279,Parallel Assignment,,Double Blind,,Treatment,
NCT00297167,Completed,Actual,Phase 3,Interventional,2,,Actual,34,Both,7 Years,0,,124,191177468,Drug,66,2,66,35,0.001,0.001,1,,,1636,477,279,Crossover Assignment,,Double-Blind,,Treatment,Safety/Efficacy Study
NCT00297258,Completed,Actual,Phase 2,Interventional,,,Actual,148,Both,21 Years,0,,403,1077334832,Drug,142,39,142,137,0.003,0.001,5,,,1636,477,279,Single Group Assignment,,Open Label,,Treatment,Safety/Efficacy Study
NCT00297492,Completed,Actual,Phase 2,Interventional,3,,Actual,750,Both,18 Years,0,,419,3898843642,Behavioral,,,,,0.3,0.3,1,,,1636,477,279,Parallel Assignment,,Open Label,,Treatment,Efficacy Study
NCT00297778,Completed,,Phase 4,Interventional,2,,Actual,296,Both,30 Years,80 Years,,345,3641618925,Drug,,12,,129,0.0007,0.8471,13,,,1636,477,279,Parallel Assignment,,Double Blind,,Treatment,
NCT00298090,Completed,Actual,N/A,Observational,,1,Actual,47,Both,18 Years,0,,340,2861880380,Device,,,,,0.55,0.55,1,,,1636,477,279,,Cohort,,Prospective,,
NCT00298233,Completed,Actual,Phase 2,Interventional,4,,Actual,326,Both,1 Years,0,,243,2524740919,Drug,326,1,326,75,0.42,0.66,3,,,1636,477,279,Parallel Assignment,,Double Blind,,Treatment,Efficacy Study
NCT00299221,Completed,Actual,Phase 4,Interventional,2,,Actual,150,Both,18 Years,80 Years,,236,346851351,Drug,150,3,,,0.44,0.44,1,,,1636,477,279,Parallel Assignment,,Open Label,,Treatment,Efficacy Study
NCT00299546,Completed,Actual,Phase 3,Interventional,3,,Actual,461,Both,18 Years,0,,44,1506984474,Drug,431,151,431,365,0.001,0.001,10,,,1636,477,279,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00300469,Completed,,Phase 3,Interventional,6,,Actual,613,Both,18 Years,0,,120,505410856,Drug,,12,,285,0.005,0.001,1,,,1636,477,279,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00300482,Completed,,Phase 3,Interventional,6,,Actual,1445,Both,18 Years,0,,155,1990608606,Drug,,35,,637,0.001,0.001,1,,,1636,477,279,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00300677,Completed,Actual,Phase 4,Interventional,1,,Actual,12,Male,18 Years,55 Years,,240,3381126066,Drug,,,12,11,,,1,,,1636,477,279,Single Group Assignment,,Open Label,,Basic Science,Pharmacokinetics Study
NCT00300885,Terminated,Actual,Phase 3,Interventional,2,,Actual,926,Both,18 Years,0,,79,1922189326,Drug,922,467,922,904,0.1015,0.915,21,,,1636,477,279,Parallel Assignment,,Double-Blind,,Treatment,Safety/Efficacy Study
NCT00301262,Completed,,Phase 4,Interventional,,,Actual,183,Male,18 Years,0,,237,2952165934,Drug,,,,,0.0001,0.0001,1,,,1636,477,279,Parallel Assignment,,Double-Blind,,Treatment,Safety/Efficacy Study
NCT00301808,Completed,Actual,Phase 2,Interventional,1,,Actual,29,Both,18 Years,0,,271,2288821332,Drug,29,15,29,29,,,1,,,1636,477,279,Single Group Assignment,,Open Label,,Treatment,Safety/Efficacy Study
NCT00301873,Completed,Actual,Phase 2,Interventional,1,,Actual,60,Both,18 Years,0,,71,780859460,Drug,59,16,59,31,0.0413,0.2212,1,,,1636,477,279,Single Group Assignment,,Open Label,,Supportive Care,
NCT00302952,Completed,Actual,Phase 2,Interventional,2,,Actual,64,Both,18 Years,70 Years,,401,2326608903,Drug,64,2,64,48,0.19,0.91,1,,,1636,477,279,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00303459,Completed,Actual,Phase 4,Interventional,2,,Actual,334,Both,12 Years,0,,383,3149469713,Drug,333,175,333,282,0.0003,1,12,,,1636,477,279,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00304031,"Active, not recruiting",,Phase 3,Interventional,3,,Actual,1173,Both,18 Years,0,,72,660508271,Drug,1114,367,1114,990,0.63,0.63,2,,,1636,477,279,Parallel Assignment,,Open Label,,Treatment,
NCT00304915,"Active, not recruiting",Anticipated,N/A,Interventional,2,,Actual,249,Both,18 Years,75 Years,,201,4148919742,Behavioral,,,,,0.003,0.003,1,,,1636,477,279,Parallel Assignment,,Open Label,,Treatment,Efficacy Study
NCT00305565,Completed,Actual,Phase 4,Interventional,3,,Actual,331,Both,18 Years,0,,133,2194019288,Device,331,66,331,318,0.803,0.813,1,,,1636,477,279,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00307151,"Active, not recruiting",Anticipated,Phase 2,Interventional,4,,Actual,452,Both,2 Months,36 Months,,199,2889579184,Drug,451,147,451,447,0.015,0.001,7,,,1636,477,279,Parallel Assignment,,Open Label,,Treatment,Efficacy Study
NCT00307333,Completed,Actual,N/A,Interventional,2,,Actual,3003,Both,0,32 Weeks,,408,3534255774,Device,2989,274,,,0.08,0.47,1,,,1636,477,279,Parallel Assignment,,Open Label,,Diagnostic,Efficacy Study
NCT00307437,Completed,Actual,Phase 3,Interventional,3,,Actual,1230,Both,18 Years,0,,381,1711367644,Drug,2438,256,2438,1361,0.014,0.001,7,,,1636,477,279,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00307489,Completed,Actual,Phase 2,Interventional,2,,Actual,106,Both,18 Years,69 Years,,94,2307672194,Drug,,16,,91,0.544,0.999,4,,,1636,477,279,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00307684,Completed,Actual,Phase 3,Interventional,3,,Actual,155,Both,18 Years,65 Years,,54,1600057117,Drug,200,13,200,141,0.2586,0.5458,7,,,1636,477,279,Single Group Assignment,,Double Blind,,Treatment,Efficacy Study
NCT00307801,Completed,Actual,Phase 3,Interventional,2,,Actual,231,Female,18 Years,0,,298,811893236,Drug,226,4,226,65,0.0001,0.0001,10,,,1636,477,279,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00308087,Terminated,Actual,Phase 2,Interventional,2,,Actual,75,Both,18 Years,0,,277,2133617614,Drug,75,12,75,71,0.5501,0.8217,2,,,1636,477,279,Parallel Assignment,,Open Label,,Treatment,Safety/Efficacy Study
NCT00308308,Completed,Actual,Phase 3,Interventional,2,,Actual,589,Both,18 Years,80 Years,,147,1915134822,Drug,565,99,565,522,0.0052,0.0001,10,,,1636,477,279,Parallel Assignment,,Open Label,,Treatment,Efficacy Study
NCT00308711,Completed,Actual,Phase 3,Interventional,3,,Actual,1308,Female,18 Years,0,,88,1606603429,Drug,1307,357,1307,391,0.011,0.974,2,,,1636,477,279,Parallel Assignment,,Double Blind,,Treatment,Efficacy Study
NCT00308737,Completed,Actual,Phase 3,Interventional,3,,Actual,2053,Both,18 Years,70 Years,,146,3392498499,Drug,2035,188,2035,1078,0.112,0.112,8,,,1636,477,279,Parallel Assignment,,Open Label,,Treatment,Safety Study
NCT00309465,Completed,Actual,Phase 4,Interventional,3,,Actual,402,Both,18 Years,0,,138,2883582343,Drug,401,1,401,3,0.031,0.332,1,,,1636,477,279,Parallel Assignment,,Open Label,,Treatment,Safety/Efficacy Study
NCT00309608,Completed,,Phase 2,Interventional,5,,Actual,333,Both,21 Years,75 Years,,144,3633170488,Drug,333,10,333,34,0.001,0.0001,6,,,1636,477,279,Parallel Assignment,,Double-Blind,,Treatment,Safety/Efficacy Study
NCT00310401,Completed,Actual,Phase 2,Interventional,2,,Actual,506,Both,14 Years,0,,69,480406809,Drug,,,,,0.98,0.98,1,,,1636,477,279,Parallel Assignment,,Double Blind,,Treatment,Efficacy Study
NCT00310466,Completed,Actual,Phase 3,Interventional,2,,Actual,226,Both,18 Years,65 Years,,18,1090996619,Biological,226,6,226,168,0.04,0.87,1,,,1636,477,279,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00311311,Terminated,Actual,Phase 3,Interventional,2,,Actual,72,Both,35 Years,0,,49,2002447835,Drug,72,38,72,69,0.0002,0.0001,2,,,1636,477,279,Parallel Assignment,,Open Label,,Treatment,Efficacy Study
NCT00311402,Completed,,Phase 3,Interventional,2,,Actual,1295,Both,50 Years,0,,87,550104849,Drug,1294,345,1294,1238,0.043,0.998,1,,,1636,477,279,Parallel Assignment,,,,Prevention,
NCT00312208,Completed,Actual,Phase 3,Interventional,2,,Actual,3299,Female,18 Years,70 Years,,73,1499605101,Drug,3269,851,3269,3263,0.371,0.978,37,,,1636,477,279,Parallel Assignment,,Open Label,,Treatment,Safety/Efficacy Study
NCT00312221,Terminated,Actual,Phase 3,Interventional,3,,Actual,418,Both,40 Years,0,,334,3213715074,Drug,1070,25,1070,343,0.007,0.707,1,,,1636,477,279,Parallel Assignment,,Double Blind,,Treatment,Efficacy Study
NCT00312494,Completed,Actual,Phase 3,Interventional,3,,Actual,680,Both,18 Years,65 Years,,64,2594871937,Drug,656,13,656,315,0.0101,0.9049,1,,,1636,477,279,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00312845,Completed,Actual,Phase 3,Interventional,2,,Actual,676,Both,18 Years,0,,321,2973869801,Drug,673,96,673,520,0.039,0.001,32,,,1636,477,279,Parallel Assignment,,Open Label,,Treatment,
NCT00313014,Terminated,Actual,Phase 3,Interventional,3,,Actual,660,Both,18 Years,0,,60,3011469154,Drug,1820,32,1820,654,0.006,0.001,1,,,1636,477,279,Parallel Assignment,,Double Blind,,Treatment,Efficacy Study
NCT00313144,Terminated,Actual,Phase 4,Interventional,1,,Actual,127,Both,18 Years,0,,19,2852224729,Drug,127,39,127,97,0.005,0.046,1,,,1636,477,279,Single Group Assignment,,Open Label,,Treatment,Safety/Efficacy Study
NCT00313716,Completed,Actual,Phase 2/Phase 3,Interventional,6,,Actual,200,Both,15 Years,0,,29,1185043251,Drug,400,335,400,356,0.01,0.13,1,,,1636,477,279,Factorial Assignment,,Double Blind,,Treatment,Efficacy Study
NCT00313846,Completed,Actual,Phase 3,Interventional,2,,Actual,529,Both,40 Years,75 Years,,334,3213715074,Drug,855,7,855,272,0.0026,0.0026,1,,,1636,477,279,Parallel Assignment,,Double Blind,,Treatment,Efficacy Study
NCT00314249,Completed,,Phase 3,Interventional,2,,Actual,1025,Both,18 Years,70 Years,,180,3671355921,Drug,1025,17,1025,816,0.001,0.001,1,,,1636,477,279,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00314951,Completed,Actual,Phase 3,Interventional,2,,Actual,629,Both,16 Years,0,,106,2853050698,Drug,623,153,623,382,0.007,0.008,2,,,1636,477,279,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00315328,Completed,Actual,Phase 3,Interventional,2,,Actual,233,Both,7 Years,12 Years,,24,825550705,Drug,,,233,19,0.04,0.01,1,,,1636,477,279,Parallel Assignment,,Open Label,,Treatment,Efficacy Study
NCT00315445,Completed,Actual,Phase 3,Interventional,3,,Actual,134,Both,18 Years,0,,59,4132948223,Drug,134,8,134,92,0.011,0.63,1,,,1636,477,279,Parallel Assignment,,Double Blind,,Treatment,Efficacy Study
NCT00315939,Completed,Actual,N/A,Interventional,2,,Actual,120,Both,18 Years,0,,143,2617365673,Device,,,,,0.001,0.001,1,,,1636,477,279,Crossover Assignment,,Open Label,,,Efficacy Study
NCT00316004,Terminated,Actual,Phase 3,Interventional,3,,Actual,1331,Both,15 Years,0,,70,3572572513,Drug,1282,282,,,0.84,0.91,2,,,1636,477,279,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00316017,Terminated,Actual,Phase 3,Interventional,3,,Actual,895,Both,15 Years,0,,409,3291828913,Drug,852,67,852,3,0.31,0.02,2,,,1636,477,279,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00316173,Completed,Actual,Phase 2,Interventional,1,,Actual,77,Female,18 Years,0,,339,2909107598,Drug,77,18,77,74,,,2,,,1636,477,279,Single Group Assignment,,Open Label,,Treatment,Efficacy Study
NCT00316303,Completed,Actual,Phase 2,Interventional,2,,Actual,236,Both,18 Years,65 Years,,199,2889579184,Drug,,,,,0.011,0.001,1,,,1636,477,279,Parallel Assignment,,Open Label,,Treatment,Efficacy Study
NCT00317642,Completed,Actual,Phase 3,Interventional,2,,Actual,326,Both,55 Years,0,,4,3894681620,Drug,632,346,632,630,0.0001,0.0001,5,,,1636,477,279,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00318565,Completed,Actual,Phase 4,Interventional,1,,Actual,291,Both,18 Years,0,,52,3316240768,Device,267,4,267,73,0.05,0.05,1,,,1636,477,279,Single Group Assignment,,Open Label,,Treatment,Safety/Efficacy Study
NCT00319644,Completed,Actual,N/A,Interventional,2,,Actual,37,Both,18 Years,0,,460,3209578115,Device,,,37,2,0.26,0.26,1,,,1636,477,279,Single Group Assignment,,Open Label,,Diagnostic,Efficacy Study
NCT00319982,Completed,Actual,Phase 2/Phase 3,Interventional,2,,Actual,39,Both,5 Years,39 Years,,234,4143189883,Drug,,,38,22,0.08,0.06,1,,,1636,477,279,Parallel Assignment,,Double Blind,,Treatment,Safety/Efficacy Study
NCT00320112,Completed,Actual,Phase 3,Interventional,2,,Actual,244,Both,21 Years,0,,138,2883582343,Behavioral,244,3,,,0.91,0.1,1,,,1636,477,279,Parallel Assignment,,Open Label,,,Efficacy Study
NCT00320385,Completed,Actual,Phase 3,Interventional,2,,Actual,296,Female,18 Years,0,,313,1776861857,Drug,295,64,295,272,0.008,0.46,13,,,1636,477,279,Parallel Assignment,,Open Label,,Treatment,Safety/Efficacy Study